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English Abstract
A novel system mimicking the ﬁrst steps of integrin-mediated cell spreading
was developed and characterized. This was achieved by reconstituting the
transmembrane protein integrin αIIbβ3 into giant unilamellar vesicles (GUVs).
The method consisted of a detergent-mediated reconstitution of solubilized
integrins into small proteoliposomes (0.1 - 0.2 µm in size) followed by elec-
troswelling of a partially dried ﬁlm of the same proteoliposomes. The reconsti-
tution process was validated by analyzing protein incorporation and biological
activity. Biological activity of integrin in GUVs was also conﬁrmed by adhesion
tests using biofunctionalized surface. The adhesion dynamics was studied ex-
perimentally and the results compared to theoretical predictions. The adhesion
started with the spontaneous formation of several small (∼ 200 nm) domains
of tight adhesion, which grew and eventually fuse to form a ring-shaped adhe-
sive patch at the border of the contact zone. This ring grew toward the center
until it formed a uniformly adhering zone. Three distinct regimes were iden-
tiﬁed: For the ﬁrst regime, the single adhesion zones were predicted to grow
with R ∼ t5/8, which agreed well with our experimental data. Disk formation
in the third regime was predicted to proceed with Ri ∼ -t, which matched the
experimental data.
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German Abstract
In dieser Arbeit beschreiben wir zum erstmals ein experimentelles System,
welches die ersten Schritte der Integrin-vermittelten Zelladhäsion nachahmt.
Mit Hilfer einer zuvor in der Gruppe von P. Bassereau entwickelten Methode
haben wir das transmembrane Protein Integrin αIIbβ3 in unilamellare Riesen-
vesikel rekonstituiert. Die Methode besteht aus einer Detergenz-vermittelten
Rekonstitution in kleine Proteoliposomen (Durchmesser 0,1 -0,2 µm). Im An-
schluß werden diese Riesenvesikell mittels Elektroformation aus einem teilweise
getrockneten Film dieser Proteoliposome erzeugt. Konfokalmikroskopische
Untersuchungen zeigten, dass die ﬂuoreszenzmarkierten Proteine homogen in
die Riesenvesikel eingebracht wurden. Die Funktionalität des Integrins wurde
mit Hilfe eines ELISA-Tests (enzyme-linked immunosorbent assay) auf kleinen
Vesikeln überprüft. Eine speziﬁsche Wechselwirkung zwischen in kleine Vesikel
eingebrachtes Integrin und RGD-funktional-
isierten Quantum Dots wurde ebenfalls nachgewiesen (RGD ist ein bekannter
Integrin-Ligand). Darüber hinaus belegte der Adhäsionstests auf mit RGD
biofunktionalisierten Oberﬂächen, dass die Proteine ihre biologische Aktivität
auch nach der Elektroformation bewahren.
Im weiteren wurde die Adhäsionsdynamik der Integrin-funktionalisierten Riesen-
vesikel auf RGD-beschichteten Obeﬂächen experimentell untersucht Der Ad-
häsionsprozess kann in drei Sequenzen unterteilt werden, die experimentellen
Daten der Sequenzen 1) und 3) wurden mit theoretischen Modellen verglichen.
Es kann gezeigt werden, dass der Adhäsionsprozess in beiden Regimen durch
die Diﬀusion der Liganden limitiert ist.
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CHAPTER 1
Introduction
More than a century ago, biologists described how cells diﬀerentiate and as-
sociate to form the diﬀerent organs in living organisms. In turn, the cell is
composed of many diﬀerent sub-units (e.g. nucleus, mitochondria, Golgi ap-
paratus, ribosomes,...) which allows the cell to act as a miniature ”factory”.
This tremendous complexity is evident in the depiction of a typical eukaryotic
cell shown in ﬁgure 1.1.
Figure 1.1. A typical eukaryotic cell. It contains intracellular compartments,
such as the nucleus, the Golgi complex, mitochondria, ribosomes and the
endoplasmic reticulum. From [2].
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With the help of speciﬁc receptor proteins, cells can interact with each
other or bind to the extracellular matrix. These interactions permit stable
connections between the millions of cells in a tissue, while still allowing the
tissue to reorganize and adapt in response to external signals. These complex
processes require a huge number of proteins and other specialized molecules.
The objective of this project was to establish a minimal system able to mimic
the ﬁrst stages of a cell undergoing protein-mediated adhesion to another
cell or the extracellular matrix. We decided to focus on integrin αIIbβ3 and
one of its ligands, the RGD-carrying protein ﬁbrinogen, as their molecular and
biochemical properties are fairly well known. The ﬁrst step in integrin-mediated
cell adhesion is thought to be the contact between integrin and ligands bearing
the tripeptide RGD. In this work, we reconstituted integrin αIIbβ3 into giant
unilamellar vesicles (= model cell) and studied their adhesion dynamics on
ﬁbrinogen-covered substrates. Our simple model system represents a ”bottom-
up” approach to study cell adhesion and reproduces several features of this
complex biological process.
Outline:
Although other groups have previously develop model systems, integrin-mediated
adhesion has not previously been studied with a system that closely mimics cell
adhesion. The goal of this study was to prepare such a biomimetic system and
to characterize it both from a functional and a physical point of view.
Chapter 2 reviews the basic biological principals of cell adhesion and spreading.
Integrin-mediated adhesion is a highly complex and regulated process involv-
ing signals from the cytoplasm (inside-out signaling) and ECM (outside-in
signaling), conformational changes of proteins, and biochemical modiﬁcations
(phosphorylation or similar processes). The last part of the chapter focuses
on the integrin family and in particular, integrin αIIbβ3.
Giant Unilamellar Vesicles (GUVs) are a very popular model for cells, as they
share an important feature : the lipid bilayer. Chapter 3 reviews a number of
experimental and theoretical studies of model systems containing lipid bilayers.
Over the years biomimetic models of the cell membrane have been improved
and complexiﬁed in order to better mimic biological cells.
The experimental and theoretical framework that inspired us to develop our
biomimetic system are described in chapter 4. The work of the group of Prof.
Sackmann (TU Munich, Germany) was particularly important in allowing us
to develop our biomimetic system of integrin-mediated cell adhesion, but the
experimental work and the theoretical framework of other studies are also pre-
sented in this chapter.
In Chapter 5, we describe the reconstitution of integrin αIIbβ3 into Giant Unil-
amellar Vesicles. The ﬁnal protocol, the diﬀerent trials to obtain a satisfactory
result, and the assays to prove protein incorporation and functionality are all
described. The aspects of proteoliposome preparation which proved to be im-
portant for the successful reconstitution of integrin αIIbβ3 are also discussed.
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Chapter 6 describes the adhesion dynamics of the integrin-containing vesicles
and the theoretical models of this process. Three diﬀerent stages of adhesion
are identiﬁed and the ﬁrst and the last stages are discussed in detail.
The conclusion can be found in chapter 7.
In appendix B we present the experimental techniques used in this work.
Materials and methods can be found in appendix A.
Detailed protocols of experiments described in chapter 5 are described in the
appendices C, D, E, and F.
This work greatly beneﬁted from the expertise in the group of Prof. Sack-
mann concerning the puriﬁcation of integrin αIIbβ3. This was combined with
the protocol developed by Girard et al. [3] which was adapted and enhanced
in order to reconstitute the integrin αIIbβ3 into giant unilamellar vesicles.
The presented project encountered several administrative and technical
challenges which had to be overcome. First, insuﬃcient amounts of human
blood, needed for the puriﬁcation of integrin αIIbβ3, were available in France.
While the Red Cross in Germany was able to help us out, because it was not
possible to get authorization to bring blood plasma to France we had to ﬁnd
a lab in Germany which was equipped for such a puriﬁcation procedure and
was willing to host us. We are very thankful that the E22 laboratory at TU
Munich hosted us repeatedly and made its lab and expertise available to us.
The continuous help and readiness of Monika Rusp and Michael Bärmann were
indispensable for the success of the puriﬁcation.
The integrin αIIbβ3 is a very large and fragile protein. Due to a limited life
time of only 6 months after puriﬁcation, we had to call upon this support on
a regular basis.
Puriﬁcation and functionality testing turned out to be diﬃcult and time con-
suming. Frequently, the puriﬁcation process either did not yield integrin or only
in insuﬃcient concentration or quality. Finally, GUVs could not be obtained as
reproducibly as had been the case for simpler transmembrane proteins studied
earlier [3], [4]. In combination, these diﬃculties made this project especially
challenging and we were unable to achieve all of our initial research goals.
However, we still succeeded reconstituting functional integrin into giant unil-
amellar vesicles which allowed us to then study the dynamics of their adhesion
onto ﬁbrinogen-coated substrates.
3
CHAPTER 1. INTRODUCTION
4
CHAPTER 2
Cell Adhesion Molecules and Integrins
Nota bene! A glossary with biological terms that might not be familiar to the
reader can be found in section D. Words listed in the glossary are marked with
a * in the text.
A Aspects of Cell Adhesion
Cell adhesion is crucial for the assembly of individual cells into three-dimensional
tissues as well as for dynamic processes such as wound healing or cell migration.
Cells do not simply ”stick” together to form tissues, but are instead organized
into very diverse and highly distinctive patterns. Tissue is constantly reorganiz-
ing via detachment and reattachment of cells, especially during development.
A variety of cell adhesion mechanisms are responsible for assembling and reor-
ganizing cells and, together with their connections to the cytoskeleton and the
extracellular matrix, help determine the overall architecture of the tissue. The
following section describes how this architecture is generated and maintained.
Typically, the functional units of cell adhesion are multi-protein complexes
made up of three general classes of proteins (see ﬁgure 2.1 for a simpliﬁed
schematic depiction):
1. cell adhesion molecules (CAMs) / adhesion receptors
2. extracellular matrix (ECM) proteins
3. cytoplasmic proteins
Cell adhesion molecules (CAMs) are usually transmembrane proteins that
mediate binding interactions at the extracellular surface and determine the
5
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speciﬁcity of cell-cell and cell-ECM recognition. They include members of the
integrin, cadherin, immunoglobulin (Ig), selectin, and proteoglycan (for ex-
ample, syndecans) superfamilies.
Figure 2.1. The four predominant families of adhesion molecules are a) cad-
herins, b) immunoglobulin (Ig) superfamily members, c) integrins, d) selectins.
From [5]
On the extracellular side, the cell adhesion receptors recognize and interact
with other cell adhesion molecules on neighboring cells or proteins of the ex-
tracellular matrix (ECM). ECM proteins are large glycoproteins, including the
collagens, ﬁbronectins, laminins, and proteoglycans that assemble into ﬁbrils
or other complex macromolecular arrays. Owing to their binding to adhesion
receptors, they can also be tightly associated with the cell surface. Figure 2.2
shows examples of adhesive interactions at diﬀerent locations on a cell.
At the intracellular surface of the plasma membrane, cell adhesion receptors
associate with cytoplasmic plaque* or peripheral membrane proteins. Cyto-
plasmic plaque proteins serve to link the adhesion systems to the cytoskeleton,
to regulate the functions of the adhesion molecules, and transduce signals ini-
tiated at the cell surface by the adhesion receptors.
6
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Figure 2.2. CAMs form diﬀerent forms of adhesive interactions at diﬀerent
locations on the cell. From [6].
Maintaining a Tissue's Three-Dimensional Structure
Stable cell-cell connections are essential for maintaining the three-dimensional
architecture of tissue. Although adhesive contacts between cells or between
cells and the neighbouring tissue are generally stable, they should not be re-
garded as static, and in many cases the maintenance of stable connections
requires active cellular processes. This will be discuss in connection with the
protein class of integrins as they are of major interest for the presented project.
B The Integrins
Integrins are the major metazoan receptors for cell adhesion to extracellular
matrix proteins and in vertebrates also play important roles in certain cell-cell
adhesions. A schematic representation is presented in ﬁgure 2.3.
In addition to mediating cell adhesion, integrins make transmembrane connec-
tions to the cytoskeleton and activate many intracellular signaling pathways.
Since the recognition of the integrin receptor family nearly 20 years ago [7],
they have become the best-understood cell adhesion receptors. Integrins and
their ligands play key roles in development, immune responses, leukocyte* traf-
ﬁcking, hemostasis, and cancer and malfunctioning or misregulated integrins
are at the heart of many human diseases, including genetic, autoimmune, and
other disorders. They are the target of eﬀective therapeutic drugs against
7
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thrombosis and inﬂammation, and they are receptors for many viruses and
bacteria.
Figure 2.3. The typical structure of an integrin. From [8].
Integrins are restricted to the metazoa; no homologs are detected in
prokaryotes, plants, or fungi [9]. The simplest metazoa, sponges and cnidaria*,
have integrins [10], [11] and it is clear that primitive bilateria had at least two
integrin αβ heterodimers, the descendents of which persist to this day in or-
ganisms as diverse as ﬂies, nematodes, and vertebrates [12]. In mammals,
19 α and 8 β subunits have been characterized, whereas the Drosophila and
Caenorhabditis genomes encode only ﬁve α and two β subunits [13] (see ﬁgure
2.4 for an overview of currently known integrins).
A single β chain can interact with multiple α chains, forming integrins that
bind to diﬀerent ligands (see ﬁgure 2.4). The heterodimer complex requires
divalent ions (Ca2+ or Mg2+, depending on the integrin) reﬂecting the presence
of divalent-cation binding domains in the extracellular part of the α and β
subunits. The type of divalent cation can inﬂuence both the aﬃnity and the
8
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Figure 2.4. α and β subunits pair to form the large family of integrins. From
[14].
speciﬁcity of the binding of an integrin to its ligand.
Most integrins are expressed on a variety of cells, and most cells express
several integrins, enabling them to bind to several matrix molecules.
Integrins typically exhibit relatively low aﬃnities for their ligands (dissoci-
ation constants KD between 10
−6 and 10−8 mol/L) compared with the high
aﬃnities (KD values of 10
−9 and 10−11 mol/L) for typical cell - surface hor-
mone receptors. However, the multiple weak interactions generated by binding
of hundreds or thousands of integrin molecules to ECM proteins allow a cell to
remain ﬁrmly anchored to the matrix. Alternatively, in situations where cells
are migrating, it is essential that the cells are able to make and break contacts
with the ECM and this is facilitated if individual contacts are weak. Cells that
express several diﬀerent integrins that bind the same ligand often can selec-
tively regulate the activity of each type of integrin, thereby ﬁne-tuning their
interaction with the matrix (see table 2.1).
B.1 The Integrin αIIbβ3
The integrin αIIbβ3 (GPIIb/IIIa following an old nomenclature) is the most
abundant transmembrane protein on platelets* [15]. 3 % of the overall pro-
tein amount and 17 % of the membrane protein amount of the platelets is
9
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The Integrin Receptor Family ∗
Subunits Ligands and Counterreceptors
β1 α1 collagens, laminin
α2 collagens, laminin
α3 ﬁbronectin, laminin, collagens
α4 ﬁbronectin, VCAM-1
α5 ﬁbronectin
α6 laminin
α7 laminin
α8 ﬁbronectin, osteopontin
αV vitronectin, ﬁbronectin
β2 αL ICAM-1, ICAM-2
αM C3b, ﬁbrinogen, factor X, ICAM-1
αX ﬁbrinogen, C3b
β3 αIIb ﬁbrinogen, ﬁbronectin, von Willebrand factor,
vitronectin, thrombospondin
αV vitronectin, ﬁbrinogen, von Willebrand factor,
thrombospondin, ﬁbronectin, osteopontin, collagen
β4 α6 laminin, ﬁbronectin type III
β5 αV vitronectin
β6 αV ﬁbronectin
β7 αV ﬁbronectin, VCAM-1
Table 2.1. Some examples for αβ combinations which form integrins and
their counterreceptors. From [8].
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αIIbβ3 [16]. Their abundance on platelets make them very accessible for
puriﬁcation (from outdated platelet donations.) Depending on the source, an
intact platelet contains on average 40.000 to 100.000 integrin complexes [15],
[17]. The average diameter of a platelet ranges from 1.5 to 3 µm.
The integrin αIIbβ3 exists as a dimer on platelets, and 1:1 stoichiometry is
also preserved after puriﬁcation in the presence of detergent. The α - subunit
has a size of 136 kDa, the β - subunit 92 kDa. Figure 2.5 shows a surface
shaded 3D density map of the integrin αIIbβ3.
Figure 2.5. Surface-shaded 3D density map of the αIIbβ3 heterodimer at 2
nm resolution. The dimensions and domains are indicated. It is presumed that
the cleft in the neck domain separates the αIIb and β3 subunits, and the larger
lobe of the cytoplasmic domain corresponds to the C tail of the β3 subunit
which is twice the size of the αIIb C tail. The model has been oriented so that
the putative transmembrane rod is roughly perpendicular to the membrane
(boxed area, 3 nm thick). From [18]
The integrin αIIbβ3 is essential for blood coagulation due to its ability to
bind to RGD*-containing ligands in an activated state. However, the selec-
tive ligand recognition by RGD-binding integrins like αIIbβ3 is determined by
additional sequence motifs in the recognition epitope in the structural frame-
work of the ECM. The integrin αIIbβ3 speciﬁcally recognizes the RGD-motif
of ﬁbrinogen*, but also a non - RGD decapeptide sequence of the γ - chain
of ﬁbrinogen [19], [20].
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Glanzmann's thrombasthenia demonstrates the important role of intact inte-
grin αIIbβ3 on platelets. Patients with this rare hereditary bleeding disorder
caused by a genetic defect have platelets less able to adhere to each other and
to the underlying tissue of damaged blood vessel. As a result, platelets fail to
form a plug at the site of an injury, and bleeding time is signiﬁcantly prolonged.
B.1.1 Activation and Binding
The integrin αIIbβ3 is a Ca
2+-dependent complex in vivo. However, in vitro
addition of Mn2+ or removal of Ca2+ strikingly increases (2-3 fold) ligand
binding aﬃnity and adhesiveness compared to adhesiveness in the presence of
Mg2+ + Ca2+ [21], [22]. Furthermore, it was shown that activation can be
mimicked in vitro by cations such as Mn2+ or Mg2+, whereas Ca2+ typically
favors the inactive state [23]. The diﬀerent eﬀects of these cations are re-
lated to their diﬀerential abilities to induce the integrin to undergo structure
changes involved in activation. An unusual feature compared to other adhesion
molecules is that the activation (e.g. in integrins αIIbβ3 on platelets) happens
on a short timescale of <1 s. [24]
In vivo, integrin αIIbβ3 binds soluble ﬁbrinogen only after platelet activa-
tion (see section B.2.2) by antagonists like ATP or thrombin [25], whereas
interaction with immobilized ligand can occur with nonactivated platelets [26].
In vitro, integrin αIIbβ3 can be fully activated, since soluble, monomeric ﬁb-
rinogen exhibits the same binding characteristics as measured for αIIbβ3 on
native platelets [27]. Binding of antibodies has been shown to change the
aﬃnity of integrins for various ligands [28], [29]. But because antibodies also
were able to cluster the integrin molecules, the mechanism of activation re-
mains unclear. Experiments with monovalent FAB (fragment antigen binding)
fragments suggested that clustering was not necessary for activation [30], al-
though this notion was later challenged by additional experiments indicating
that clustering is essential for ligand binding [31]. The structural basis of the
activation process remains the subject of lively discussion [13], [32], [33], [34],
[35], [36].
The integrin αIIbβ3, reconstituted into a planar lipid bilayer [37], binds
ligand via a two-step mechanism, comprised of an initial reversible and a sub-
sequent irreversible step. Analysis of the binding kinetics with surface plasmon
resonance and immobilized integrin molecules conﬁrmed these observations
[38]. The initial reversible complex, the result of a low-aﬃnity interaction with
an equilibrium dissociation constant Kd = 155-180 nM, is slowly converted
into a more stable and irreversible complex which binds ﬁbrinogen with higher
aﬃnity (Kd = 20-70 nM). This irreversible binding event was also observed in
the physiological interaction between activated platelets and ﬁbrinogen [27].
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B.2 Examples of the Role of Integrin: Leukocytes and Platelets
The dynamic aspects of cell adhesion described brieﬂy above underline the
need to regulate cell adhesions receptors at the cell surface. Many diﬀerent
adhesion receptors among them the class of integrins are known to be subject
to regulation, as they control complex and very dynamic processes (for example
reorganization and diﬀerentiation during tissue development). Integrins are
known to be regulated at several levels [39], [40].
Modulation of the aﬃnity of the adhesion receptor for ligand (called aﬃn-
ity modulation) is a very important mechanism for the activation of platelet
aggregation and is thought to underlie activation of leukocyte adhesion (ﬁgure
2.6C) which will be described below. Adhesive strengthening by the cluster-
ing of adhesion receptors or by cytoskeletal-dependent processes such as cell
spreading (ﬁgure 2.6B) is known to be crucial for strong cell attachment, the
control of cell growth, and cell motility. These regulatory changes occur ei-
ther in response to intracellular events (hence, sometimes called inside-out
signaling), as a result of EC ligand binding (often called post-receptor occu-
pancy events), or in many instances from both. Some integrins are subject to
multiple levels of regulation (see below).
B.2.1 Inﬂammation: Leukocyte Adhesion
Tissue damage or injury, characterized by redness, heat, swelling, and pain,
causes a defense reaction of the aﬀected tissue called inﬂammation. The
inﬂammation reaction enables the host to localize and eliminate the irritant
and repair the surrounding tissue. For the survival of the host, inﬂammation
is therefore a necessary process. Leukocyte transmigration through endothe-
lium* and accumulation at the site of injury is a major event in inﬂammation
(see ﬁgure 2.7).
The leukocyte adhesion cascade is a sequence of adhesion and activation
events. After extravasation of the leukocyte (movement out of the circulatory
system toward the site of tissue damage or infection), the cell exerts its eﬀects
(localization, elimination of the irritant, tissue repair) on the inﬂamed site (see
ﬁgure 2.7). The adhesion cascade includes at least ﬁve steps: 1) capture, 2)
rolling, 3) slow rolling, 4) ﬁrm adhesion, and 5) transmigration. Each of these
ﬁve steps appears to be necessary for eﬀective leukocyte recruitment, because
blocking any of the ﬁve can severely reduce leukocyte accumulation in the
tissue.
The ﬁrst contact of a leukocyte with the activated endothelium is called
capture or tethering. Capture occurs after margination*, allowing leukocytes
to move close to the endothelium and away from the central blood stream.
During the inﬂammatory response endothelial activation is required to initiate
capture.
P-selectin on endothelial cells is the primary adhesion molecule for capture
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Figure 2.6. Mechanisms for regulating the binding activities of adhesion recep-
tors (A) Aﬃnity modulation. A conformational change in the EC adhesion-
binding site occurs in response to intracellular signals. The conformational
change is propagated from the cytoplasmic tail to the EC domain and is prob-
ably triggered by unknown cytoplasmic tail-binding proteins. (B) Adhesion
receptor clustering and cytoskeletal interactions are associated with the de-
velopment of extensive tight adhesion, such as spreading and focal adhesion*
formation. (C) Diﬀerent adhesive states exhibited by β1 integrins during lym-
phocyte endothelial interactions under conditions of ﬂow. In the inactivated
state, the integrin can mediate tethering and rolling, which probably repre-
sents weaker attachments with high on and oﬀ rates. The same integrin can
be activated to mediate arrest and tight binding. From [41].
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Figure 2.7. Inﬂammation: The leukocyte adhesion cascade. From [42].
and the initiation of rolling. The main leukocyte ligand for P-selectin is PSGL-
1 (P-Selectin Glycoprotein Ligand-1).
After capture leukocytes transiently adhere to the venular endothelium
and begin to roll. Rolling occurs at or below the velocity of freely ﬂowing cells
like erythrocytes in the same radial position in the same vessel. The selectin
family of transmembrane adhesion receptors mediates this rolling process. P-
selectin is the most important selectin involved in rolling and it can support
both capture and rolling in the absence of L-selectin. Upon stimulation, P-
selectin is rapidly surface-expressed on the venular endothelium, and it makes
the endothelium ”sticky” to leukocytes. PSGL-1 is constitutively expressed
on all lymphocytes, monocytes, eosinophils, and neutrophils. During rolling,
bonds are formed at the leading edge of the rolling cell and broken at the
trailing edge.
L-selectin and E-selectin also take part in the rolling process. L-selectin is
necessary for the normal inﬂammatory response in capturing leukocytes and
initiating rolling. E-selectin is thought to be responsible for slow rolling inter-
actions below 5 µm/s and possibly for the initiation of ﬁrm adhesion.
The key parameters in determining the success of the recruitment process
as reﬂected in ﬁrm adhesion are 1.) the time that the leukocyte takes to
pass through the microcirculation and 2.) the time during which it is in close
proximity with the endothelium. The important role of leukocyte transit time
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is dependant on chemokines, a class of cytokines*, that are presented on the
endothelial surface and are likely to be accessible to a leukocyte as long as
it rolls. Rolling leukocytes are likely to be activated by these surface-bound
chemoattractants and through adhesion molecule-based signaling.
E-selectin also participates in the conversion of rolling to ﬁrm adhesion. In
cytokine-induced inﬂammation, slow-rolling leukocytes do not stop abruptly,
but show a gradual decrease of their rolling velocity before becoming adherent
[43]. This deceleration is strictly dependent on CD18 integrins. Since rolling
leukocytes show a graded elevation of intracellular free calcium as rolling slows,
it appears that rolling leukocytes are partially activated before arrest. This
process takes place on a times scale of one minute or more.
Leukocytesmigrate across the resting endothelium if an exogenous chemoat-
tractant is present. Integrins play an important role in this process, which has
been termed ”leukocyte driven” or chemotactic transmigration. The patho-
physiological characteristic of established inﬂammatory transmigration is en-
dothelial activation, an event requiring transcription and protein synthesis. As
a result, adhesion molecules are upregulated. Upregulation means that they
are activated and become more adhesive to their receptor, probably due to a
conformational change of the protein.
Inﬂammatory mediators are produced and the endothelium secretes chemoat-
tractants, all of which contribute to transmigration. The stimulus for en-
dothelial activation in vivo is probably local production of cytokines and other
inﬂammatory mediators released on tissue injury.
A number of adhesion molecules have been implicated in transmigration(for
example PECAM-1, ICAM-1, VE-cadherin, CD11a/CD18 (LFA-1), IAP (CD47)
and VLA-4 integin), although the level of conﬁdence in their actual involve-
ment varies .
It has been recently shown that a single type of integrin can mediate all
adhesive phases including the initial tethering and rolling. For example, α4β1
(VLA4) mediates tethering and rolling on vascular cell adhesion molecule 1
(VCAM-1), an endothelial integrin ligand belonging to the immunoglobulin
superfamily [44]. As expected, this integrin can also become activated to
bring about arrest and tight adhesion. Thus, prior to activation, the integrin
exhibits binding properties that support tethering and rolling.
The spectrum of behaviors exhibited by leukocytes under shear ﬂow and in
responses to physiological stimuli highlight the diversity of mechanism that cells
can use to regulate the dynamics of adhesion. It is possible that similar mech-
anisms are relevant to the problems of cell motility and cell rearrangements in
tissue morphogenesis. A comprehensive illustration of the processes involved
in leukocyte rolling and capture emphasizing the inside-out and outside-in sig-
naling is shown in ﬁgure 2.8.
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Figure 2.8. Leukocyte rolling and capture A) Selectin ligands on the leukocyte
(yellow and purple) bind to selectins (blue) (homophilic* interaction), and low
aﬃnity integrins on the leukocyte (green) interact with ICAMs (pale yellow)
on the endothelial surface facilitating cell tethering and rolling. Together with
chemokines, this generates inside-out signals (yellow arrows) that shift the
bound integrins to a high-aﬃnity ligand-binding state. B) Leukocyte arrest is
mediated by clustered high-aﬃnity integrins (red) binding to ICAMs on the en-
dothelial cells. These protein clusters can signal outside-in to aﬀect functions
such as cell polarization and migration. From [45].
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B.2.2 Injury: Platelet Adhesion
At the site of injuries, the hemostatic plug closing the wound is initially formed
through platelet adhesion. When injury occurs to the endothelium, platelets
leave the blood vessel. Under the high shear ﬂow stress at the site of injury
they come in contact with and adhere to subendothelial tissues (see ﬁgure
2.9). Platelet adhesion is mediated by von Willebrand Factor (vWF)*, forming
bridges or connections between the integrin αIIbβ3 and components on the
subendothelium (mostly collagen ﬁbers). Recently, it was shown that shear-
induced unfolding of vWF triggers adhesion [46]. The process continues with
attachment of platelet receptors to several adhesive proteins in the matrix of
the connective tissue. Other platelets spread in a similar fashion, covering the
collagen surface with a single layer of platelets.
Figure 2.9. Platelet activation: A) Normal platelets ﬂow in the blood stream
without adhering. B) When the endothelial is damaged, platelets adhere and
undergo activation. C) Platelets aggregate at the site of injury, forming a
hemostatic plug. From [47].
When platelets adhere to collagen ﬁbers in the subendothelium, a series of
morphologic and functional changes known as activation occurs. Though not
fully understood, platelet activation involves changes to platelet metabolic bio-
chemistry, shape, surface receptors, and membrane phospholipid orientation.
Platelets can be activated by many mechanisms. Most of the substances re-
leased by these cells (in particular adenosine diphosphate, serotonin, thrombox-
ane and others) can, in an autocrine (relased by the cell itself) and paracrine
(released by a neighboring cell) fashion, further enhance platelet activation
and aggregation. During activation of the coagulation cascade, thrombin is
formed, which also markedly stimulates platelet activation. The activation of
the the platelet surface molecule integrin αIIbβ3 is most important.
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One of the biochemical changes that occurs within the platelet is an in-
crease in internal calcium levels. When these levels reach a threshold a change
in the shape of the platelet occurs. The activated platelet is transformed from
a disc-shaped cell to a sphere with spiny projections called pseudopods. This
change in shape results in an increase in the surface area available for bio-
chemical reactions and increased chance of contact with other platelets. As
they change shape platelets spread over the surface of the collagen to which
they adhere, ﬁlling in the spaces between pseudopods.
During platelet activation, integrin αIIbβ3 is activated. Activation also
causes a ”change” in the membrane surface. This change enables ﬁbrin-
forming proteins (coagulation factors) to bind to the membrane.
The major platelet integrin αIIbβ3 is thought to be activated by aﬃn-
ity modulation [48], [49]. These proteins have been shown to undergo con-
formational changes during activation, as detected by antibody binding to
activation-induced epitopes. Moreover, ligand binding studies indicate that
these conformational changes are associated with changes in binding aﬃnity.
In fact, many integrins can be activated by the binding of certain monoclonal
antibodies, presumably because the antibodies favor binding to the activated
conformations of the molecules.
During platelet activation the integrin αIIbβ3 is converted to a high aﬃnity
state for binding to soluble ﬁbrinogen or von Willebrand factor. This regula-
tory event is very important, of course, to prevent circulating platelets from
aggregating in the absence of an appropriate hemostatic stimulus. αIIbβ3
can, however, mediate the adhesion of inactivated platelets to immobilized
ﬁbrinogen, presumably to facilitate recruitment of platelets to a preexisting
hemostatic platelet plug. This demonstrates the important point that the in-
activated αIIbβ3 is not truly an inactive or nonfunctional molecule, but rather
that activation causes the conversion of a functional adhesion receptor to a
diﬀerent aﬃnity state or binding speciﬁcity.
The molecular mechanisms underlying aﬃnity modulation are only partially
understood. Although activation by physiological signals must normally be ini-
tiated in the cytoplasm, the conformational change underlying the change in
ﬁbrinogen binding aﬃnity can be triggered in isolated αIIbβ3 molecules by bind-
ing of activating antibodies. The propagation of the conformational change
can occur at long range over the length of the molecule, since the activat-
ing antibodies bind to the ”stalk” region near the membrane anchor, while
the ligand-binding region of αIIbβ3 is known to reside at the distal ”head” of
the protein. This is consistent with the hypothesis that structural alterations
in the integrin cytoplasmic tails are somehow propagated across the mem-
brane to induce conformational changes at the ligand-binding sites. Indeed,
there is abundant evidence that the cytoplasmic tails of αIIbβ3 and leukocyte
β2 integrins control the aﬃnities or the adhesive states (or both) of the EC
domains [50]. It is likely that speciﬁc cytoplasmic tail binding proteins are in-
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volved in regulation, since overexpression of isolated cytoplasmic tail domains
speciﬁcally inhibit activation of αIIbβ3 [51]. Thusfar, the identity of such
a protein is unknown; it is not clear whether the known cytoplasmic plaque
integrin-binding proteins, such as talin, α-actinin*, paxillin, or focal adhesion
Tyr kinase* (FAK), or novel unknown proteins are required for regulating aﬃn-
ity.
Following platelet activation, formation of the primary hemostatic plug
continues with platelet aggregation. This is the phase in which activated
platelets become attached to one another. After the release of agonists such
as adenosine diphosphate (ADP) by platelets and the injured vessels, platelets
undergo a change in shape and integrin αIIbβ3 receptor sites become ex-
posed. These changes enable the activated platelet to stick readily to those
adhering to collagen. Aggregation takes place in two phases. In the primary
phase, platelets attach loosely and, if the agonist stimulus is weak, they can
be separated. The secondary phase requires a longer period of time in which
platelets release their own ADP, further stimulating the aggregation process.
When activation and primary adhesion have been achieved, platelets discharge
their granule contents. Granule contents include ADP, adenosine triphosphate
(ATP), serotonin, calcium, vWF, Factor V, and ﬁbrinogen. The secreted sub-
stances further promote formation of the platelet plug by means of stimulating
other platelets to adhere, aggregate and secrete.
C Cell Spreading and Reorganization in vitro
The goal of this thesis was to mimic integrin-mediated cell adhesion. There-
fore, several steps involved in cell spreading are discussed below. Cell-cell or
cell-ECM adhesion has been described in classical molecular biology textbooks
for many years [8], [52]. However, the detailed underlying molecular processes
which are responsible for signaling between the cell and its surrounding en-
vironment are often only poorly understood. Physical and biological in vitro
experiments provide insights into the mechanisms of cell spreading and signal-
ing. Some relevant results will be described here.
Recently it was shown by Cuvelier et al. that the very early steps of cell
spreading dynamics follows a universal power-law behavior that is indepen-
dent of adhesion molecules or substrate properties, and applies to various cell
types [53]. The spreading dynamics of several cell types (wild-type and mu-
tant) were studied after contact initiation and preceding cell polarization. The
growth rate of adhesion zones was unaﬀected by the concentration of adhesive
molecules on the substrate and was shown to be uniform among diﬀerent cell
types (see ﬁgure 2.10). The authors suggest that the complex mechanisms of
cell spreading are ultimately limited by collective aspects of the cell's material
properties, such as its geometry and thermodynamic and mechanical proper-
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ties. During the early stages of adhesion, cells can be eﬀectively modeled as
a viscous adhesive cortical shell enclosing a less viscous interior. Thus their
behavior appears to be independent of the complex biochemical interaction
and signaling cascade that will set in shortly afterward. It was found that the
contact radius follows an initial diﬀusive regime summarized by the scaling law
R ∼ t 12 before slowing down to a sub-diﬀusive behavior, R ∼ t 14 .
Figure 2.10. The growth of adhesive patches during early stages of spread-
ing exhibits a universal power law that is independent of cell type, substrate,
and adhesion receptors. The following cells are shown: black square: HeLa
cell/ﬁbronectin (1 mg/µl) substrate, green triangle: E-cadherin S180 cell/E-
cadherin substrate, red circle: Cdc42DN S180 cell/ﬁbronectin substrate, pur-
ple square: nocodazol-treated HeLa cell/ﬁbronectin substrate, blue trian-
gle: HeLa cell/polylysine substrate, and orange circle: biotinylated red blood
cell/streptavidin. From [53].
Shortly after this ﬁrst contact between the cell and the underlying sub-
strate mimicking the ECM, a complex, tightly regulated process switches on,
which further controls the cell spreading. Depending on the chemical and phys-
ical properties of the substrate, the cell responds with spreading, proliferation,
diﬀerentiation or apoptosis. The cell attaches to the ECM, and regulates
the adhesion-mediated signaling via focal adhesions and similar structures.
Through cytoplasmic anchor proteins, integrin receptors link the actin* cy-
toskeleton to the ECM, usually through RGD-motifs. Integrins are found to
cluster in focal adhesions. Complex pathways are involved, including protein
activation or conformation change of focal adhesion molecules as well as pro-
teins of the cytoplasm and the ECM. Focal adhesion signaling can occur in
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both directions (inside-out and outside-in) and inﬂuences these proteins, the
reorganization of actin cytoskeleton on the inside of the cell and the adhesion
molecules on the outside of the cell.
In order to understand these complex biochemical processes, one approach
is to develop substrates which can be functionalized and controlled on micro-
or nanometer scale in order to mimic eﬃciently the ECM. The group of J.
Spatz. developed a substrate consting of a nanopattern of gold dots func-
tionalized with an RGD-motif that is recognized by numerous integrins [54]
(see ﬁgure 2.11). For geometric reasons, the size of a functionalized gold dot
allows the binding of only one integrin. Using such precise tools, they found
a universal length scale for integrin clustering and activation that is within
the range of 58 to 73 nm. A separation larger than 73 nm between adhesive
dots results in limited cell attachment and spreading, and dramatically reduces
the formation of focal adhesions and actin stress ﬁbers. Separations smaller
than 73 nm between the dots allowed eﬀective adhesion. This result can not
attributed to an insuﬃcient number of ligands but rather to the restriction
of integrin clustering. The same length scale was found for several cell types
indicating a universal spacing for eﬀective adhesion mediated by integrins. Re-
cent developments permit transfer of the gold patterns to almost any type of
soft surface [55], thereby allowing considerable control of surface properties
which are known to have an impact on cellular responses [56]. Furthermore,
nanopatterns have been prepared on non-planar surfaces such as curved glass
ﬁbers with varying diameters. The universal scale length of the range of 58 to
73 nm has been conﬁrmed in such experiments [57].
Integrins are associated via their cytoplasmic domains with a protein com-
plex including vinculin, talin, paxillin, tensin and many other proteins (for a
schematic description see [58]) which are all involved in the dynamic associ-
ation with actin ﬁlaments. Integrins are found in several complex structures
including dot-like complexes (0.5 -1 µm) at the edge of lamellipodia known as
focal complexes and elongated (3-10 µm in length) streak-like structures (fo-
cal contacts or focal adhesions) which are associated with actin- and myosin-
containing stress ﬁbers. The bundles of actin ﬁlaments lie adjacent to the
adhesion complexes, oriented parallel to the membrane [8]. The actin is con-
nected to an extensive trans-cellular network. This network can contract with
the help of myosin motor proteins during processes such as cell motion or cell
division.
The detailed molecular architecture of focal contacts remains unknown, al-
though several interaction pathways have been identiﬁed.
Focal complexes are thought to be the precursors for most focal contacts.
Their formation is induced by the small Rho-family* G-protein Rac [59], [60].
It is possible that the attachment to the ECM induces binding of activated
Rac to the membrane [61], where it can stimulate actin polymerization and
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Figure 2.11. Gold nanostructures functionalized with an RGD-motif that is
recognized by integrins on the cell surface. The distance between two gold
dots varies, 28 nm, 58 nm, 73 nm, 85 nm. No nanostructures are located
on the right side of the images. Cells mark the borderline (white arrows)
between nanostructured areas and areas entirely passivated by PEG. Yellow
arrows indicated quiescent cells. The insets show magniﬁcation of a typical
cell attached to the indicated surface. From [54].
branching*. Rapid actin ﬂow in turn promotes integrin clustering. There
are three partners of Rac mediating these eﬀects: 1) type PIP 5-kinase α
which catalyzes PIP2 production, leading to uncapping of actin ﬁlaments, 2)
IRSp53 protein activating WAVE/Scar, which in turn activates actin ﬁlament
nucleation via Arp2/3 complex and 3) the serine-threonine kinase PAK. These
details are mentioned above to illustrate the multitude of proteins involved in
the process and underline the complexity of focal complex formation. However
they shall not be commented upon in further depth. Transformation of focal
complexes into focal contacts requires the activation of Rho, but the mech-
anism is still poorly understood [60], [62]. Active Rho has multiple targets
which modulate some functions of the actin cytoskeleton, but it appears that
the combined action of just two of them, ROCK and mDia1 is suﬃcient to
substitute for Rho in the process of focal contact assembly [63] (see ﬁgure
2.12).
The main function of the ROCK-dependent pathway is to activate myosin-
II-driven cell contractility through the augmentation of phosphorylation* of
myosin II regulatory light chain (MLC). The level of MLC phosphorylation
is controlled by balanced phosphorylation by MLC kinase (MLCK) and de-
phophorylation by MLC phosphotase (MLCP). This induces a conformational
change of ROCK. In addition, ROCK can directly activate contractility by
phophorylating MLC just like MLCK [64], [65]. The mDia1-dependent path-
way includes activation of actin polymerization (both locally, in the proximity of
the growing focal contact, and globally, in distal regions) and possibly target-
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Figure 2.12. Rho-dependent growth of focal contacts. Rho induces for-
mation of the focal contacts by activating two essential pathways: ROCK
dependent (shown in yellow) and mDia1-dependent (shown in green). IN the
presence of active mDia1, the application of a force triggers the growth of the
focal contact (black box). Three hypothetical models are suggested: a) The
”perturbation-recovery” model, b)the ”sorting” model, c) the ”conformational
switch” model. ROCK and mDia1 are suﬃcient to substitute for Rho in
the process of focal contact assembly. All are explained further in the text.
Mt=microtubule. From [63].
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ing of microtubules and subsequent microtubule-dependent delivery of certain
components. As for ROCK, this includes a conformational change, activating
the protein for interaction with various downstream targets (see ﬁgure 2.12).
Other possible targets for Dia action are microtubules. Thus it is possible that
microtubule-dependent processes regulated by Dia might aﬀect focal contact
assembly [66].
The formation and stability of focal contacts depends strictly on myosin-II-
driven contractility. For example, chemical inhibitors of MLC phosphorylation
suppress focal contact and stress ﬁber formation. This sensitivity to myosin
II inhibition is a characteristic feature of focal contacts discriminating them
from other types of actin-integrin adhesion complexes.
The phosphorylation pathway for ROCK can be bypassed if a force is ap-
plied externally, if mDia1 is active, application of tension force triggers the
growth of the focal contact [67]. The molecular mechanism of the force-
induced focal contact growth is not clear, but experiments with force applica-
tion by micropipette showed that force-dependent regulation of focal contact
assembly is a local process. In non-motile cells it was shown that the size
of the contact depends on the force applied to it, and the force per unit area
remained constant (about 5 nN/µm2). Microtuble ends are often inserted into
regions of leading lamella where focal contact formation occurs [68], [69]. Dis-
ruption of microtubules increases tension and promotes focal contact growth,
whereas growth of microtubules in the proximity of contact sites induces local
relaxation of tension and suppresses focal contact growth [69], [70]. Thus a
correlation between applied tension and protein recrutement seems to exist.
Three hypothetical models suggesting how such a ”mechanosensory switch”
might work to induce focal contact growth are depicted in the bottom part
of ﬁgure 2.12. (a) The ”perturbation-recovery” model suggests that force
applied to focal contacts perturbs the integrity of the protein meshwork as-
sociated with the adhesion sites, creating spaces that can accommodate new
subunits. (b) According to the ”sorting” model, force might selectively displace
some components from the adhesion site, changing their molecular microenvi-
ronment. (c) The ”conformational switch” model suggests that force applied
to speciﬁc adhesion-associated mole-
cules might induce conformational changes, leading to their transition into
”active conformation”.Several detailed theoretical models have been proposed
[71], [72].
D Glossary
Some terms that might not be familiar to the reader are brieﬂy explained in
this glossary.
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α actinin:
Actinin is a microﬁlament-binding protein. α-Actinin is necessary for the at-
tachment of actin ﬁlaments to the z-line membrane (the borders that separate
and link sarcomeres (see below) within a muscle) in muscle cells. The func-
tional protein is an anti-parallel dimer, which cross-links the thin ﬁlaments in
adjacent sarcomeres (A sarcomere is the basic unit of a muscle's cross-striated
myoﬁbril (cylindrical organelles, found within muscle cells)), and therefore co-
ordinates contractions between sarcomeres in the horizontal axis.
Actin Filaments:
Actin is an abundant protein that forms ﬁlaments in all eukaryotic cells. It is
the major constituent of the cytoskeleton of all eukaryotic cells and part of
the contractile apparatus of skeletal muscle.
Branching morphogenesis:
Branching morphogenesis is the process in which epithelium invades embryonic
connective tissue (mesenchyme) to form a composite organ (the lung is a
typical example). Complex dynamic interactions between mesenchymal and
epithelial tissues are involved. ECM turnover and cell proliferation occur at
the tips of the buds, while ECM accumulates in the clefts where there is little
growth.
Cnidaria Cnidaria is a phylum containing some 9,000 species of animals
found exclusively in aquatic, mostly marine, environments. Despite their early
appearance in the evolutionary history of animals and their simple morphology,
the modern forms are genetically sophisticated and biochemically complex.
There are four main classes of Cnidaria: 1) Class Anthozoa (anemones, corals,
etc.), 2) Class Scyphozoa (jellyﬁsh), 3) Class Cubozoa (box jellies), and 4)
Class Hydrozoa (Obelia, Aequorea, Portuguese Man o' War, etc.)
Cytokine:
Cytokines are proteins and peptides that are used for cell signaling. They are
produced by animal and plant cells to communicate with other cells. Cytokines
act on cytokine receptors located on the surface of cells. The cytokine family
consists mainly of small, water-soluble proteins and glycoproteins (proteins
with an added sugar chain) with a mass of between 8 and 30 kDa.
Cytoplasmic plaque proteins:
Cell adhesion receptors associate with cytoplasmic plaque or peripheral mem-
brane proteins. Cytoplasmic plaque proteins serve to link the adhesion systems
to the cytoskeleton, to regulate the functions of the adhesion molecules, and
to transduce signals initiated at the cell surface by the adhesion receptors.
Endothelium:
The endothelium is the thin layer of cells that line the interior surface of blood
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and lymph vessels, the heart, and the serous cavities of the body to form an
interface between circulating blood in the lumen and the rest of the vessel
wall. Endothelial cells line the entire circulatory system, from the heart to the
smallest capillary. These cells reduce the friction from the blood ﬂow allowing
the ﬂuid to be pumped further.
Epithelium:
The epithelium is a tissue composed of layers of cells that line the cavities
and surfaces of structures throughout the body. It is also the type of tissue of
which many glands are formed. Epithelium lines both the outside (skin) and
the inside cavities and lumen of bodies such as intestine. The outermost layer
of our skin is composed of dead, stratiﬁed, squamous, keratinized epithelial
cells.
Gap junctions:
Gap junctions are connections between two cells' cytoplasms. The Gap junc-
tion allows ions and small molecules to pass from one cell to the other.
Fibrinogen:
Fibrinogen (also called factor I) is a 340 kDa soluble plasma glycoprotein
synthesised in the liver. It contains the tripeptide sequence RGD (Arginine-
Glycine-Aspartic acid), which is a ligand to integrin. In its natural form, ﬁbrino-
gen can form bridges between platelets, by binding to their GpIIb/IIIa surface
membrane proteins (αIIbβ3).
Focal adhesion:
A type of anchoring cell junction, forming a small region on the surface of
a cell that is anchored to the extracellular matrix. Attachment is mediated
by transmembrane proteins, such as integrins, which are then linked through
other proteins to actin ﬁlaments in the cytoplasm. Focal adhesion sites serve
as signaling platforms to transduce information from the outside to the inside
of the cell and vice versa.
Homophilic, heterophilic interaction: In this chapter, these terms de-
scribe interactions between adhesion molecules. Homophilic interaction exists
between two molecules of the same type (e.g. cadherins) while heterophilic
interaction means that the adhesion molecule recognizes a diﬀerent molecule
(e.g. integrin-RGD-interaction).
Intermediate Filament:
The intermediate ﬁlament is a ﬁbrous protein ﬁlament (about 10 nm in di-
ameter) that forms ropelike networks in animal cells. It is one of the three
most prominent types of cytoskleton ﬁlaments, besides actin ﬁlaments and
microtubules.
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Leukocyte:
White blood cells, or leukocytes, are cells of the immune system defending
the body against both infectious disease and foreign materials. Several dif-
ferent types of leukocytes exist, but they are all produced and derived from
multipotent cells in the bone marrow known as a hematopoietic stem cells.
Leukocytes are found throughout the body including the blood and lymphatic
system.
Margination:
Margination is the process in which free-ﬂowing leukocytes exit the central
blood stream and initiate leukocyte-endothelial interactions by close mechani-
cal contact. The underlying mechanisms of margination involve the interaction
of leukocytes with erythrocytes ﬂowing in the same microvessel, whereby de-
formed erythrocytes push leukocytes to a marginating position due to their
smaller cross section and higher ﬂow velocity.
Mesenchyme:
Immature, unspecialized form of connective tissue in animals, consisting of
cells embedded in a thin extracellular matrix. Mesenchymal tissue is made up
of clusters of cells grouped together but not closely adherent to one another.
The cells compose a highly hydrated gel, rich in salts, ﬂuid, and ﬁbres, known
as the interstitial matrix.
Phosphorylation:
Phosphorylation is the addition of a phosphate (PO4) group to a protein
molecule or a small molecule. Another way to deﬁne it would be the in-
troduction of a phosphate group into an organic molecule. It is often involved
in the regulation of proteins or small molecules.
Platelet:
Platelets are fragments of megakaryocyte cells that do not contain a nucleus
(but do contain actin ﬁlaments and other cell organella). They are released
from the bone marrow into the blood. They assist in blood clotting by adhering
to other platelets and to damaged epithelium  also called blood platelet,
thrombocyte.
Protein kinase:
A protein kinase is a kinase enzyme that modiﬁes other proteins by chemi-
cally adding phosphate groups to them (phosphorylation). For example, ser-
ine/threonine protein kinases phosphorylate the OH group of serine or threo-
nine (which have similar sidechains).
RGD
RGD is a tripeptide, RGD standing for the aminoacid sequence arginine-
glycine-aspartic acid in the one letter code system.
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Rho family The Rho family of GTPases is a family of small (∼21 kDa)
signaling G proteins (more speciﬁcally GTPases), and is a subfamily of the
Ras superfamily. The members of the Rho GTPase family have been shown
to regulate many aspects of intracellular actin dynamics, and are found in
all eukaryotic organisms as well as in yeasts and some plants. Described as
”molecular switches”, the Rho family members play roles in cell proliferation,
apoptosis, cell division, gene expression, and several other common cellular
functions
von Willebrand factor:
Von Willebrand factor is a blood glycoprotein involved in hemostasis (blood
coagulation).
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CHAPTER 3
Biological and Model Membranes
A Biological Membranes: Components and Charac-
teristics
Cellular membranes have diverse functions in the diﬀerent regions and in the
diﬀerent organelles of a cell. The cell as well as its internal compartments are
enclosed by membranes. These isolate the interior from the outside both pas-
sively due to limited permeability of the membrane (to ions or small molecules)
and actively via certain transmembrane proteins which consume energy (e.g.
to maintain ion gradients). Cellular membranes contain a variety of lipids,
proteins and carbohydrates, and can be linked to the cytoskeleton (see ﬁgure
3.1).
However, despite of their various functions and constituents, all biological
membranes consist of a lipid bilayer [8].
Typical compositions of biological membranes can be found in ﬁgure 3.2.
A.1 Lipids and Organisation in Lipid Bilayers
A lipid is an amphiphilic molecule, which has a polar hydrophilic head and one
or several non-polar hydrophobic tails with a typical length of 2-3 nm. The
surface of the hydrophilic head is about 0.5 nm2.
the major types of lipids that predominate in eukaryotic membranes are the
phosphoglycerides (or phospholipids), the sphingolipids, and cholesterol (see
ﬁgure 3.3).
The lipid molecules self-assembled because of their amphiphilic character.
They usually assemble into a bilayer made of two lipid leaﬂets. In the lipid
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Figure 3.1. Schematic representation of a cell membrane and its principal
components: the lipid bilayer and some transmembrane proteins. From [73].
Figure 3.2. The weight composition of various membranes found in cells by
protein, lipid, and carbohydrate content. From [8]
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Figure 3.3. Major types of lipids in biological membranes a) phosphoglycerides
(or phospholipids), b) the sphingolipids, and c) chlosterol. From [8].
bilayer, the hydrophilic heads are oriented towards the aqueous solution and
shield the hydrophobic chains from water.
The geometry of the molecule is the crucial factor in determining the local
shape of the membrane. For instance, quasi-cylindrical molecules prefer to
arrange in ﬂat or curved bilayers, whereas cone-like molecules form spherical
micelles [74]. The lipid membrane in a biological system can be considered as a
two-dimensional ﬂuid that is held together mainly by non-covalent interactions
[75]. The lipids are arranged in a bilayer with a thickness of 5-7 nm.
In contrast to the artiﬁcial membranes studied in this work, biological mem-
branes are asymmetric, meaning the lipid distribution in the two leaﬂets of the
membrane is not the same [76], [77]. Sphingolipids, for example, are always
found on the outside of the plasma membrane. In human erythrocytes, as
well as in many other cell types, lipids with PC heads are essentially found on
the outer membrane of the cell, whereas the inner membrane also contains
PE and PS lipids. Since PS lipids are negatively charged, a signiﬁcant charge
diﬀerence between the two leaﬂets can exist.
Above their transition temperature Tc, the lipid molecules can move freely
in the bilayer, and the bilayer has the property of a two dimensional ﬂuid (see
ﬁgure 3.4). The lateral diﬀusion coeﬃcient is very fast in a monolayer: typ-
ically, the diﬀusion coeﬃcient is of the order of a few µm2/s in a membrane
in the disordered liquid phase. Lipid diﬀusion coeﬃcients have been measured
with the help of several techniques including NMR [78], single-particle tracking
[79], Fluorescence Recovery After Photobleaching (FRAP) [80], and Fluores-
cence Correlation Spectroscopy (FCS) [81]. The diﬀusion coeﬃcients depend
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on the nature of the lipids [75].
The lipid molecules can also rotate around their own axis, with a rotational
diﬀusion coeﬃcient of the order of D∼108 s−1 [82]. Since the polar head group
has to pass through the non-polar region in the center of the lipid bilayer,
transversal diﬀusion (ﬂip-ﬂop or transfer between the two lipid leaﬂets) occurs
only at a rate of D∼10−8 s−1 for phospholipids and is a very improbable process
in a model membrane [8]. It is faster for lysolipids (with only one chain) [75].
In biological membranes, this process can be accelerated by proteins present
in the membrane, called ﬂippases [77].
Figure 3.4. Lipid behavior in a bilayer depending on the temperature. Tc is
the transition temperature of the lipids. From [75].
A lipid membrane has variable permeability, meaning that some molecules
can diﬀuse freely through the membrane even in the absence of specialized pro-
teins like transporters, channels or pumps. Molecules diﬀuse at diﬀering rates
depending upon their ability to enter the hydrophobic interior of the bilayer.
The bilayer is virtually impermeable to large molecules, relatively impermeable
to charged ions such as Na+ and K+, (for phosphatidylcholine bilayers: Na+:
ΛP = 10−14 ms , K
+: ΛP = 3×10−14 ms ) [83] but quite permeable to lipid
soluble low molecular weight molecules such as ethanol. The layer is much
more permeable to water molecules: for an EPC membrane, a permeability
coeﬃcient Λ = 40 × 10−6 ms was measured [84], [85].
Because free edges of a membrane have a very high free energy, any breaks
or ruptures of the cell membrane can spontaneously be repaired provided that
the pore radius does not exceed a critical value [86].
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Figure 3.5. The three possible deformation modes: a) compression-extension
mode, b) shear mode, and c) curvature mode. From [91].
A.2 Mechanical Properties of Lipid bilayers
On a mesoscopic level, membranes can be described by the geometric prop-
erties and physics of elastic ﬂuids. Classical descriptions have been given
by Canham [87], Helfrich [88], and Evans [89] and [90]. The elastic energy
results from three deformation modes - a) compression-extension mode, b)
shear mode, and c) curvature mode. All deformations can be formed from a
combination of these three basic deformations (see ﬁgure 3.5).
 The ﬁrst type, the compression-extension mode, is an elastic deformation
characterized by a compression modulus, χ (in J/m2) (see ﬁgure 3.5a).
The associated energy per surface, Hext, depends quadratically on the
variation of the surface area,
Hext =
1
2
χ
(
∆A
A
)2
(3.1)
where χ is the compression modulus (about 0.2 J /m2 for vesicles, as
estimated by micropipette aspiration technique [92], [93]) and ∆A/A is
the relative variation of the surface area associated with the deformation.
This variation never exceeds 8 % as beyond this point, pores open and
the vesicle lyses at a critical tension around 10−3N/m. Built-in tensio-
active molecules can slow down the lysis of the membrane [94].
 The shear mode is a deformation in the plane of the membrane at con-
stant area (see ﬁgure 3.5b). The associated energy per unit surface
area, Hshear, is obtained from Hooke's law and gives:
Hshear =
1
2
µ(λ2 + λ−2 − 2) (3.2)
where λ = (L0 + ∆L)L0 is the lateral extension rate and µ the shear mod-
ulus. In the case of ﬂuid membranes, the energy is negligible: with con-
stant area, the lipids can diﬀuse freely and do not resist shearing. This
deformation becomes important however in the case of more complex
systems such as when the membrane is associated with the cytoskeleton.
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 The curvature term combines all deformations which are not in the plane
of the membrane or which do not occur on a constant surface (see ﬁgure
3.5c). It is the dominant deformation of the three:
Hcurv =
1
2
κ(c1 + c2 + c0)2 + κGc1c2 (3.3)
where c1 = 1/R1, and c2 = 1/R2 are the principal curvatures of the
membrane, and R1, R2 are the two principal radii in perpendicular di-
rection. c0 is the spontaneous curvature; that is the local curvature of
the membrane without mechanical constraint. This term corresponds
to a possible asymmetry of the membrane due to diﬀerences in the lipid
composition in the two leaﬂets of the membrane. The product c1c2
is the Gaussian curvature. The Gauss-Bonnet theorem shows that the
integrated product over the surface of the vesicle is a topological invari-
ant. Deformations applied to the surface of the vesicle generally do not
alter the topology. Therefore, the term characterized by the Gaussian
curvature κG is frequently neglected. κ is the bending rigidity modulus
of the curvature. It depends on the temperature and the composition
of the membrane. Numerous techniques to measure this modulus exist,
such as by Fourier analysis of the vesicle shape [95], [96], [97], [98].
Other methods study the elastic behavior of the membrane after me-
chanical deformation by electrical [99] or magnetic ﬁelds [100], or by
micropipette aspiration[90], [92], [101]. For vesicles made of the same
lipid type, some dispersion of the bending rigidities is observed. This
can be explained by the sensitivity of diﬀerent techniques to diﬀerent
wavelength ranges. For instance, contour analysis is sensitive to larger
length-scales than micropipette aspiration.
The energy associated with the integrated curvature over the whole
membrane is given by the following hamiltonian [87], [88]:
H =
∮
HcurvdA =
∮ (
1
2
κ(c1 + c2 + c0)2
)
dA (3.4)
To a ﬁrst approximation, this hamiltonian is suﬃcient to describe mem-
brane deformations and additional corrections were later added to take
into account the asymmetry of the bilayer and its thickness. However,
this hamiltonian does not allow for the existence of structure within a
bilayer, nor the fact that two monolayers can have two diﬀerent surface
areas, which could induce an additional curvature [102]. These eﬀects
will be discussed below together with the area diﬀerence elasticity model
(ADE) [103].
Some typical values for the compression modulus, the shear modulus, and
the curvature modulus are given in table 3.1 and compared to standard
materials.
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Material Compression Modulus Shear Modulus Curvature Modulus
χ (J/m2) µ (J/m2) κ (J)
Steel 100 100 10−15
Poly-Ethylene 5 5 5×10−17
Red blood cell 10−5 6×10−6 2-70×10−20
Lipid bilayer 100-700 × 10−3 0 4-40×10−20
Table 3.1. Some typical values for the compression modulus, the shear mod-
ulus, and the curvature modulus. From [104].
 The lateral tension, σ, is an intensive parameter associated with the
vesicle area, σ=∂F/∂A where F is the free energy of the membrane.
Two regimes can be deﬁned as a function of the extension: the enthalpic
and the entropic regime. The enthalpic regime corresponds to large
extensions whereas the entropic regime corresponds to small extensions.
In the enthalpic regime, the membrane has already undergone a large
extension, and so further stretching increases the average surface area
per lipid. When the membrane is expanded, its area increases with ∆A,
which increases the elastic term, Hext. If the shear mode is neglected,
the elastic energy per surface area can be written as follows:
H = Hext +Hcurv =
1
2
χ
(
∆A
A
)2
+
1
2
κ (c1 + c2 + c0)
2 + κGc1c2 (3.5)
The total elastic energy of the membrane is therefore HA. The tension
is then
σ =
δ(HA)
δ(∆A)
(3.6)
For a ﬂat membrane, this gives
σ = χ
∆A
A
(3.7)
The origin of this tension is enthalpic. However, this equation is only
valid for tensed membranes (ﬁgure 3.6b), when vesicle area and projected
area are equal (ﬁgure 3.6c).
Experimentally, vesicles are often not tensed and can then undergo large
thermal ﬂuctuations because of their low bending modulus κ (see ﬁgure
3.6a). In aqueous solution, collisions with water molecules make the
membrane ﬂuctuate around an average position. These ﬂuctuations (in
the case of red blood cells) have been observed already about a century
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ago by T. Browicz [105] and called ﬂickering and have been explained by
F. Brochard and J.-F. Lennon in terms of thermal ﬂuctuation in 1975
[106]. Hence, the observed area ( e.g. by microscopy) does not the
correspond to the real surface of the vesicle.
Figure 3.6. GUV under light microscope A) Floppy vesicle: The membrane
ﬂuctuations are optically visible. B) Tensed vesicle: The vesicle appears per-
fectly round and no ﬂuctuations are optically detected. C) Schematic repre-
sentation of a ﬂuctuating membrane. A represents the real area, while AP
represents the projected area. From [107]
In this case, an increase in the projected membrane area can be achieved
by reducing the size of membrane ﬂuctuations. However, reducing the
membrane ﬂuctuations decreases the entropy of the membrane and so
it increases the free energy of the membrane. If the real surface area of
the vesicle doesn't change, the surface energy density can be described
with the help of a Lagrange multiplier associated with the area dA, cor-
responding to the local membrane tension. Since the surface is ﬂuid, the
tension is homogeneous along the membrane, and this multiplier is just
the global tension of the membrane, σ. The total energy is then given
by:
H =
1
2
κ(c1 + c2 + c0)2 + σ
(
∆A
A
)
(3.8)
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The tension of the membrane can then be calculated by applying the
energy equipartition theorem to give :
σ = σ0exp
(−8piκ
kBT
(
A−AP
A
))
(3.9)
where σ0 is the membrane tension related to a microscopic ”cut-oﬀ”
associated with the lipid size [108], kB is the Boltzmann constant and
T the temperature. This tension has an entropic origin. The higher
the diﬀerence between projected and real area is, the more the vesicle
ﬂuctuates and the lower its membrane tension is.
In the general case, it was shown experimentally [92] and theoretically
[109] that the area excess ∆A/A can be expressed as a function of
the membrane tension by adding the two contributions of the ﬂuctua-
tions (entropic, low stretching regime) and the elasticity (enthalpic, high
stretching form). The variation of the surface excess area ∆AA between
an initial state with zero tension and a ﬁnal state with a tension σ, ∆α
= α0- α, results from both the ﬂattening of membrane ﬂuctuations and
the extension of the membrane [92]:
∆α =
kBT
8piκ
ln(1 + cAσ) +
σ
χ
(3.10)
where c = 124pi and A is the area of the vesicle (if we suppose that
area and volume remain constant). This expression frequently used to
describe micropipette experiments in which the vesicle is aspirated into
a micropipette to produce a controlled membrane tension [90]. At low
tension (σ < 10−5 N/m) only the ﬁrst term is taken into account. This
technique was used to measure the bending rigidity of membranes [92],
[101] (see also ﬁgure 3.7). Tension generally ranges between 10−8 to
10−3 N/m and the bending rigidity around 10−20 to 10−19 J. Using the
data given in table 3.1, it can be shown that surface area excess cannot
exceed 8 % for these tensions.
J.-B. Fournier et al. [109] were able to give a deﬁnition for tension which
accounts for the entropic and enthalpic terms without simply adding the
two. For this, they distinguished between the microscopic area (which
was here called the real area A), the area L2 (before called the projected
area), and the optical area A< which corresponds to the area visible in
the microscope, and diﬀers from the simple projected area L2 (see ﬁgure
3.8).
The ”coarse-graining” is related to the resolution limit of an optical
microscope. The tension is then an intensive variable associated with
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Figure 3.7. Examples of apparent area expansion measured over tensions
ranging from 0.001 to 8 mN/m for two vesicles of diﬀerent lipid composition.
A) Linear plot of tension versus apparent area expansion. Using equation
3.10 the characteristic parameters of the membrane (membrane rigidity κ and
compressibility modulus χ) can be obtained. (B) Semilog plot of tension versus
apparent area expansion. Slopes of the linear ﬁts (dashed lines) in the ﬁrst part
of the curve applied to the range of very low tensions yield the elastic bending
modulus κ. The second part of the curve corresponds to the enthalphic regime.
C) Video micrograph of a vesicle area expansion test. (a) The vesicle at low
tension. (b) The vesicle at high tension. The change in projection length ∆Lp
is proportional to the change in apparent surface area ∆ A. From [92]
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Figure 3.8. Membranes with a microscopic area A and an optically visible area
A<, attached to a ﬁxed frame of area L2. The eﬀective, optically measurable
tension of an initially ”ﬂat” membrane (b1), can be further increased by an
external perturbation (b2) Similarly, an initially ”ﬂoppy” membrane(a1) can be
externally driven into a tense regime (a2). From [109].
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the observed area A<, and not to A. In the non-tensed state, the tension
can be written as
σ = σ0exp
(
− 8piκ
kBT
(
A−A<
L2
))
(3.11)
which can be compared to equation 3.9. In the general case, the tension-
surface area excess relation has the same form as equation 3.10.
A.3 Vesicle Shapes
The shape of vesicles can be obtained by minimizing their energy. Even
though a spherical form often corresponds to the equilibrium shape, other
shapes can be found by varying the characteristic parameters of the
vesicle - volume, surface, spontaneous curvature, or temperature [75].
The obtained phase diagrams depend on the complexity of the model
that is used:
 The simplest model consists only of minimizing the curvature en-
ergy of the vesicle (given by the Canham-Helfrich hamiltonian,
equation 3.4):
* Without spontaneous curvature (c0 = 0), the equilibrium shape
only depend on the dimensionless volume v = V /(43 pi R
3),
where R represents the radius of the vesicle. Ellipsoids, prolate
dumbbells, oblate discocyte, stomatocytes, and ﬁnally spheres
are obtained when increasing v.
* When including the spontaneous curvature (c0 6= 0), the phase
diagram depends on the dimensionless volume and the dimen-
sionless curvature cR. In the case of c0 > 0, pear-shaped
vesicles are observed, while c0 < 0 favors the oblate shape.
However, this simple model is not capable of describing all exper-
imentally observed shapes, for example the starﬁsh shape [110].
One reason is that the model does not take into account the asym-
metry between the two leaﬂets.
 The Area Diﬀerence Elasticity model (ADE model) includes this
asymmetry between the two leaﬂets. When the membrane is posi-
tively curved, the inner leaﬂet is more compressed then the external
leaﬂet. Therefore, the two leaﬂets do not have the same total sur-
face. This asymmetry is also present if the two leaﬂets do not
contain the same number of lipids. The ADE model takes this into
account via a non local elasticity model κ [102], [112]. A term for
the energy which represents the stretching of one bilayer relative
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Figure 3.9. A) Phase diagram of possible vesicle shapes in the ADE model,
parameters are the reduced volume v and the area diﬀerence between the two
leaﬂets ∆a0. From [103]. B) Transition prolate - pear during, increasing
temperature leads to the formation of a daughter vesicle. From [111]. C)
Transition discocyte-stomatocyte through increasing temperature, From [111]
D) Starﬁsh-shaped vesicle. From [110].
43
CHAPTER 3. BIOLOGICAL AND MODEL MEMBRANES A
to the other is added to the Canham-Helfrich hamiltonian [113]
(equation 3.4 without spontaneous curvature nor gaussian curva-
ture). This is a non local term (it results from integration over
the whole surface), unlike the other terms listed above (extension,
curvature, etc.) The total energy integrated over the whole surface
of the vesicle can be written as:
H =
∮ (
1
2
κ(c1 + c2)2
)
dA+
piκ
2Ad2
(M −M0)2 (3.12)
where d is the bilayer thickness, M is the area diﬀerence between
the two leaﬂets (M= d
∮
(c1+c2)dA) and M0 is the area diﬀerence
only due to the diﬀerent number of lipids in the two leaﬂets. M0
(integrated quantity over the whole vesicle) reﬂects the asymme-
try between the two leaﬂets and illustrates the tendency of the
membrane to curve but is diﬀerent from the spontaneous curva-
ture which is a local factor. An estimation for non-local curvature
is given by κ = 4κ/pi, corresponding to typically 10-100 kBT [114],
[115].
The obtained phase diagram depends on three parameters: 1) the
dimensionless volume v= V
(4/3)pi(A/4pi)
3
2
which describes the swelling
state of the vesicle. The denominator would be the volume of the
vesicle if it were spherical. 2) the ratio between the two elastic mod-
uli q = κ/κ [116]. 3) The dimensionless area diﬀerence between
the two leaﬂets: ∆a0 = M0
8pid(A/4pi)
3
2
. Figure 3.9A shows a phase
diagram resulting from varying only parameters, v and ∆a0. ∆a0 is
the dimensionless eﬀective area between the two leaﬂets given by
the sum of spontaneous and area diﬀerence curvature (∆a0 = ∆a0
+ 12piqc0).
Some transitions have been studied in more detail, such as the
prolate-oblate transition [116], [117], [118] or the prolate-pear tran-
sition [119]. The latter explains theoretically the experimental re-
sults of J. Käs and E. Sackmann who had observed the formation
of a daughter vesicle from an initial mother vesicle by increasing the
temperature progressively [120] (see ﬁgure 3.9B). It is also possi-
ble to vary the other parameters to observe the variation of the
shape of the vesicle. An osmolarity diﬀerence between the outer
and the inner medium of the vesicle is commonly used to vary the
ratio between surface and volume. Formation of daughter vesicles
and ﬁssion is also observed in this case [121]. It is also possible to
add lipids to one of the leaﬂets [122]. The average forms obtained
theoretically are all axisymetrical, but it is also possible to obtain
non-axisymmetrical shapes numerically with the help of the ADE
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model or the curvature model including a spontaneous curvature
term which is non-zero [117], [123]. If the vesicles are suﬃciently
deﬂated, the ADE model allows starﬁsh shaped vesicles (see ﬁgure
3.9D). The diﬀerent models have been summarized by U. Seifert
in [113].
B Model Membranes: Giant Unilamellar Vesicles
Because of the complexity of biological membranes, simpliﬁed and reproducible
model systems composed only of lipids were developed to permit comparison
to theory. Various examples for model membrane systems exist (for a review
see [124]) including the lamellar phase (bilayer stacks), suspended bilayers
(including black lipid ﬁlm), supported lipid bilayers and vesicles. Diﬀerent
types of vesicles exist, which can be distinguished according to their size:
 SUVs are small unilamellar vesicles with a size smaller than 100 nm in
diameter.
 LUVs are large unilamellar vesicles with a size ranging between 100 nm
and 1 µm.
 GUVs are giant unilamellar vesicles with a size larger than 1 µm.
GUVs were used in this project and will therefore be described in detail.
B.1 General Characteristics
GUVs are composed of a single bilayer, and have, most frequently, a spherical
topology. In general, they have a diameter ranging between 5 and 100 µm and
as their size is similar to cells, they can be observed with optical microscope
(see ﬁgure 3.10). Because they consist of a single lipid bilayer, they are
therefore called unilamellar (in comparison with multilamellar vesicles, also
called ”onions”). Since the end of the 1970s, GUVs have been used to study
the physical properties of lipid bilayers.
B.2 Standard Methods for the Preparation of GUVs
Giant Unilamellar Vesicles (GUVs) can be prepared using several techniques.
Only the ﬁrst technique presented here was used in this study.
B.2.1 Electroformation
In the presence of an AC electric ﬁeld, the swelling of lipid bilayers in aqueous
sugar solution yields GUVs with a homogeneous population of spherical and
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Figure 3.10. A defect-free vesicle of about 20 µm in diameter, unilamellar
and spherical, observed in phase-contrast microscopy.
unilamellar vesicles [125], [126]. A theoretical explanation for the growth pro-
cess of giant unilamellar vesicles has been developed [127]. For the application
of the AC electric ﬁeld, two types of electrodes can be used. Either the lipid
solution is applied to conductive wire [125], [128], or to glass slides coated
with a thin conductive indium tin oxide layer (ITO) [126].
During application of the voltage a progressive increase in size of the vesi-
cles can be observed [ﬁgure 3.11]. Classically, the typical AC electric ﬁeld is
∼ 1 V (RMS), applied for 3hrs with a frequency of 10 Hz.
Figure 3.11. Growth of giant unilamellar vesicles with electroformation a)
after 30 minutes, b) after 55 minutes, c) after 95 minutes, d) after 120
minutes, phase contrast microscopy. From [129].
The small vesicles that are initially formed fuse to reach a maximum di-
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ameter of about 30 to 60 µm [ﬁgure 3.11]. A drawback of this method is
that it only tolerates very low ion concentrations (< 3 mM). However, recent
publications show that ionic strength similar to cellular concentrations can be
used, if high frequency voltage is applied during GUV preparation (see below)
[128], [130]. Another possibility is the use a spontaneous swelling technique
(see below). Our detailed experimental protocol is described in appendix D.
B.2.2 Spontaneous Swelling
Swelling a ﬁlm of lipids for long time (∼ 10-20 h) in aqueous solution typically
produces giant vesicles. This technique allows encapsulating of a variety of
objects (e.g. polymers, proteins, or magnetic colloids). However, the size of
the encapsulated objects is limited to a maximum of 10 nm in diameter. Var-
ious swelling solutions with diﬀerent conditions can be used, and the method
works with pure water as well as with physiological buﬀer with high salt con-
tent. However, reproducibility is a problem. The size distribution is often large
and multi-lamellar objects can form. Typically only a few percent (∼ 5 %) of
unilamellar vesicles are obtained with this technique [131], the majority being
multilamellar.
Figure 3.12. Swelling of the lipid bilayer in presence of water. From [132].
B.2.3 Electroinjection Technique
A fairly recent development to obtain giant unilamellar vesicles is the electroin-
jection technique. The method is a combination of spontaneous swelling and
electroporation. This was initially developed by O. Orwar's group [133] and
later by Nicolas Biais [134]. A lipid ﬁlm is dried and re-hydrated in the desired
buﬀer solution. After a few minutes a combination of multi- and unilamellar
vesicles develops (see ﬁgure 3.13).
A thin graphite electrode is placed onto the membrane. A second electrode
is positioned in a micropipette against the vesicle and a short electric pulse
is applied to open a pore. The pore closes rapidly, and the membrane seals
around the micropipette. Buﬀer can then be injected with the help of the
micropipette. The unilamellar liposome is ﬁlled with more buﬀer solution until
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Figure 3.13. Typical vesicle prepared or the electroinjection method, consist-
ing of a multilamellar and a unilamellar part.
the desired size is reached. This is possible since the liposome can recruit more
lipids from the multilamellar reservoir. The obtained giant vesicle is detached
from the multilamellar part with the help of the carbon electrode. With this
technique the size of the giant unilamellar vesicles as well as their content
can be controlled. Buﬀer of larger osmolarity or larger objects (size of a few
microns) can be introduced in these vesicles [134].
B.3 Functionalized Giant Unilamellar Vesicles
Giant Unilamellar Vesicles are useful models for biological systems, since they
consist of a closed lipid bilayer with a diameter of a biological cell. They can be
further functionalized by using functionalized lipids or by introducing charges
[135]. Formation of macroscopic domains has been observed [ﬁgure 3.14]
[136], [137], and diﬀerent lipids or lipid mixtures with diﬀerent functions can
be used [138]. Phase separation in GUVs has been extensively studied during
the recent years stimulated by the observation of small lipid domains in the
cell membrane (”rafts”).
Proteins can also be incorporated [3], [139] or attached to the membrane
[140] to mimic the properties of biological systems. In addition, cytoskeleton
elements can be incorporated inside the GUVs to further resemble biological
cells [141], [142] (see also ﬁgure 3.15 ). Microtubules trapped inside giant
unilamellar vesicles produce shapes reminiscent of living cells, and their me-
chanical properties can be compared to biological systems (ﬁgure 3.15) [143],
[144]. Giant unilamellar vesicles are very well adapted for adhesion studies. Cell
adhesion molecules (CAMs) can be ﬁxed to a substrate, their (simpler) recep-
tors can be incorporated in the membrane and the adhesion of the membrane
on the functionalized substrate can then be studied. This system represents
a signiﬁcant step towards mimicking the process of cell-extracellular matrix
adhesion [140], [145].
The electroinjection method and the spontaneous swelling method described
above are powerful methods to ﬁll GUVs with the desired content. Recently,
other techniques have been developed including one based on an adaption of
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Figure 3.14. Giant unilamellar vesicle containing sphingomyelin, cholesterol,
and DOPC, as well as two dyes showing lipid phase separation; all images are
superpositions of red and blue channels , except c (red channel only). d, Scale
bars, 5 µm. From [136].
the Langmuir- Blodgett technique using emulsions [146], [147], and another
one using microﬂuidic jetting [148]. These methods also allow for a control of
the internal content of the GUV.
The ultimate goal of all of these techniques is to create a simpliﬁed model
cell.
Figure 3.15. Bending microtubules inside of lipid vesicles. From [143].
B.3.1 Methods to Reconstitute Membrane Proteins into GUVs
The cell membrane is a highly complex structure containing transmembrane
proteins. In order to reproduce this complex structure in a model system,
the group of Patricia Bassereau developed a new and general method for the
reconstitution of membrane proteins into GUVs [3]. They systematically an-
alyzed the reconstitution of two radically diﬀerent membrane proteins - the
sarcoplasmic reticulum Ca2+-ATPase and the H+ pump bacteriorhodopsin.
The ﬁrst step of the method involves a detergent-mediated reconstitution of
solubilized membrane proteins into proteoliposomes of 0.1-0.2 µm in size. In
a second step, these preformed proteoliposomes are partially dried under con-
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trolled humidity followed, in a third step, by electroswelling of the partially
dried ﬁlm to give GUVs. The reconstitution process was further characterized
by analyzing protein incorporation and biological activity. Both membrane pro-
teins have been homogeneously incorporated into GUVs at lipid/protein ratios
ranging from 5 to 40 (w/w). After reconstitution, both proteins retained their
biological activity as demonstrated by H+ or Ca2+ pumping driven by bacteri-
orhodopsin or Ca2+-ATPase, respectively.
Doeven et al. [139] have shown that adding small amounts of sucrose to
the proteolipid mix prevented denaturation of proteins (four distinct mem-
brane proteins were tested) during the dehydration process. The amount of
sucrose was optimized (minimal amount of 0.02 g sucrose/g lipid) such that
the proteins retained 100 % biological activity. The proteoliposomes could be
dried in vacuum without losing membrane activity. Proteo-GUVs were then
reproducibly obtained. Furthermore, they showed that the presence of neg-
atively charged lipids (DOPS) helped to reconstitute the membrane proteins
into liposomes. This result was later used in our project.
B.3.2 GUV Formation under Physiological Conditions
As mentioned above, the classical electroformation only works in ionic strength
up to a few mM, which is far below the physiological level. However, in order to
come closer to biomimetic systems, GUVs have to be prepared in buﬀers with
high ionic strength. With the help of the protocol developed in the Bagatolli
lab [128], this problem was recently be solved. It was shown that GUVs can
be prepared either from native membranes or lipid mixtures at physiological
strength using and electroformation method that uses 500 Hz AC ﬁelds and
conductive wires. Additionally, for GUVs composed of native membranes, the
membrane proteins and glycosphingolipids preserved their natural orientation
after electroformation.
Bagatolli et al. suggested that it might be important to revisit a variety of
experiments performed with GUVs under low or no salt conditions. Model
systems containing proteins are likely to be aﬀected by the amount of salt
present in the solution. This might also apply to the results presented in our
study.
C Interactions between Membranes
Two types of interaction between objects (here lipid bilayers) in aqueous solu-
tion will be discussed in this section:
1. The non-speciﬁc or generic interactions
2. The speciﬁc interactions
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While non-speciﬁc interactions are always present between two objects
(here lipid bilayers) in aqueous solution, speciﬁc interactions depend on the
presence of special molecules which recognize each other (often compared
to a lock and a key). These speciﬁc interactions correspond to the speciﬁc
recognition of two proteins located on the two facing lipid bilayers.
C.1 Generic Interactions
Non-speciﬁc interactions are mediated by the generic intermolecular forces,
such as van der Waals forces, electrostatic forces, solvation and steric forces.
C.1.1 Van der Waals forces
The van der Waals interaction energy per unit area between two planar surfaces
at distance D is attractive and is given by [74]
W (D) = − A
12piD2
(3.13)
where A is the non-retarded Hamaker-constant.
The van der Waals contribution between bilayers is fairly weak and has an
eﬀective range of less than 15 nm. Beyond this range Van der Waals forces
are too weak to be signiﬁcance.
C.1.2 Repulsive Forces
For interacting bilayers there can be up to four diﬀerent types of repulsive steric
forces that are independent of the solvent [74]. These are the undulation force,
the peristaltic force, the protrusion force and the steric overlap force between
surface-anchored polymer brushes or head groups. The two most important
are the undulation force [88] and the steric overlap force. Only the undulation
force is expected to be long-range; the other three forces will decay rapidly
to zero beyond a certain distance roughly equal to the lengths of the lipid
molecules. However, at small separations below about 2 nm, the protrusion and
head group overlap forces are expected to dominate the undulation repulsion.
The role of electrostatic interactions in the adhesion of biological systems is
complex. Charges are present in physiological solutions in form of ions as well
as on surfaces (surface proteins, lipids,...). Theoretical details can be found in
[149].
C.2 Speciﬁc Adhesion
Even though generic forces are always present, cells do not always stick to
each other which is essential for cell migration or ﬂow (e. g. in the blood
stream). A system is therefore necessary that can prevent cells from sticking
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to each other through generic interactions, but allow them to adhere to each
other when needed. The ﬁrst system to prevent non-speciﬁc interactions is
the hyaluronic acid present on the outer cell membrane. The hyaluronic acid
forms a polymer brush and shields the cell membrane from generic interactions
while also mediating weak long distance interactions [150]. To mediate speciﬁc
adhesion, proteins on the cell surface interact with other proteins (e.g. on the
membrane of a second cell or in the extracellular matrix) like a lock and a key.
Only an appropriate receptor-ligand pair can recognize each other [8]. The
receptors are either an integral part of the lipid membrane, attached to the
periphery of the lipid bilayer or anchored via polymers. They are highly speciﬁc
and allow cells to selectively bind to a neighboring cell or the extracellular
matrix that expresses the appropriate receptor.
Figure 3.16. Three possibilities for receptor-ligand interactions. From [151]
Describing the adhesion of a biological cell to another cell or to the extra-
cellular matrix requires elements from cell biochemistry, structural mechanics,
and surface bonding. As described in ﬁgure 3.16, interaction between a lig-
and and a receptor is mediated via a homophilic interaction, a heterophilic
interaction or a connection through a linker molecule.
While the function of adhesion molecules at the molecular level follows
this scheme (see ﬁgure 3.16), the adhesion of cells also depends on how these
adhesion molecules assemble into ordered structures, such as focal contacts.
Moreover, cascades of signaling pathways leading to interactions with the inte-
rior of the cell, such as the cytoskeleton, have been identiﬁed [67]. Eventually,
the cytoskeleton may organize to form stress ﬁbers in response to adhesion.
Adhesion molecules can also be up-and downregulated, as occurs when they
become more ”sticky” by activation. The biochemistry of adhesion and the
sequence of reorganization in cell spreading is discussed in chapter 2.
A ﬁrst step to characterizing cell adhesion is to study protein-protein in-
teractions on the single molecule level. Combining molecular cell biology with
single molecule techniques (biomembrane force probe, AFM) has given con-
siderable insight into the complexity of cell adhesion. Studies have focused on
understanding how cell signaling processes strengthen adhesion bonds and how
forces applied to cell-surface bonds act on intracellular sites to catalyze chem-
ical processes. This approach can reveal important links in the communication
between mechanical and chemical circuitry of a cell and has been actively pur-
sued by many biophysics groups.
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The physical role of a cell adhesion bond is to attach a cell to another cell or
surrounding tissue while supporting the forces involved in cell function. How-
ever, a single adhesion bond eﬀectively resists force only for time periods less
than that needed for its spontaneous dissociation under thermal activation.
Indeed, mechanical force applied to a bond between two interacting proteins
decreases the activation energy barrier along kinetic pathways, or switches
biochemical pathways that lead to dissociation (ﬁgure 3.17).
Figure 3.17. Conceptual view of force propagation to a bond and its impact
on the chemical energy landscape governing bond kinetics. From [152].
Pulling on a molecular bond creates a mechanical ”springlike” potential
(dashed blue curve in ﬁgure 3.17) that alters the chemical energy of interaction
or ”landscape” (solid and dashed red curves in ﬁgure 3.17) along the reaction
coordinate deﬁned by the pulling direction [152]. The slope of the spring
potential at the origin of interaction is the pulling force f, i.e. the product of
the eﬀective spring constant κs of the structural linkages with the increase
in their separation xseparation under pulling. The dissociation energy depends
on the velocity through the loading rate [153]. Of greatest impact on bond
survival, the spring potential reduces the height of the activation energy barrier
governing the oﬀ-rate kinetics located at xβ by ∼ -fxβ. First described by Bell
in 1978 [154], the change in Arrhenius factor predicts a large exponential-
like reduction in bond survival time, toff (f) ≈ toff exp(-f/fβ), relative to its
apparent unstressed lifetime toff (For adhesive interactions relevant in soft
tissues and organs of eukaryotic cell systems, the average times toff reported
for spontaneous dissociation of ligand/receptor bonds range from a fraction
of a second to 100 s or more).
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C.2.1 Techniques
At least three diﬀerent methods [155] have been developed to monitor the
rupture of individual ligand-receptor bonds subjected to applied forces in the
piconewton range.These have shown that non-covalent associations between
biomolecules can be rapidly ruptured with forces ranging between a few tens
and hundreds of piconewtons.
 Hydrodynamic ﬂow This method was used by the group of P. Bongrand
[156] to determine the detachment kinetics of single bonds formed by
E-selectin and its ligands by ﬂowing leukocytes. A particle of radius a
coated with ligands is bound to another particle or a macroscopic surface
coated with receptors. If the ﬂuid has a viscosity of µ with a locally
varying shear ﬂow rate G then the particle is subjected to a force of the
order of µa2G. If bonds are ruptured, particles will then be transported
in the ﬂow with a velocity of order of aG. Thus, if we consider a cell-
size particle of 10 µm radius in a ﬂuid of 0.001 Pa·s viscosity such as
water, a shear rate of 10 s−1 may generate a hydrodynamic drag of
order of 0.1 pN and a relative velocity of 100 µm s−1. Therefore, the
mere observation of the particle with a conventional microscope may, in
principle, allow a detailed examination of single-bond rupture with a time
resolution of a few tens of milliseconds.
 Biomembrane force probe (BFP) technique This approach was pio-
neered by Evans et al. [153], [157]. A typical experiment consists of
using a red blood cell (RBC)aspirated at controlled tension as the force
transducer. As BFP tip, a glass microbead is chemically glued to the
membrane, which is functionalized with one type of ligand. A second
bead held by a second pipette and functionalized with the receptor is
brought into contact by precision piezo control (see ﬁgure 3.18). After
allowing bonds to form, a pipette is pulled out under microscopic con-
trol. The applied force results in RBC membrane deformation, and a
spherical shape is recovered when the last bond is ruptured. Thus, the
experimental result is the unbinding force rather than the bond lifetime.
As emphasized by the authors, the power of this approach is that the
surface tension of the red blood cell may be varied over a wide range
by controlling the aspirating pressure applied through the pipette. RBCs
can indeed be subjected to a distractive force ranging between less than
1 and 100 pN. Diﬀerent loading rates are accessible as the pipette ap-
proach velocity can be varied over a large range. With fast video (≈1,000
frames per s) processing, image tracking of the bead is possible, which
yields a resolution of 8-10 nm for transducer deﬂection. The deformation
of the membrane may be analyzed in order to calculate the force.
 Atomic force microscopy (AFM) The principle consists of moving a
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Figure 3.18. BFP. Studying individual ligand-receptor bonds with the biomem-
brane force probe. A typical experiment uses a red blood cell aspirated at
controlled tension in a micropipette as the force transducer. As the BFP tip,
a glass microbead is chemically glued to the membrane which is operated on
the stage of a microscope. The BFP (on the left) is kept stationary and the
microbead test surface (on the right) is translated to/from contact with the
BFP tip by precision piezo control. From [153].
ligand-coated surface towards a very thin receptor-bearing tip mounted
on a very soft cantilever (a typical spring constant is about 100 mN m−1)
(see ﬁgure 3.19). The surface is then pulled out, resulting in continuous
increase of the force, with continuous monitoring of the cantilever defor-
mation. The rupture of the last bond between surfaces results in a sharp
jump of the cantilever, allowing experimental measurement of the un-
binding force. The cantilever position may be monitored with ångström
accuracy with optical techniques. The optical limit set by thermal ﬂuc-
tuations to the force sensitivity is about (kT/λ)1/2, where λ is the spring
constant. The reported force sensitivity is of the order of 10 pN in liquid
medium (Erlandsson and Olsson in [155], and [158]).
C.2.2 The example of the Streptavididn-biotin pair
The ligand-receptor pair streptavidin-biotin is a standard system which has
been studied using the above methods.
 AFM Chronologically, the AFM technique was used ﬁrst to study the
avidin-biotin system. A tip was coated with biotinylated albumin and
brought into contact with soft agarose beads bearing streptavidin binding
sites [158]. Using the force scan mode, multiple approach-retract cycles
were performed and hundreds of unbinding events could be visualized
as sharp jumps of the cantilever. The distribution of unbinding forces
displayed quantized peaks that appeared as multiples of 160±20 pN.
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Figure 3.19. Studying individual ligand(L)-receptor(R) bonds with an atomic
force microscope. A receptor-bearing tip (a few nanometer thickness)
mounted on a very soft cantilever is brought in contact with a ligand-coated
surface. The unbinding force is then measured.
This was considered as representative of the detachment force of a single
bond. Further, when biotin was replaced with iminotiotin, an analogue
with 25 000-fold lower aﬃnity to streptavidin, the unit separation force
was reduced to 85±15 pN.
 Hydrodynamic ﬂow Pierres et al. [159], [160] used the ﬂow cham-
ber technology to study the high aﬃnity interaction between biotin and
streptavidin. The lifetime of interactions between biotinylated surfaces
and streptavidin-coated spheres was of the order of several seconds, i.e.
5-50-fold higher than determined on selectin/ligand or CD2/CD48 mod-
els [161]. Further, this lifetime was not decreased when the shear rate
was increased from 10 to 40 s−1. However, it was concluded that the
ﬂow chamber was not well suited to the study of strong interactions,
since (i) the chamber ﬂoor was rapidly ﬁlled with deﬁnitively attached
particles, which made it diﬃcult to follow a suﬃcient number of trajec-
tories in a single experiment, and (ii) it was somewhat diﬃcult to obtain
a reliable distribution of arrest durations, since the computer-assisted
apparatus was not adapted to the monitor very long arrests.
 Biomembrane Force Probe Technique Evans et al. [153], [162] re-
ported a study of biotin-streptavidin association. When bonds were sub-
jected to a loading rate of 100 pN s−1, the unbinding force was about
50 pN. The force was reduced when streptavidin was replaced by avidin.
The measured value was 4-5-fold lower than that measured with atomic
force microscopy (see above), but the loading rates were probably diﬀer-
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ent in these two cases. The group of Evans was the ﬁrst to emphasize
the importance of the loading rate and probe the dependence of the
unbinding force on the loading rate.
Figure 3.20. Force vs. loading rate diagram measured with BFP, showing the
behavior when streptavidin is replaced by avidin. From [153].
Indeed, it is very interesting to note that very diﬀerent values were obtained
for the same ligand-receptor pair. This suggests that the results from these
three techniques may only be comparable if the same loading rate is used in
the experiment. This is not emphasized in the ﬁrst two publications.
It is important to note, however, that cellular adhesion is a collective phe-
nomena, involving many diﬀerent types of cell adhesion molecules which are
present in large numbers on cell surfaces and the extracellular matrix. It
is therefore necessary to study the behavior of ensembles of cell adhesion
molecules.
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CHAPTER 4
Adhesion in Model Systems
A Basic Principles
Quite a few systems for modeling cell adhesion have been studied both theo-
retically and experimentally, and these studies have shown the importance of
speciﬁc interactions and the involvement of the cytoskeleton and other cellu-
lar structures. Nevertheless, the shape of a water droplet wetting a surface, a
model cell (vesicle), and a cell adhering to a surface show remakrable similar-
ities (see ﬁgure 4.1).
Figure 4.1. Similarities in shape between 1) A water droplet 2) A giant vesicle
3) A cell, spreading on a surface scale bar: 1) 1 mm 2) 10 µm, 3) 5 µm. From
[163].
Indeed, the behavior of a water droplet deposited on a surface illustrates
many of the important concepts in surface adhesion.
A.1 Water Droplet on a Surface
The shape of a water droplet on a surface depends both on its size (a semi-
spherical cap in the capillary regime or ﬂattened in the gravity-dominated
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regime) and on the diﬀerence between its surface tension and the surface
energy of the solid substrate [164], [165]. On clean glass (high surface energy,
hydrophilic) the droplet wets the surface and forms a thin water ﬁlm across
the entire surface (total wetting situation).
If the surface energy of the substrate is lowered, the droplet spreads out
into the shape of a truncated sphere (partial wetting situation).
The spreading parameter, S, which is the diﬀerence between the surface
energy of the dry and wet surface determines whether or not a water droplet
spreads on a surface. It is given by
S = Edry − Ewet (4.1)
which is equal to
S = γSA − (γSL + γLA) (4.2)
where γSL is the surface tension between the solid and the liquid phase, γSA is
the surface tension between the solid and the gaseous phase (air), and γLA is
the surface tension between the liquid and the gaseous phase (air) (see ﬁgure
4.2). If S>0, the liquid completely wets the surface (total wetting) forming a
thin ﬁlm on the surface, while partial wetting occurs when S<0.
Figure 4.2. Partial wetting of a liquid on a solid substrate deﬁning the contact
angle θ at the contact line.
The static contact angle θ can be obtained by balancing forces balance at
the contact (see ﬁgure 4.2) to give
γLA cos θ = γSA − γSL (4.3)
for the contact angle θ: This can be expressed as the Young - Dupré equation
by
S = γLA(cosθ − 1) (4.4)
The greater the value of θ, the less the liquid wets the surface. The range
-1≤cosθ≤1 corresponds to partial wetting, while (cosθ>0) corresponds to a
total wetting situation.
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A.2 Adhesion of Vesicles : Static Approach
The adhesion of vesicles depends upon the nature of the interaction between
the substrate and the vesicles. For instance, electrostatic interactions between
a poly-lysine-coated glass slide and a vesicle made from phosphatidylcholine
lipids lead to spreading of the vesicle on the surface. If the surface density
of poly-lysine is high enough, the vesicle will rupture to form a lipid bilayer
[86]. When the surface is passivated (coated with casein, a BSA layer, or a
hydrophilic polymer like PEG), the vesicle can settle on the surface, but does
not adhere [153], [166], [167]. For intermediate cases, the vesicle can bind
to the substrate and assumes a truncated spherical shape, very similar to the
water droplet described above (see ﬁgure 4.1).
Figure 4.3. A) A vesicle sitting on a passivated surface with a contact angle
greater than 90◦. B) A vesicle adhering to a surface covered with a low density
of poly-lysine and a contact angle smaller than 90◦.
In the case of strong adhesion mediated by long-range interactions, the
vesicle assumes the shape of a spherical cap characterized by a contact angle
θ. The point of contact can be described by the Young - Dupré equation which
in this case links the adhesion energy W per unit area, the membrane tension
γ and the contact angle θ (see equation 4.5).
The adhesion energy W is deﬁned as
W = γ(1− cosθ) (4.5)
In principle, knowing the membrane tension and measuring the contact
angle, the adhesion energy can then be deduced [168], [169], [170].
Seifert et al. have also modeled the adhesion of vesicles theoretically [171].
The attractive adhesion energy (e. g. van der Waals interactions, electrostatic
forces,...) is partially compensated by the bending rigidity κ and the volume
of the vesicle is not assumed to be constant. In the model the competition
between adhesion and bending is described by the dimensionless parameter,
w= WR
2
κ , where R is the radius of the vesicle. w > 1 characterizes a strongly
adhering vesicle, while w ∼ 1 corresponds to a weak adhesion state.
The initial tension of the membrane also has to be taken into account.
For ﬂoppy vesicles, this is described by the reduced volume of the vesicle v =
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V
4pi
3
×( A
4pi
)
3
2
, where V is the volume and A is the area of the vesicle. For ﬂoppy
vesicles, v < 1. Using w and the reduced pressure p (p = PR3κ where P
is the osmotic pressure diﬀerence between the outside and the inside of the
vesicle.), a phase diagram for bound vesicles was calculated by minimizing the
associated free energy via Monte Carlo simulations [171], [172], [173]. An
example of the vesicle deformation due to changes in interaction (w) and in
the reduced pressure p (i.e. in membrane tension) is given in ﬁgure 4.4.
Figure 4.4. Shapes of bound vesicles that all have the same area A = 4pi
a.) for reduced pressure p=0 and reduced contact potential w = 2.0, 2.9, 4.1,
6.4, 10.2 with increasing contact area A*. Shapes for p < 0 look similar. b.)
(p,w) =(14.6, 2.0), (14.0, 6.1), (14.1, 12.9) with increasing A*. From [171].
For the case of strong adhesion,Tordeux et al. [174] found analytic descrip-
tions for the shape of the contact zone and the contact angle of an adhered
vesicle. They assumed that the volume V and the area A of the vesicle are
constant and deﬁned a number of geometrically measurable parameters (L =
adhesion disk radius, λd =
√
κ
σ = extrapolation length, θ = contact angle, R =
the vesicle radius , H = height of the vesicle measured on the revolution axis
z) (see ﬁgure 4.5). A parameter to describe adhesion was introduced, which
for strong adhesion was deﬁned as
 =
1
L
√
κ
W
 1 (4.6)
Figure 4.6 depicts the geometry of the contact between the vesicle and
the substrate. The membrane curves up from the actual point of contact such
that at distances greater than λd it approaches the limiting value of θ (see
also ﬁgure 4.6) [166]. The authors also discussed the eﬀect of the adhesion
energy on the height, H, of the adhered vesicle.
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Figure 4.5. Analytical description of a strongly adhered vesicle using geomet-
rically measurable parameters: L = adhesion disk, the extrapolation length λd
=
√
κ
σ , θ = contact angle, R = the vesicle radius , H = height of the vesicle
measured on the revolution axis z. From [174].
Figure 4.6. Geometry of the contact. A) The contact angle θ deﬁnes the
contact between vesicle and substrate on a macroscopic scale. B) The proﬁle
close to the contact line is actually not the vertex of the contact angle θ. Due
to the curvature of the membrane, the angle increases from 0 to θ over a
characteristic length, λd, the extrapolation length. [166]. From [163].
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A.3 Comparing Water Droplet and Vesicle Spreading
In recent years, speciﬁc adhesion of vesicles (mediated by proteins on the vesi-
cle surface and the substrate to which the vesicle adheres) has been studied
both theoretically and experimentally. In general, speciﬁc adhesion of vesicles
is more complicated than the case of wetting of a simple ﬂuid droplet on a
surface. This is because some parameters change during the adhesion process.
First,
 While the surface energy of a liquid is constant, the membrane tension
of a vesicle can increase during vesicle adhesion. The transition from
a sphere to a truncated sphere induces an area increase that reduces
membrane ﬂuctuations. If the vesicle gets too tense, pores can open
[175], and the vesicle can eventually rupture [86].
 Secondly, the ligands on the membrane bilayer can diﬀuse freely, and can
therefore aggregate at the adhesion zone, thus inﬂuencing the adhesion
energy.
We have mentioned above some studies of vesicle shape under static con-
ditions. In recent years, only a few theoretical and experimental studies of the
adhesion kinetics of vesicles have been published and these will be described
in section B.
B Theory: Adhesion Kinetics of Model Membranes
Mediated by Speciﬁc Interactions
The results of several theoretical and experimental studies are brieﬂy summa-
rized.
B.1 Simulations
B.1.1 Numerical Simulations on Spreading of a Model System for Cell
Adhesion
Hodges et al. [176] modeled cell adhesion via numerical simulations. The
cell was treated as an extensible membrane under tension containing ﬂuid of
constant volume. Assuming rapid binding kinetics, molecular binding forces
were described through a contact potential that was attractive at long ranges
but repulsive at short ranges. Using lubrication theory to describe the thin-
ﬁlm ﬂow between the cell and the plane, they modeled the sedimentation of
the cell onto the plane under adhesive forces. They then studied the removal
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of the cell from the surface under the action of an external force. The au-
thors calculated the adhesion dynamics by averaging numerous dimensionless
molecular parameters. For these numerical simulations, adhesion and detach-
ment events were dominated by quasi-steady spreading and peeling motions,
which could be described using an asymptotic analysis. The analysis was then
extended to model a cell tank-treading over an adhesive wall under the inﬂu-
ence of an external shear ﬂow. The relation between cell rolling speed and
shear rate was determined. At low speeds it was linear and independent of the
viscosity of the suspending ﬂuid, while at higher speeds it was nonlinear and
viscosity-dependent.
B.2 Analytical approaches
B.2.1 Kinetics of membrane adhesion mediated by ligand-receptor in-
teraction (Boulbitch et al. approach)
This work employed both experimental and theoretical techniques. The ﬁrst
model for speciﬁc ligand-interaction mediated adhesion was proposed by A.
Boulbitch [140]. For the experimental work, vesicles were prepared carrying
RGD-anchored lipids, representing the ligand, and PEG-polymer, mimicking
the cell glycocalix. Their adhesion onto a surface covered with the integrin
αIIbβ3, (a receptor for the RGD-peptide) was then studied. The experiments
are presented in detail in section C.4 Their theoretical study distinguished two
situations: 1) a diﬀusion-dominated regime when the vesicle is covered by a
low density of ligands. For this case the diﬀusion of the ligands to the adhesion
zone limits the adhesion. 2) a regime of high ligand density dominated by the
kinetics of ligand-receptor association. The spreading of the vesicle is then
limited by the reaction time between ligand and receptor.
The authors showed both experimentally and theoretically that at low lig-
and concentrations, the kinetics of the displacement of the front of tight
adhesion followed the square root law, which can be expressed as R ∼ t1/2
(R being the radius of the adhesion zone). At high ligand concentrations, a
linear law R ∼ t was found. In the ﬁrst case, the scaling law was obtained by
choosing adequate boundary conditions and by combining the diﬀusion equa-
tion with the conservation of the total number of molecules. For the high
ligand concentration, the characteristic time for displacement of the adhesion
front was controlled by the bond formation kinetics corrected by a Boltzmann
factor taking into account the ﬂuctuation energy imposed by the PEG polymer
brush. For this case, the adhesion zone increases with a constant velocity and
R ∼ t.
The proposed model introduced a large number of parameters that could
not be easily measured. However, the model gave an excellent ﬁt to the
experimental data presented in [140].
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B.2.2 Growth and Shape Stability in an Adhesion Plaque in the Diﬀusion-
Mediated Regime (Shenoy et al.)
A more recent theoretical approach was published by Shenoy et al. [177]. The
authors focus on the process of expansion of an adhesion zone with a low
density of ligands, as is typical in cellular adhesion. The recruitment of new
ligands at the edge of the adhesion zone was modeled through a gradient of
chemical potential between the adhesion zone and the rest of the non-adhering
membrane.
The evolution of the circular adhesion front in the diﬀusion-limited regime
varies with R ∼ α√Dt, where D is the diﬀusion constant and α a prefactor
that is discussed in detail and compared to [140]. The evolution of the radius
R ∼ √t is in agreement with Boulbitch et al.. The authors insist furthermore
on the existence of an original instability of the circular shape of the adhesion
zone.
B.2.3 A More General Approach: de Gennes and Brochard-Wyart
F. Brochard-Wyart and P.-G. de Gennes proposed several theoretical scenarios
to explain the adhesion of a vesicle on a variety of substrates [165], [178],
[179].
As in the approaches described above, they considered a vesicle carrying
on its surface a small number of mobile ”stickers”. When facing a substrate
with suitable receptors for the stickers, the vesicle builds up an adhesion patch.
They analyzed the patch growth dynamics under a variety of situations. They
took into account the variation of surface preparation (mobile or immobile re-
ceptors on the surface), the presence or absence of non-speciﬁc interactions,
the preparation of vesicles (i.e. ”heavy” vesicles due to osmolarity diﬀerence
with the surrounding medium), the inﬂuence of the membrane tension, the
competition of diﬀusion of the ligands and the reaction time, and the distri-
bution and accessibility of the receptors in the adhesion zone. The authors
showed that each parameter can have a signiﬁcant inﬂuence on the growth
rate of the adhesion zone. We will later discuss the theory in detail, as we will
use this approach to analyze our experimental data in chapter 6.
Even though the approaches described above ﬁnd similar power laws for
R(t), this agreement might be coincidental as the underlying mechanisms dif-
fer.
Our results will be analyzed with the theoretical approach by F. Brochard-
Wyart, as this approach uses the smallest possible number of unknown physical
parameters. We will carefully compare our experimental data to the results ob-
tained by P.-H. Puech for ﬂoppy biotinylated vesicles adhering to streptavidin
covered supported lipid bilayers, and the corresponding theoretical explanation
by de Gennes and Brochard [179] (see also chapter 6). Our vesicles were
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ﬂoppy just like the vesicles studied in [179]. Most parameters in the model
could be obtained independently of the current experiments which allowed a
simple comparison of the theoretical predictions to our experimental data.
C Experiments: Functionalized GUVs Mimicking Cell
Adhesion
Several experimental system have been developed using functionalized GUVs
to mimic cell adhesion. Even though not all of them have been used to study
adhesion dynamics, all the systems will be presented to characterize the state-
of-the-art in adhesion model systems involving GUVs.
C.1 Adhesion Dynamics of GUVs mediated by Biotin-Streptavidin
Systems
The biotin-streptavidin pair is a very popular receptor-ligand pair (used in in-
AFM, Biomembrane Force Probe, Hydrodynamic Flow studies, see also chapter
3) and has also been used in adhesion studies of functionalized GUVs. Studies
have been done both for immobile ligands on the substrate and with mobile
ligands incorporated into a supported lipid bilayer.
C.1.1 Immobile Receptors on the Substrate
Cuvelier et al. [180] studied the kinetics of giant vesicle adhesion mediated by
the receptor-ligand pair biotin-streptavidin. Two types of substrates with im-
mobile ligands (biotin) were prepared that diﬀered in their chemical preparation
and it was found that substrate preparation had a large impact on the resulting
adhesion dynamics. Egg phosphatidylcholine (EPC) vesicles were doped with
0.05 to 5% in weight of biotinylated lipid. After electroformation, strepta-
vidin was added to the vesicle suspension in order to bind to the biotinylated
lipid. After binding, excess streptavidin was removed by centrifugation. As
target surfaces, two kinds of biotinylated substrates were generated, refered
to as 1) casein-biotin and 2) PEG-biotin surfaces. The former was obtained
by adsorption of casein pretagged with a short biotin derivative, NHS-biotin.
The latter was obtained by grafting a long and ﬂexible SBA-PEG3400-biotin
cross-linker (NHS ester of PEG butanoic acid) to an aminosilanized glass slide.
Both had similar surface density of biotin groups available to streptavidin.
The adhesion dynamics of streptavidin-functionalized vesicles spreading onto
biotinylated substrates was in both cases followed by RICM (see ﬁgure 4.7).
The adhesion kinetics strongly depended upon the chemical preparation
of the substrate. Vesicle adhesion was completed within a few seconds on
PEG-biotin substrate although this could be slowed for vesicles with lower
streptavidin density Γ0. In contrast, for casein-biotin substrates spreading took
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Figure 4.7. RICM image sequence of the contact zone of a vesicle at strep-
tavidin coverage Γsat/10 a) on a PEG-biotin surface, Γsat = the saturated
concentration of streptavidin in the adhesion zone; b) on a casein-biotin sur-
face. The time interval between two images is 5s for a) and 30s for b), bar =
5 µm. From [163].
more than 10 minutes and was not aﬀected by Γ0 (see ﬁgure 4.8). Since these
diﬀerences cannot be attributed to a diﬀerence in biotin density on the surface,
the theoretical modeling took into account diﬀerences in the chemical state
of the two substrates. It was proposed that for the casein-biotin substrate,
the accessibility of the biotin to streptavidin is reduced in comparison to the
PEG-biotin surfaces. In this case, the limiting event is the reaction between
the streptavidin and biotin. Adhesion to PEG-biotin gave a growth law of R
∼ t 12 , while the growth rate on the casein-biotin substrates followed R ∼ t 27
Figure 4.8. Typical time evolution of the patch normalized by the radius of
the streptavidin vesicle with diﬀerent streptavidin densities Γ0 adhering onto
diﬀerent biotin surfaces. The dashed line shows the ﬁts obtained from theo-
retical predictions. (A) PEG-biotin, B) casein-biotin) From [180].
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C.1.2 Mobile Receptors on the Substrate
Puech et al. [179] studied the adhesion of a slightly diﬀerent biotin-streptavidin
system. Unlike the experiments by Cuvelier et al., the biotin-streptavidin re-
ceptors were mobile on the substrate, since streptavidin was attached to a
lipid-anchored biotin incorporated into a ﬂuid supported lipid bilayer. Vesicles
made from 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC) containing 1 %
of 1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPE) Cap biotin. Supported
lipid bilayers were formed with the same lipid composition on clean glass sub-
strates, and were incubated with streptavidin leading to a substrate with mobile
streptavidin ligands. The adhesion kinetics of biotinylated GUVs adhering on
the streptavidin substrate was followed with RICM.
The adhesion dynamics of 1) tense vesicles and of 2) ﬂoppy vesicles were
studied separately.
1. Kinetics of tense vesicles For non-adhered vesicles the membrane ten-
sion varied from ∼ 10−7 to ∼ 10−4 N/m. Fairly tense vesicles appeared
as a spherical object in light microscopy. When adhering via the strep-
tavidin/biotin couple, the contact zone appeared as an almost perfectly
circular dark shape in RICM as in the case described in section C.1.1. The
contact zone grew slowly over several minutes. Extracting the power law
of the area A versus growth time t gave A ∼ t0.4, and as the adhesion
patch was circular, its radius varied as R ∼ t0.2 (see image 4.9). For
the work of Cuvelier et al. the vesicles were tense. However, strikingly
diﬀerent growth laws were obtained. This shows the large inﬂuence of
the mobility of the stickers on the growth rate.
2. Kinetics of ﬂoppy vesicles When one introduces a diﬀerence in osmo-
larity between the inside of the vesicle (-) and its surrounding media (+),
water ﬂows through the membrane to compensate this osmotic diﬀer-
ence, leading to an increase of the surface to volume ratio. The mem-
brane is then subjected to large amplitude thermal ﬂuctuations [181].
As depicted in the ﬁrst picture of the sequence of ﬁgure 4.10A and de-
scribed in detail in [179], the contact zone was much larger than for the
tense vesicles. (It is important to distinguish the contact zone and adhe-
sion zone. While the contact zone is the zone where the vesicle is close to
the surface (the whole circular area in ﬁgure 4.10A), the adhesion zone
is the part where the membrane actually adheres (black areas within the
circular area).) The gray levels in the contact zone were ﬂuctuating,
indicating ﬂuctuations in the distance between the membrane and the
surface. These ﬂuctuations have been described theoretically, in partic-
ular by W. Helfrich [88]. Due to the relatively low bending rigidity of the
membrane, thermally excited ﬂuctuations occurred which had optically
detectable amplitudes. As explained in [178], ﬂoppy vesicles sit on a
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Figure 4.9. a) Adhesion of a fairly tense vesicle on a substrate with mobile
stickers (image taken in RICM). The single adhesion patch grew from the
middle and was almost circular. b) Area of the adhesion patch as a function
of time. c) Log-log plot of the area A versus growth time t gives A ∼ t0.4.
From [179].
liquid cushion. The adhesion process started when a membrane ﬂuctua-
tion pierced this cushion and the membrane bound to the complementary
surface (black arrow on the ﬁrst picture of the sequence). Usually, these
events occured at the edge of the contact zone and not in the center,
probably because of the existence of a central dimple [178]. Then, over
several seconds, multiple small adhesion spots grew in a rather circular
manner and fused (white arrow in the second picture of the sequence,
ﬁgure 4.10A. After a few minutes, almost all the individual adhesion
patches fused. They formed a single, irregular shaped, adhesive contact
that kept on growing but with a slowing rate (ﬁgure 4.10C). Because
of the relatively rapid fusing behavior of the small adhesive spots it was
diﬃcult to follow them for a long time (usually this can be done from 1
second to 1 minute). The growth of the total contact area followed a
power law for a single patch at short times (ﬁgure 4.10D), A ∼ t leading
to R ∼ t0.5 for its radius (ﬁgure 4.10D), and A ∼ t1.9 leading to R ∼ t
for an equivalent radius (ﬁgure 4.10E) at long times. These two regimes
have been studied theoretically. The paper did not discucs whether the
adhesion process continued (as in our experiments) or stopped after ring
formation.
The theoretical explanations presented in the paper agreed well with the
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Figure 4.10. a) Adhesion of a very ﬂoppy vesicle (2Rv ∼ 100 µm) on mobile
ligands as seen in RICM. Small adhesion spots appear (black arrow in image 1),
grow and eventually fuse. The remaining non-adhering membrane is ﬂuctuating
(grey part). b) Area of two small spots as a function of time c) Plot of the
total area of the spots versus time. c) Plot of the total area of the spots
versus time d) calculation of the power laws for a single patch A ∼ t, leading
to R ∼ √t e) Calculation of the power law for the total contact area, A ∼ 1.9
leading to R ∼ t for an ”equivalent” radius. From [179]
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experimental data, as they matched the experimentally found power laws for
the growth of the adhesion zones for both ﬂoppy and the tense vesicles. The
theory of the ﬂoppy case will be discussed in chapter 6, as it closely corresponds
to our experimental conditions.
C.2 The Homophilic Receptor Contact Site A from Dictyostelium
Discoideum
The group of Prof. Sackmann at the TU Munich developed a system mimick-
ing cellular adhesion using the homophilic (self-recognizing), lipid-anchored gly-
coprotein Contact site A from cells of the slime mold Dictyostelium discoideum
[182]. This was one of the ﬁrst attempts to build up a biomimetic adhesive
system. The receptor was incorporated into giant vesicles as well as into a solid
supported bilayer on the target surface. Additionally, lipopolymers PEG2000
were incorporated into the vesicles in order to form an artiﬁcial glycocalix. The
interactions of the functionalized vesicles with the substrate were studied with
RICM, and the adhesion strength was then evaluated. At low receptor con-
centrations, adhesion-induced receptor segregation in the membrane lead to
decomposition of the contact zone into domains of strong (receptor-mediated)
adhesion and regions of weak adhesion while at high receptor densities contin-
uous zones of strong adhesion formed. Four diﬀerent receptor concentrations
in the giant vesicles were tested with protein-to-lipid molar ratio rP/L rang-
ing from 4x10−6, 8x10−6, 4x10−5 to 8x10−5 (concentrations if 100 % of the
proteins were incorporated). The protein-to-lipid molar ratio rP/L in the solid
lipid bilayer was 2x10−3. The RICM images of the four diﬀerent conditions
are shown in ﬁgure 4.11. With the help of contour analysis of the shape of
the edge [183], the adhesion strength was described in terms of the spreading
pressure S (=gain of energy due to the adhesion of the vesicle, [184]).
Figure 4.11. Eﬀects of ligand concentration on vesicle adhesion. The csA-
concentration was successively increased from the left to the right and span a
range of 20x. The areas marked by white contours deﬁne the tight adhesion
domains that are observed by time averaging of the intensity distribution to
average out intensity ﬂuctuations due to ﬂickering. From [182].
The authors found that three states of adhesion could coexist at interme-
diate concentrations of csA. (see also image 4.11):
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 The ﬁrst was a state of weak adhesion, which was associated with strong
ﬂickering (4.11A). No bonds between csA pairs are found.
 The second was a state of intermediate adhesion strength (4.11B and
C). Zones of tight adhesion (marked with white contours) coexisted with
regions of weak adhesion. The weak adhesion zones ﬂuctuated strongly.
 Third, a state of strong adhesion was observed (4.11D) forming an
essential circular adhesion patch. No or small ﬂuctuations were observed.
C.3 The Ligand- Receptor Pair Sialyl-Lewisx - E-Selectin
Another system mimicking cellular adhesion was developed in the group of
Prof. Sackmann using the weakly interacting ligand receptor pair sialyl-Lewisx
- E-selectin (the binding aﬃnity is estimated to be between 5 and 7 kBT)
[185], [186]. As described in chapter 2, cells such as leukocytes or cancer cells
depend on a selectin-based mechanism to establish weak, reversible adhesion
that permit then to roll along vessel walls. Compared to the streptavidin-biotin
model, the selectin system is of high biological relevance. In the developed
model system, giant vesicles were functionalized with lipid-anchored sialyl-
Lewisx molecules and the substrate was coated with E-selectin. The vesicles
also contain lipid-anchored PEG2000 molecules in order to mimic the cell
glycocalix. The equilibrium state of adhesion was analyzed in detail using
RICM technique. The authors found that the adhesion process relied purely
on the formation of one or more adhesion domains within the vesicle-substrate
contact zone. The adhesion was studied as a function of ligand concentration
on the surface. It was found that the ligand content in the vesicle must
be greater than 5 mol-% to establish speciﬁc contacts (in the absence of
PEG). However, all concentrations for sialyl-Lewisx above 8 mol-% provided
a similar ﬁnal state of adhesion. Finally, the size and shape of the adhesion
domains strongly depended on both the concentration of E-selectin (0-3500
molecules/µm2) and PEG2000 (0 - 5 mol-%). At 3500 molecules/µm2 and
small concentrations of PEG2000 (ﬁgure 4.12), the vesicle-substrate contact
was maximized and consisted of a single adhesion domain. At concentrations of
5 mol-%, PEG2000 completely inhibited binding to the substrate. It should be
noted that a concentration of 3500 molecules/µm2 of E-selectin corresponds
to the typical concentration at cell surfaces.
C.4 The Ligand-Receptor-Pair Integrin- RGD
The group of Prof. Sackmann developed a third model system in which the
surface was coated with the transmembrane protein integrin αIIbβ3, whose
biochemical properties were presented before (see chapter 2). Giant vesicles
were functionalized with a cyclic lipid-anchored RGD that is selectively recog-
nized by integrin αIIbβ3 [140], [168]. In order to mimic the cell glycocalix, the
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Figure 4.12. Adhesion as a function of E-selectin surface density at constant
1 mol % PEG2000 content. RICM images of the adhered vesicles are shown in
the top row. The numbers underneath the micrograph denote the number of
E-selectin molecules per square micrometer. The graph shows the normalized
adhesion domain area as a function of the surface coverage. A strong increase
at low coverage is followed by saturation at high coverage. (Inset) Adhesion
strength increases over the whole observed range of surface density. From
[186].
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vesicles were also doped with PEG-polymer-carrying lipids. Although this ge-
ometry is the inverse of a biological situations, this work was essential for the
implementation of our own model system as we beneﬁtted from the expertise
of the Sackmann group in membrane protein puriﬁcation and handling.
The adhesion of these functionalized vesicles onto the integrin-covered
surfaces was studied. Two diﬀerent versions of the systems were developed
with a) the integrin immobilized on the surface (physisorbed integrin) and
b) the integrin able to diﬀuse over the surface (integrin incorporated into a
supported lipid bilayer).
a) Physisorbed Integrin
The integrin was solubilized with the help of a detergent (Triton) and
was ﬁxed on glass substrates by physisorption [168]. This decorated
surface played the role of a target cell (see ﬁgure 4.13).
Figure 4.13. Vesicles carrying lipid-anchored RGD adhere to immobilized
physisorbed integrin receptors. From [168].
This system was used to study several aspects of the interaction of the
RGD-covered vesicles with the integrin-functionalized surfaces.
First, the unbinding forces of the RGD-integrin couple was measured
by pulling on magnetic beads attached to the top of an adhered vesi-
cle. Force was generated with magnetic tweezers while de-adhesion was
monitored with RICM (see ﬁgure 4.14) [168]. RICM images showed that
the adhesion zone was heterogeneous, which was explained as a result
of the mobile ligands in the vesicle membrane. Pinning sites of a radius
of the order of 100 nm (triangular shapes in RICM image when force is
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Figure 4.14. Pulling on a RGD vesicle adhering on an integrin surface with
magnetic tweezers. a) The force transducer consists of a magnetic bead
(acting as a tweezer) which is coupled to the membrane at the top of the
vesicle and pulled in vertical direction with the help of magnetic tweezers. b)
The development of the de-adhesion of the vesicle due to the applied force is
followed by RICM technique. The black area shows the adhered part of the
vesicle and is decreasing when force is applied. From [168].
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applied, image 4.14B) were observed which contained large numbers of
ligand-receptor pairs. In general, it was possible to unbind these pinning
centers with applied force of order of 1 pN or less. Single-molecule force
studies of ligand-receptor pairs report rate-dependent unbinding forces
in the range of 50 pN or more. The authors interpreted these results
as fracturing of the receptor-ligand pairs due to a torque on the edge of
the adhesion disk. This torque was more important than the traction.
Furthermore, the kinetics of vesicle adhesion to an integrin-covered sub-
strate was studied experimentally [140]. The theoretical part of this
work was already brieﬂy described above in section B.2.1. The adhesion
of the vesicle to the integrin-covered surface started with the sponta-
neous formation of a small (∼ 200 nm) domain of tight adhesion, which
then gradually grew until the whole adhesion area was a state of tight
adhesion (ﬁgure 4.15). The time of adhesion varied from few tens of
seconds to about one hour depending on the ligand and PEG-lipopolymer
concentration.
The kinetics of adhesion of a single giant vesicle was controlled by the
competition between membrane-substrate interaction (speciﬁc ligand-
receptor interaction, gravitation, and Helfrich repulsion) and followed by
RICM. At small ligand concentrations, the displacement of the front of
tight adhesion followed the square root law R ∼ t 12 , whereas, at high
concentrations a linear law R ∼t was found. [140].
Figure 4.15. Adhesion area of a RGD-functionalized vesicle adhering to an
integrin-covered surface. a) The vesicle in the weak adhesion state. b) Nucle-
ation of the state of strong adhesion. c) and d) The strongly adhered patch
grows. From [140].
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Moreover, the segregation of RGD-ligands and enrichment within the
adhesion patch was visualized by ﬂuorescence (see ﬁgure 4.16). A ﬂuo-
rescently labeled RGD-lipid was synthesized which could be easily incor-
porated in giant vesicles. The adhesion of these vesicles was then studied
simultaneously by RICM and ﬂuorescence microscopy [187]. They ob-
served the micro-segregation of RGD lipids in the contact zone during
adhesion (see ﬁgure 4.16). It was shown that the ﬂuorescent marker
was only located in the contact zone indicating that strong adhesion
was established via the RGD-integrin bond.
Figure 4.16. A vesicle labeled with the ﬂuorescent RGD adhering onto a
substrate coated with physisorbed integrin. a) RICM image of the vesicle. The
dark part corresponds to the adhered part of the membrane. b) Fluorescence
image: all ﬂuorescent spots are localized in the contact zone. From [187].
b) Mobile Integrin incorporated into a Supported Lipid Bilayer
The experimental system was improved by spreading small vesicles bear-
ing the integrin αIIbβ3 on ultrathin ﬁlms of cellulose, forming a con-
tinuous supported lipid bilayer on the substrate [169]. Spreading the
78
C. EXPERIMENTS: FUNCTIONALIZED GUVS MIMICKING CELL
ADHESION C
integrin onto a cellulose cushion improved the protein functionality by
reducing the contact between protein and surface. The functionality
of the receptor on bare glass (system a) and on cellulose cushions was
compared by measuring the adhesion strength of giant vesicles carrying
the lipid-anchored RGD. The system was studied with ﬂuorescence mi-
croscopy and RICM, and the free adhesion energy W was measured. The
receptor-ligand binding energy was estimated to be wI−RGD ∼ 10 kBT
under bioanalogous conditions. With a receptor density nI ∼ 7x1013
m−2, the speciﬁc adhesion energy was then estimated to be Wad ≈
nIxwI−RGD ≈ 3x10−6 Jm−2. According to ﬁgure 4.17, this is only 3
to 10 times larger than the largest spreading pressure ∆gad found for
vesicles containing 2 % and 3 % PEG lipids, respectively. It is 30 times
larger than the largest value of ∆gad found for vesicles containing 2 %
of PEG on pure glass substrates (no cushion). (There is only a small
discrepancy between ∆gad and Wad: ∆gad = Wad - ∆piR - ∆piLi, where
∆piR and ∆piLi are the osmotic pressure diﬀerence of the repellers and
ligands, respectively. For details see [169].)
Figure 4.17. Histograms of measured values of free energies of adhesion ∆gad
of vesicles containing 2 and 3 mol % of repeller lipids (PEG lipids) on cellulose
(black and dotted lines, respectively) and of vesicles containing 2 mol % PEG
lipids on bare glass substrates (gray lines). The largest value correspond to re-
gions of tight adhesion, whereas the lowest values correspond to the spreading
pressures of the regions of weak adhesion. TMSC = trimethylsilyl cellulose.
From [169]
Fluorescence microscopy showed heterogeneous and numerous dark patches
in the case of physiadsorbed ﬂuorescently labeled integrin, accounting for
incomplete coverage of the surface (see image 4.18). In the improved
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system with the cellulose cushion, the formed membrane was ﬂuid and
homogeneous and the integrin could diﬀuse over the surface.
Figure 4.18. Fluorescently labeled integrin on the substrate a) Physisorbed
integrin. The surface is heterogeneous with numerous dark patches are visible.
b) Integrin incorporated into a SLB. The surface is homogeneous and the
surface is fully covered by integrin. From [169].
The functionality of the integrin in the supported lipid bilayer (SLB)
was tested with the help of RGD-binding tests. Fluorescently labeled
RGD was incubated with the protein-containing SLB, rinsed, imaged with
ﬂuorescence microscopy to show that the RGD bound to the integrin in
the SLB.
As mentioned before, the development of the RGD-integrin system in the
group of Prof. Sackmann was crucial for the implementation of our own
model system, as we beneﬁtted from the group's expertise in membrane protein
puriﬁcation and handling. Their work inspired us to develop a system in which
the integrin receptor was integrated in the vesicle membrane. This geometry
more closely resembles the structure of a biological cell.
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The group of Prof. Erich Sackmann at TU Munich developed the ﬁrst exper-
imental model systems using the transmembrane protein integrin to study cell
adhesion [188], [168], [169]. From the vast family of adhesion proteins, they
studied the speciﬁc interaction of the transmembrane protein integrin αIIbβ3
(described before, see chapter 2) with RGD. They decided to use this particular
integrin since it is fairly easy to obtain, and most importantly, its biochemical
and structural properties are very well characterized. To model the cell, giant
unilamellar vesicles were employed as they comprise the basic structure of the
cell envelope - the lipid bilayer. It is not easy to reconstitute transmembrane
proteins into giant vesicles while preserving their biological functionality and
at that time, the Sackmann group were unable to ﬁnd a protocol for recon-
stituting integrin. Instead, they chose to functionalize the giant vesicle with
RGD-lipids, and adsorbed the integrin to the surface (at ﬁrst, directly and
later via a 2D supported lipid bilayer - see ﬁgure 5.1). This provided an ele-
gant proof of the functionality of the protein and experiments studying GUV
spreading were then possible.
Nevertheless, their approach had several disadvantages:
-The integrin was in direct contact with the glass substrate, which altered its
functionality.
-The geometry limited the range of possible experiments with the system. In a
real cell, the integrin is not only in contact with the outside of the cell, but also
receives signals from the inside and is directly connected to actin cytoskeleton
via coupling proteins (see also chapter 2).
The experimental approach by the Sackmaann group was a signiﬁcant step
towards the challenging goal of reconstituting integrin into GUVS. This goals
was the ﬁrst and most diﬃcult objective of this thesis. More generally, this
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Figure 5.1. Model system of the Sackmann group, TU Munich. A) A
schematic view of the system: A RGD-functionalized GUV adheres to an in-
tegrin covered surface. B) RICM image of the adhering vesicle. C) Schematic
close-up of the integrin-containing bilayer. In the reﬁned system, the integrin
is protected by a cellulose layer from interactions with the glass substrate.
From [189].
approach opens up numerous possibilities to bring model cells closer to the
complexity of a biological system.
A Reconstitution of integrin αIIbβ3 into Giant Unil-
amellar Vesicles
A.1 General Scheme
Based on a method previously developed in the group of Prof. Bassereau [3],
for the ﬁrst time the transmembrane protein αIIbβ3 (described earlier) was
successfully reconstituted into giant unilamellar vesicles (GUVs). First, the
integrin αIIbβ3 was puriﬁed from human platelets (in collaboration with Dr.
M. Bärmann, TU Munich, Germany) and then ﬂuorescently labeled (for details
see appendix C). The next step of the method involved the detergent-mediated
reconstitution of solubilized membrane proteins into small proteoliposomes.
This process can be schematically summarized as follows (detailed proto-
cols in appendix D):
a) Reconstitution of Integrin in SUVs The integrin is reconstituted into
proteoliposomes following a general procedure described in references [190],
[191]. The integrin is mixed with the lipid and a detergent (Triton). With
the help of the detergent, which solublizes the protein and the lipid, micelles
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Figure 5.2. The ﬁrst step of the method involves the detergent-mediated
reconstitution of solubilized membrane proteins into small proteoliposomes.
containing all three components are formed. After removal of the detergent
using biobeads®, vesicles form that contain only the integrin and the lipid. All
reconstitution protocols used in the presented text require Biorad biobeads®
for detergent removal. These macroporous polymeric adsorbents of high sur-
face area have to be activated by removing trapped air from the pores. This
activation is crucial for correct functioning of the adsorbent. The use of these
polystyrene beads to remove detergent is a highly reproducible way to gener-
ate unilamellar proteoliposomes. In addition, it allows quasicomplete removal
(only traces of less than 1 % (sensitivity limit of the used technique, likely to
be even less) can be found after treatment with biobeads®) of detergent
[192]), which is important for GUVs since detergent destabilizes them [181].
When the detergent concentration diminishes, proteoliposomes consisting only
of lipid and protein form spontaneously. The proteoliposomes are about 100
to 200 nm in diameter [188]. This technique for removing detergent from
lipid-protein-detergent micellar solutions has been reported to be very eﬃcient
and suitable for the reconstitution of many membrane proteins [193].
With the help of electron microscopy, Hu et al. [188] showed that the
integrin αIIbβ3 was indeed incorporated in the small proteoliposomes (see ﬁg-
ure 5.3). Little is known about the orientation of the integrin in these small
vesicles. In platelets, the sialic acid residues of integrin are oriented on the out-
side. Neuraminidase hydrolysis of sialic acid residues in intact and detergent-
solubilized small vesicles showed that at least 55 % of the total sialic acid was
accessible to neuraminidase in the absence of Triton X-100, indicating that
55% of the αIIbβ3 was oriented right-side out in the small vesicle, and, there-
fore, available for instance to bind to ﬁbrinogen [194]. Methods like electron
microscopy should provide further insight. It is probable that the majority are
oriented in the "right way "(extracellular part outside) since the extracellular
part of integrin is rather large and can induce curvature of the membrane.
This has been shown in the case of other membrane proteins with a large
extracellular portion (e.g. Ca2+-ATPase for which ∼ 80 % are oriented with
their large cytoplasmic domain toward the outside [190]).
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Figure 5.3. A1  A4: a series of cryo EM snapshots of a mixture of inte-
grin vesicles and cRGD vesicles. Arrows point to integrin/RGD bridges be-
tween vesicles. Dark spots in panel A3: 5 nm gold particles. Magniﬁcation
31000×; scale bars: 50 nm. B: a mixture of integrin vesicles with pure lipid
vesicles (DMPC/DMPG = 1/1), scale bar: 200 nm. Arrowheads point to
integrin/integrin attachments. C: a mixture of cRGD-vesicles with pure lipid
vesicles as in B, scale bar: 200 nm. All but the 40 integrin-containing vesicles
were produced by extrusion. Note that, for a better overview, B and C are
shown at lower magniﬁcation than A1 A4. The irregular dark objects in the
upper right corner of B are artifacts of the preparation. From [188].
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Figure 5.4. A) The droplets are dried under saturated atmosphere for up
to 12h. B) Chamber for preparation of GUVs consisting of ITO-conductive
glass slides, separated by a Teﬂon® spacer. A voltage is applied through two
copper strips. GUVs form from partially dried droplets of proteoliposomes in
contact with an aqueous sucrose solution.
b) Formation of Giant Unilamellar Vesicles (GUVs) using Electrofor-
mation In the second step, small droplets (1.5 µl each) of these preformed
proteoliposomes are partially dried under controlled humidity on ITO treated
glass slides. No vesicles grow from completely dehydrated (vacuum) droplets,
probably because the integrin is denatured during the process. It has been
shown that complete dehydration under high vacuum can have deleterious
eﬀects on the biological activities on other proteins as well [3]. Thus, it is
essential to perform a partial dehydration of the proteoliposomes under con-
trolled humidity (i.e. in the vapor from a saturated salt solution).
After the droplets have partially dried, the ﬁlm is rehydrated in sucrose
solution while exposed to an AC electric ﬁeld (see ﬁgure 5.4, for detailed
protocols see appendix D). The resulting are 10 - 100 µm in diameter.
Figure 5.5. Integrin containing GUVs are formed from proteoliposomes by
electroformation.
85
CHAPTER 5. THE MINIMAL SYSTEM A
A.2 Challenges
A major challenge was to adapt the existing protocols to integrin αIIbβ3 so as
to yield giant unilamellar vesicles larger than 15 µm. Two approaches existed:
1. Initial Paris Protocol
The general protocol developed by Girard et al. [3] for reconstitut-
ing other membrane proteins (bacteriorhodopsin and Ca2+-ATPase) into
GUVs.
2. Initial Munich Protocol
The protocol used in the Munich lab to prepare 2D-lipid bilayers con-
taining integrin αIIbβ3 [188], [195].
(Proteo-GUVs and protein-containing lipid bilayers both use proteolipo-
somes for the initial step.)
These protocols did not produce vesicles, but rather multi-lamellar objects
with non-spherical shapes and small size (see ﬁgure 5.6).
Figure 5.6. Phase contrast microscopy showing the multilamellar objects
formed with the initial reconstitution methods (in this case the initial Paris
protocol), bar = 10 µm.
After exhaustive testing and development, a ﬁnal protocol was developed
which led to large (larger than 15 µm in diameter) unilamellar spherical vesicles.
The ﬁnal, functional protocol as well as the two initial protocols are pre-
sented in the appendix D. Although, the diﬀerences between the ﬁnal protocol
and the initial ones may seem minor, these small, apparently minor changes
turned out to have a decisive eﬀect on the eﬀectiveness of the protocol.
The parameters which appeared to be crucial for integrin reconstitution
into GUVs are listed below:
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1. The lipid composition of the vesicle was crucial for forming large, spher-
ical, defect-free vesicles. In the original protocols, only zwitterionic lipids
were used (phosphocholine, PC).
 Negatively charged lipids have been reported to help in the pro-
tein reconstitution step [139] as well as in the activation of cer-
tain integrins [196]. Using L-α-Phosphatidic Acid (Egg, Chicken-
Monosodium Salt, EPA) improved integrin incorporation as shown
by adhesion tests. Control tests (same lipid composition without in-
tegrin) did not show unspeciﬁc adhesion under same conditions (see
below). Note that using 1,2-dioleoyl-sn-Glycero-3-phosphoserine
(DOPS), a negatively charged lipid, did not bring much enhance-
ment (adhesion of vesicles in adhesion tests only rarely observed).
Integrin GUVs were used in adhesion studies on biofunctionalized
surface, as described below and in the next chapter.
 PEG-functionalized lipids formed much larger vesicles and helped
prevent unspeciﬁc adhesion. In the presence of divalent ions, vesi-
cles without PEG lipids adhere with each other and with the sur-
face, or burst (as visualized by RICM on the surface of the observa-
tion chamber). This result was previously shown by another group
at Institut Curie,[197]. Steric repulsion due to the grafted PEG
polymers is an eﬃcient inhibitor of non-speciﬁc adhesion and help-
ing prevent non-speciﬁc adhesion due to divalent ions [198]. PEG
functionalized lipids have been used previously to mimic the glyco-
calix of the cell [182]. Diﬀerent PEG-lipids were tested and the
length of the PEG-polymer (M.W. 2000, 3000, or 5000) was not
found to be crucial. DOPE-PEG2000 (1,2-Dioleoyl-sn-Glycero-3-
Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-2000]) lipid
was replaced by DPPE-PEG2000 (1,2-Dipalmitoyl-sn-Glycero-3-
Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-2000])lipid
for its lower susceptibility to light and oxidation.
In order to distinguish speciﬁc adhesion events from non-speciﬁc inter-
action caused by divalent ions / negative charge on the lipids, all lipid
compositions without integrin were tested under the same conditions
(same buﬀers, same surfaces) as used later in the adhesion experiment.
The adhesion of lipid vesicles was tested on a passivated surface (casein-
covered cover slips) and an adhesive surface (ﬁbrinogen-covered cover
slips), in the presence of divalent ions, which are necessary for the func-
tioning of the integrin.
Results for a range of lipid compositions are reported below:
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Lipid mol-% Comment*
EPC 100 large vesicles,
explosion and adhesion with divalent ions
EPC 95 very large vesicles,
DOPE-PEG2000 5 no or unfrequent explosion/adhesion with divalent ions
EPC 95 very large vesicles,
DOPE-PEG2000 5 no or unfrequent explosion/adhesion with divalent ions
EPC 95 very large vesicles,
DOPE-PEG3000 5 no or unfrequent explosion/adhesion with divalent ions
EPC 95 very large vesicles,
DOPE-PEG5000 5 no or unfrequent explosion/adhesion with divalent ions
EPC 95 very large vesicles,
DPPE-PEG2000 5 no or unfrequent explosion/adhesion with divalent ions
EPC 85 very large vesicles,
EPA 10 no or little explosion/adhesion with divalent ions
DMPE-PEG2000 5
*EPC = L-α -phosphatidylcholine
explosion = vesicles explode, the membrane fragments can be observed
on the glass surface by light microscopy
large = larger than 15 µm in diameter
adhesion = vesicles adhere to each other, or to the surface
Conclusion: As is evident from the table above, the composition 85 %
EPC, 10 % EPA, 5% PEG2000 was best suited and was therefore used.
2. The integrin/lipid ratio proved to have a major inﬂuence on the GUV
size and shape. Using high integrin (1 integrin per 1000 lipids or higher,
equivalent to about 1000 integrins per µm2) concentrations led to small
(smaller than 10 µm in diameter) or non-spherical vesicles, often multi-
lamellar in appearance as showed above (see ﬁgure 5.6). The initial
Munich protocol uses about 20 times as much integrin as used in the
initial Paris protocol (1 integrin per 1000 lipids) for other membrane
proteins. However, even the concentration of the initial Paris protocol
turned out to be too high.
The lipid/integrin ratio on platelets is 1000/1 while on other cell types
5.000-10.000 lipids are found per integrin [199]. Using a 1000/1 mixture
yielded multi-lamellar object of diﬀerent shapes.
Conclusion: Using a lipid/integrin ratio of 8000 lipids per integrin, equal
to about 1000 integrins per µm2, (and within the biological range) yielded
nice almost defect-free vesicles.
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3. Furthermore, Munich and Paris protocols diﬀer in the reconstitution
temperature: (Munich: 15 and 37 °C, Paris: room temperature). Final
reconstitution was performed at room temperature. As shown by Levy
and Rigaud [190], [191], many proteins are stable at room temperature
in the presence of detergent.
Conclusion: Reconstitution was performed at room temperature.
4. The duration of exposure to biobeads is another crucial factor (Mu-
nich: 1h, Paris: at least 3h). In the ﬁnal protocol, this step was prolon-
gated and biobeads® were stirred overnight to improve the removal of
detergent. GUVs with a diameter of 20-70 µm were obtained, conﬁrm-
ing the absence of detergent in the ﬁnal state.
Conclusion: The reconstitution solution was exposed to biobeads over-
night.
5. The duration of the electroformation process was lengthened from
the 4h period of the initial Paris protocol to overnight (12h). Increas-
ing the growth period mainly changed the size of the vesicles and larger
vesicles could be obtained.
Conclusion: Electroformation was extended to an overnight process.
6. Aging of the integrin solution heavily inﬂuenced the quality of ob-
tained GUVs. Reconstitutions with freshly puriﬁed integrin yielded al-
most defect-free vesicles, while aged integrin led to multilamellar non-
spherical objects. Generally, six months after puriﬁcation, no vesicles
could be obtained. It was furthermore documented [200] that integrin
αIIbβ3 showed heavily reduced activity as shown through the activity
test ELISA. Storage temperature was also crucial. While -70 °C and 0
°C did not inﬂuence the integrin's activity, storage at -20 °C reduced its
activity by 30% independent of previous shock freezing in liquid nitrogen.
Conclusion: Integrin was used only within 5-6 months after puriﬁcation
and stored at -70 °C.
Finally, it has to be noted that reliabiltiy of vesicle growth protocol was a major
issue. Frequently, the protocol would not yield vesicles and this could last for
a period of a few weeks. Detailed experimentation analysis of the likely factors
did not reveal the cause of this variability.
A.2.1 Other Tested Procedures
A.2.1.1 Inﬂuence of Sucrose during Reconstitution Doeven et al. [139]
reported that addition of sucrose during the dehydration step of the GUV-
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formation process prevented four distinct membrane protein(s) (complexes)
from inactivating. They optimized the amount of sucrose so that the pro-
teins retained 100% biological activity, and many proteo-GUVs were obtained.
Depending on the protein, as little as 20 mg sucrose/g of lipid was suﬃcient
to retain full activity. In their protocol, sucrose is added to the SUV solution
which is then dehydrated in vacuum. This protocol did not work for integrin
containing GUVs and either no GUVs were obtained, or the small numbers of
GUVs obtained did not adhere onto the surface in adhesion assays.
A.2.1.2 The Eﬀect of Divalent Ions on the Growth of Vesicles
The biological function of the integrin complex αIIbβ3 (see chapter 2.1) de-
pends on divalent ions, mainly Mg2+, Ca2+ and Mn2+ and it would be desirable
to add these ions to the sucrose solution in the growth chamber. However,
the presence of divalent ions inhibited vesicle growth via electroformation.
The following growth buﬀer solutions were tested:
Composition Buﬀer Result
100 mol% DOPC buﬀer A∗ no vesicles
1mM Ca2+
100 mol% DOPC buﬀer A∗ no vesicles
1mM Ca2+
119 mM sucrose
100 mol%DOPC 180 mM sucrose no vesicles
1mM Ca2+
2 mM KCl
85 mol% EPC 180 mM sucrose no vesicles
10 mol EPA% 1mM Mg2+
5 mol% DMPE-PEG2000 1 mM Mn2+
100 mol%DOPC 180 mM sucrose unilamellar, spherical vesicles,
85 mol% EPC 180 mM sucrose large, spherical vesicles,
10 mol EPA%
5 mol% DMPE-PEG2000
∗ buﬀer A:
pH 7.4
150 mM NaCl
10 mM Tris
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A.3 Summary
A mixture of EPC, EPA and DMPE-PEG2000 lipid yielded spherical,
mainly uni-lamellar vesicles (see ﬁgure 5.7.)
 EPA was introduced to improve integrin incorporation into vesicles.
 PEG2000 lipids were used to screen non-speciﬁc attraction induced by
divalent ions.
 The integrin concentration was lowered, but was within biological con-
centrations found on cells.
 Biobeads® were incubated all night in order to fully remove the deter-
gent.
 The electroformation process was prolonged in order to obtain larger
vesicles.
 Integrin was used less than 6 months after puriﬁcation
The following image shows vesicles obtained using the improved protocol:
Figure 5.7. Integrin proteoliposomes formed using a mixture of EPC, EPA
and DMPE-PEG2000 were predominantly spherical and uni-lamellar. Phase
contrast microscopy, bar = 10 µm.
A.4 GUVs from Native Membranes
A second approach to form GUVs containing integrin αIIbβ3 was also exam-
ined. Since integrin αIIbβ3 is the most abundant protein on platelets, the
strategy was to purify the platelet membrane and to grow GUVs from this
91
CHAPTER 5. THE MINIMAL SYSTEM B
natural lipid-integrin mix. For detailed protocol see appendix C. Such a mem-
brane puriﬁcation is also likely to preserve some of the proteins which link the
integrin to the actin cytoskeleton (for details see chapter 2). These linking
proteins could facilitate the extension of the model system (e. g. the incor-
poration of actin cytoskeleton into the GUVs).
Membrane was puriﬁed following a protocol by Smyth et al. [201]. Electro-
formation of the obtained membrane solution did not produce vesicles.However,
by diluting the obtained membrane solution with the puriﬁcation buﬀer, vesi-
cles could be obtained (see ﬁgure 5.8).
Figure 5.8. Formation of GUVs from native membrane (growth chamber). A)
The undiluted membrane solution does not produce vesicles. B) diluting the
obtained membrane solution before electroformation leads to vesicles (dilution
with buﬀer 1:1 in volume). C) dilution with buﬀer 1:5 in volume. Phase
contrast image, bar = 10 µm.
Despite these promising results, this approach was abandoned because
there was no access to suﬃcient amounts of outdated∗ platelets in France
as well as insuﬃcient infrastructure for membrane puriﬁcation at the Institut
Curie. However, this approach seems to be a very promising way to obtain
integrin- covered GUVs with a biological composition, especially since some of
the linker proteins to the cytoskeleton might be retained.
∗Outdated platelets are too old for transfusion. For experiments, platelets are used within
14-21 days after venipuncture.
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B Incorporation and Functionality
The reconstitution process was validated by analyzing protein incorporation
and biological activity.
B.1 ELISA-Test on Integrin-Containing SUVs
The activity of the integrin after reconstitution and after electroformation
was tested with the help of qualitative Enzyme-Linked Immunosorbent Assay
(ELISA). The test consisted of checking the capacity of a speciﬁc anti-human
β3 antibody to bind to integrin αIIbβ3, which then reacted with a second
labeled antibody. A postive test, corresponding to active integrin, occurred
when the ﬁnal solution turned yellow. The detailed protocol can be found in
appendix C. A solution of SUV reconstituted integrin was checked. Secondly,
in order to obtain the same integrin concentration for ELISA after electro-
formation, the eﬀect of electroformation was mimicked by exposing the same
volume of integrin-containing SUVs to an electric ﬁeld for 12 h (see ﬁgure
5.9). The results of the ELISA tests were compared. Qualitatively, no diﬀer-
ence in activity was observed as both samples (before and after exposure to
electrical ﬁeld) showed approximately the same color intensity.
Figure 5.9. ELISA test. Eﬀect of electric ﬁeld on the integrin activity.
Conclusion: The integrin retains its activity after electroformation.
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B.2 Confocal Microscopy
Confocal microscopy showed that the ﬂuorescently-labeled protein were incor-
porated into the membrane.
Figure 5.10. Confocal image of the membrane of a GUV in which 5% of the
integrins are labeled with a TAMRA-label, bar 10 µm. The elliptic shape of
the vesicle is due to the scanning speed of the confocal microscope.
Incorporation was homogeneous with no clustering of integrins (see ﬁgure
5.10). The integrin was labeled with 5(6)-TAMRA, a rhodamine derivate,
which ﬂuoresces at red wavelengths (emission maximum = 576 nm). 5% of
the total integrins was labeled.
Conclusion: The integrin was present in GUVs as shown by confocal im-
ages.
B.3 Quantum Dots Assay
The activity of integrin αIIbβ3 was further tested through interaction assays
with functionalized quantum dots (QDs) carrying an RGD- tripeptide or a
PEG-sequence. Functionalized quantum dots were kindly provided by the
group of V. Marchi-Artzner, University of Rennes.
Two types of PEG- functionalized QDs were provided. One type was termi-
nated by a negative charge while the second was terminated with a zwitteri-
onic endgroup. The QDs had an emission maximum wavelength of 603 nm
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(red). The hydrodynamic diameter of the QDs was 15 nm (RGD), and 11 nm
(EO6D), respectively. The chemical formulas are shown in ﬁgure 5.11. QDs
were stored in a borate buﬀer at pH 8.3.
Figure 5.11. The functional group on the QDs - A) negatively charged
PEG, B) RGD, C) the zwitterionic group. Private communication A. Dif
/ V. Marchi-Artzner.
To determine if the RGD-tripeptide was recognized by the integrin on the
giant vesicle both ﬂuorescence microscopy and spectroﬂuorimetry were per-
formed. For ﬂuorescence microscopy, only the results from platelets (Integrin
αIIbβ3 is the most abundant protein on platelets) are shown here. The ex-
periments on GUVs containing the integrin αIIbβ3 are still underway. For
spectroﬂuorimetry, assays were performed on proteoliposomes and platelets.
B.3.1 Fluroescence Microscopy on Platelets
Two samples were prepared. Platelets were mixed with either RGD-QDs or
negatively charged PEG-QDs and then observed in epiﬂuorescence microscopy
(A green ﬁlter (λexc = 525 nm, λem = 565 nm) was used.) (detailed protocol
in appendix F). Fluorescence images showed that the RGD quantum dots
rapidly bound to the platelet membrane (see ﬁgure 5.12). In contrast, the
unexpected binding of the PEG-QDs could have resulted from nonspeciﬁc
interaction between the negative charge on the PEG-group and the protein on
the platelets.
Conclusion: These experiments show that the RGD-QDs are able to interact
speciﬁcally with the integrin αIIb β3 on platelets.
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Figure 5.12. A) RGD-QDs (50 % RGD) are immediately visible on platelets,
images after 5(left) and 20(right) minutes. B) Platelets incubated with PEG-
functionalized QDs after 5(left) and 20(right) minutes. Epiﬂuorescence image,
bar = 10 µm.
B.3.2 Spectroﬂuorimetry on Platelets
As it was diﬃcult to quantify the ﬂuorescence on platelets and GUVs using epi-
ﬂuorescence microscopy, a second quantitative technique, spectroﬂuorimetry,
was used. Platelets were incubated for 15 minutes with QDs (either PEG- or
RGD-functionalized QD), unbound QDs were removed by centrifugation (for
detailed protocols see appendix F) and the concentration of the bound QDs
was then measured via spectroﬂuorimetry.
Several samples were prepared:
1. A blank sample containing only QDs in HEPES buﬀer
2. Platelets + RGD-QDs (50 % functionalized)
3. Platelets + negatively charged PEG QDs
Fluorescence was excited (λexc = 360 nm) and the ﬂuroescence inten-
sity was measured as a function of emission wavelength. Figure 5.13 shows
ﬂuorescence intensity as a function of wavelength for all three samples.
As can be seen from the graph, although the negatively charged PEG-
functionalized QDs interact with the platelets, the ﬂuorescence from RGD-
carrying QDs is much stronger. This conﬁrms the speciﬁc interaction between
the RGD-carrying QDs and the integrins on the platelet surface.
Conclusion: The spectra showed that the interaction of platelets with
RGD-functionalized QDs is much stronger than their interaction with PEG-
functionalized QDs.
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(a) Blank sample
(b) Platelets
Figure 5.13. A) Fluorescent spectrum from a blank sample of QDs (50
% RGD, 16 nM) in HEPES buﬀer. B) Fluorescence spectrum of platelets
incubated with a) 50 % RGD QDs, b) neg. PEG QDs
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B.3.3 Spectroﬂuorimetry on Proteoliposomes
Samples were prepared (200 nM QDs in solution) with:
1. A blank sample containing only QDs in HEPES buﬀer
2. Proteoliposomes (SUVs) + RGD QDs
3. Proteoliposomes (SUVs) + zwitterionic PEG QDs
4. Lipid mix w/o integrin (SUVs) + RGD QDs
5. Lipid mix w/o integrin (SUVs) + zwitterionic PEG QDs
The proteoliposomes or liposomes were incubated for 5 minutes with the
QD solution. Unbound QDs were then removed via ultra-centrifugation on
a sucrose gradient. First, the liposome / proteoliposome solution was mixed
with a 60 % sucrose solution to a ﬁnal volume of 1 ml. This was transfered to
a centrifuge tube and a sucrose gradient prepared by carefully layering on top
ﬁrst 6 ml of 40 % sucrose solution, then 3.5 ml of a 5 % sucrose solution. After
centrifugation (12 hrs, 4 °C (for detailed protocol see appendix F), a white
band containing the proteoliposomes / liposomes formed at the interface of the
5 % and the 40 % solution. This fraction was extracted and the ﬂuorescence
emission spectrum measured (λexc = 360 nm).
Figure 5.14. Fluorescence from the sample containing proteoliposomes +
RGD-QDs is much higher than from the other prepared samples, indicating
the speciﬁc recognition of the RGD-peptide by the integrin αIIbβ3
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As can be seen from the graph (ﬁgure 5.13B), the integrin in the prote-
oliposomes interacted with the RGD-functionalized QDs, while practically no
ﬂuorescence was observed in the proteoliposome- PEG-functionlized QDs mix.
The PEG-functionalized QDs did not interact with either the pure lipid mix or
with the proteoliposomes.
Thus the RGD-QDs speciﬁcally interact with the integrin containing pro-
teolipsomes. conﬁrming that the integrin is still active at this stage of the
reconstitution.
Conclusion: QD assays using epiﬂuorescence and spectroﬂuometry con-
ﬁrm that RGD-QDs speciﬁcally interact with the integrin on platelets and on
proteolipsomes. The integrin was able to recognize the RGD motif, indicating
that the protein was still active in the proteoliposome preparation.
B.4 Adhesion Tests
To further test the functionality of integrin αIIbβ3 after reconstitution and
electroformation, adhesion studies were performed using passivated and bio-
functionalized solid substrates.
B.4.1 Passivated Surfaces
As a control, two types of passivated surfaces were prepared
 a glass surface coated with grafted PEG polymers
 a glass surface coated with physisorbed casein
These two types of surfaces were used to limit protein interaction between
the protein and the substrate [153], [202].
B.4.1.1 PEG-Coated Surfaces Glass substrates were silanized and PEG
polymers grafted on top of them (detailed protocols in appendix E). Contrary
to expectations, integrin-containing vesicles adhered to the surface (see ﬁgure
5.15).
As a control, vesicles without protein were prepared, and adhesion was
again observed (see ﬁgure 5.16). Furthermore, vesicles containing neither
integrin nor PEG lipids also adhered (see ﬁgure 5.17).
The same experiments were repeated in a buﬀer without divalent ions,
and no adhesion was observed for both the integrin-containing vesicles and
the pure lipid vesicles.
These results are somewhat surprising since PEG polymers are widely used
to inhibit unspeciﬁc interactions and protein adsorption. However, other ex-
amples of ambiguous PEG behavior have been reported [203], [204], [205],
although not for cell adhesion. It might be that cells in adhesion studies are
less sensitive to electrostatic interaction with polymer-complex ions, because
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Figure 5.15. Integrin containing vesicles adhering to a PEG-coated substrate
in the presence of divalent ions. Bar = 10 µm, RICM image.
cells are protected by their own polymer coat (glycocalix). Furthermore, in
studies on biological model systems like GUVs ”simple” buﬀers are often used
which do not contain divalent ions. Therefore, electrostatic interaction with
PEG-chains may not have been signiﬁcant in earlier studies. However, it has
been shown that PEG can become charged in the presence of mono-or diva-
lent ions leading to interaction in biological systems (private communication
B. Desbat and [203], [206]) It would be interesting to explore this question
further in order to establish eﬀective passivation techniques for sensitive model
systems.
Figure 5.16. GUVs containing PEG lipids, but no integrin, adhere to a PEG
surface in the presence of divalent ions. Bar = 10 µm, RICM image.
The following table summarizes the results of these adhesion studies.
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Figure 5.17. GUVs without PEG or integrin adhere to a PEG-coated surface
in the presence of divalent ions. Bar = 10 µm, RICM image.
Lipid mol-% buﬀer composition Comment
EPC 95 buﬀered glucose* vesicles adhere to surface
DOPE-PEG2000 5
EPC 95 buﬀered glucose* vesicles adhere to surface
DOPE-PEG2000 5
integrin αIIbβ3
EPC 100 buﬀered glucose* vesicles adhere to surface
EPC 95 pure glucose no adhesion
DOPE-PEG2000 5
EPC 95 pure glucose no adhesion
DOPE-PEG2000 5
integrin αIIbβ3
EPC 100 pure glucose no adhesion
*buﬀered glucose:
buﬀered glucose
pH 7.4
180 mM glucose
10 mM TRIS
1 mM Mg2+
1 mM Mn2+
As can be seen from the table, adhesion on PEG-coated surfaces is inde-
pendent of the presence of integrin or PEG-lipids on the vesicle and depends
only on the presence of divalent ions in the buﬀer solution. After making this
discovery PEG-coated substrates were no longer used in this study.
B.4.1.2 Casein-Coated Surfaces Casein was found to be suitable for prepar-
ing passivated surfaces. First, an observation chamber with a casein-covered
surface was prepared and the chamber was ﬁlled with HEPES buﬀer of pH
7.4, which has been proven to help the integrin to retain its functionality Fur-
thermore, divalent ions (2 mM Mg2+, 2 mM Mn2+) necessary for the correct
functioning of the integrin were also present in solution [16]. Integrin- con-
taining GUVs injected (for preparation details see appendix E).
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RICM showed that integrin containing GUVs, even in the presence of di-
valent ions, did not spread onto the surface coated with casein.
Figure 5.18. No adhesion was observed on casein-coated substrates, even in
the presence of divalent ions. Bar = 10 µm, RICM image.
Conclusion: No unspeciﬁc adhesion was detected on casein-coated sub-
strates. Casein-coated surfaces were therefore used as passivated substrates.
B.4.2 Adhesive Surface
Fibrinogen, an RGD-carrying protein, is the natural ligand to integrin αIIbβ3
in platelets and was therefore used to functionalize surfaces for adhesion tests.
In principal, an active integrin correctly incorporated into the membrane of a
GUV should be able to recognize its RGD-ligand on a surface. Accordingly,
an observation chamber with a ﬁbrinogen-functionalized surface was prepared
and integrin- containing GUVs injected (for preparation details see appendix
E). As for the studies with casein-coated substrates, the chamber was ﬁlled
with HEPES buﬀer of pH7.4.
Integrin-containing vesicles adhered and spread on the ﬁbrinogen-covered
surfaces (see ﬁgure 5.19(a)), whereas no adhesion was observed on the pas-
sivated, non-adhesive surface coated with casein (see ﬁgure5.19(b)).
Thus, integrin αIIb β3 retains its biological activity after reconstitution
and electroformation as demonstrated by adhesion test onto surfaces
covered with ﬁbrinogen, an RGD-carrying ligand oﬁntegrin αIIbβ3.
B.4.3 Adhesion Assay in the Presence of Soluble RGD
To prove that the adhesion of integrin-containing GUVs on RGD-covered sur-
faces originated from speciﬁc interactions with the ﬁbrinogen coated surface,
vesicles were incubated with soluble RGD before exposure to the ﬁbrinogen
surface. RGD in solution can interact with the integrin on the vesicle, thereby
blocking interactions with the substrate. For these conditions, integrin was not
able to adhere to the surface, indicating that a most of the integrin receptors
were occupied by soluble RGD in solution (see ﬁgure 5.20)
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(a) Adhesion on RGD-covered substrate
(b) No adhesion on passivated substrate
Figure 5.19. Adhesion tests. A) Adhesion of an integrin-covered GUV to
an RGD-covered surfaces (ﬁbrinogen). The vesicle was fully adhered after 22
minutes. Bar = 10 µm, RICM image. B) Schematic of the adhesion system.
C) No Adhesion of integrin GUVs is observed on passivated surfaces (casein).
Bar = 10 µm, RICM image. D) Schematic of the process.
Figure 5.20. A) Schematic drawing: Integrin-GUVs are incubated with sol-
uble RGD. Soluble RGD interacts with the integrin receptor on the GUVs,
thereby inhibiting integrin interaction with the RGD on the glass substrate.
Integrin-containing GUVs do not adhere to Fibrinogen-covered surfaces. B)
Corresponding RICM image with free RGD in solution, bar = 10 µm.
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Conclusion: RGD-containing GUVs adhere speciﬁcally to ﬁbrinogen cov-
ered surfaces, while they do not interact with passivated, casein-coated sur-
faces. Furthermore, in the presence of soluble RGD, which should block the
integrin receptors on the GUVs, the GUVs do not adhere to ﬁbrinogen covered
surfaces. Thus the integrin is still biologically active after the electrofor-
mation process.
C Conclusion
The developed preparation protocol eﬃciently reconstitutes integrin αIIbβ3
into giant unilamellar vesicles. Incorporation was proven by confocal mi-
croscopy. Integrin maintains its biological functionality as shown by
 spectroﬂuorimetry using RGD-functionalized quantum dots
 adhesion experiments on RGD-covered surfaces
 adhesion experiments on RGD-covered surfaces in the presence of soluble
RGD
This is the ﬁrst time that such a biomimetic system has been successfully
prepared. In the next chapter, the spreading kinetics of these biomimetic GUVs
on ﬁbrinogen-coated surfaces will be discussed and compared to results of the
biomimetic system studied by P.-H. Puech [179].
104
CHAPTER 6
Adhesion Dynamics
A Adhesion Dynamics: First Observations
Using the previously described reconstitution protocol, it was possible to pre-
pare giant unilamellar vesicles containing integrin αIIbβ3 with diameters be-
tween 5 and 60 µm in diameter. Confocal microscopy showed that the ﬂuo-
rescently labeled integrin was incorporated and that the integrin retained its
functionality (QD assays, adhesion tests).
The integrin-containing vesicles speciﬁcally adhere not only adhered to
biofunctionalized substrates in adhesion tests (see ﬁgure 6.1), but also showed
reproducible adhesion dynamics. This allowed us to study the spreading
mechanism described in this chapter.
Figure 6.1. A) Adhesion of an integrin GUVs on an RGD-covered surfaces
(ﬁbrinogen). The vesicle was fully adhered after 22 minutes. Bar = 10 µm,
RICM image. B) Schematic drawing of the adhesion process: The integrins
on the GUV adhere to the ﬁbrinogen adsorbed to the glass surface.
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Figure 6.2 shows the sequence of steps during a typical adhesion event
observed in reﬂection interference contrast microscopy (RICM):
Figure 6.2. Image sequence of an integrin-containing vesicle adhering onto a
ﬁbrinogen covered surface. Images taken after A) 0, B) 1, C) 2, D) 3, E) 4,
F) 7, G) 12, H) 22 minutes (RICM technique).
Image A) and B): single adhesion patches appear. Image C)-E): the patches
grow and fuse. Image F) and G): A ring-shaped adhesion patch is formed
and grows toward the center until in Image H) the adhesion zone appears
homogeneous. Bar = 10 µm
After injection, individual vesicles sedimented onto the ﬁbrinogen surface.
A circular region at the bottom of the vesicle then ﬂuctuated within a distance
of a few µm above the surface. This ﬂuctuating circular region (see ﬁgure
6.2A) determined the part of the vesicle that was already fairly close to the
surface (contact zone). A ﬁrst contact was established at the rim of the
contact zone (see ﬁgure 6.2B) as is evident in RICM. More attachment points
followed which were all located in the same zone (ﬁgure 6.2C). These adhesion
patches grew (ﬁgure 6.2D-E), eventually fused and formed a closed adhesion
ring at the border of the contact zone (see ﬁgure 6.2F). The transition from
adhering ring to homogeneous adhesion disk (ﬁgure 6.2I-H) typically took
about 10 minutes although the exact rate depended on the size of the vesicle
(small vesicles adhered faster). Interestingly, the adhesion dynamics went at a
similar rate to the spreading dynamics of cells. Eventually, after longer times
(30 - 60 minutes) blisters occasionally appeared in the middle of the (previously
homogeneous) adhesion zone (see image 6.3). As this occurred infrequently,
it will not be discussed further and the analysis concentrates on the spreading
dynamics.
From the image sequence in ﬁgure 6.2, it is apparent that the adhesion
dynamics can be separated into three essential steps:
1. Formation of single adhesion patches
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Figure 6.3. After longer times (30 - 60 minutes) blisters sometimes appear
in the middle of the (previously homogeneous) adhesion zone. Bar = 10 µm,
RICM image.
2. Coalescence of single patches and ring formation
3. Ring to disk transition
The variation of the total area with time (see ﬁgure 6.4) had a complex
behavior due to the fusion of patches. The total area corresponds to the sum
of the black area (= adhesion zone of each image). The three regimes cannot
be clearly distinguished.
To resolve the individual steps during adhesion, the area of individual ad-
hesion patches was analyzed as a function of time (see ﬁgure 6.5). The total
area, representing the sum of the area of all the individual adhesion patches,
was plotted for comparison. A systematic, approximately linear, increase is
evident for each curve. This linear growth was hidden in the plot of the total
area because of fusion events between patches.
After the individual patches fuse to form a ring, the adhered area continues
to grow thereby converting the adhesion ring to an adhesion disk at longer
times. To understand this change, the outer and inner perimeters of the
adhesion ring were plotted as a function of time (see ﬁgure 6.6).
At the moment of ring formation, the outer perimeter is smaller then the
sum of the perimeters of the single adhesion patches and it remains roughly
constant at longer times. As soon as the ring formed, an inner perimeter could
be deﬁned. The inner perimeter decreased linearly with time as the adhesion
zone extended towards the center.
The dynamics of the formation of single patches and the adhesion disk
will be compared with theoretical predictions in the following section. The
intermediate state, where some patches have fused and others have not is
complex and will not be discussed.
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Figure 6.4. Growth of the total adhesion area with time. The three consec-
utive steps are depicted.
Figure 6.5. Growth of individual adhesion patches with time. The total area
(grey) representing the sum of all individual adhesion patches is plotted for
comparison.
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Figure 6.6. Variation of the outer perimeter and the inner perimeter of the
adhesive zone with time.
Note that only large ﬂoppy vesicles (initial membrane tension ∼ 10−6 Nm) were
considered. In general, ﬂoppy vesicles underwent all three stages of adhesion.
However, it was diﬃcult to treat the data for small vesicles because they adhere
to quickly and single patches not be distinguished clearly enough to be treated
with imaging software.
B Adhesion Dynamics: Detailed Description
B.1 Formation of Single Adhesion Patches
As explained in reference [178], ﬂoppy vesicles sit on a liquid cushion. The
adhesion process starts when a membrane ﬂuctuation pierces this cushion and
integrins on the vesicle membrane can bind to RGDs on the surface (ﬁgure
6.2A). Usually, this occurs at the border of the contact zone which is probably
because of the existence of a dimple at the center of the contact zone[178].
The nucleation of an adhesion patch at the edge of the contact zone and the
existence of a dimple have been observed in earlier studies of the adhesion of
elastomers to a wet surface (mimicking a tire on a road) [207].
Subsquently, other adhesion patches appear and grow in a circular manner
and within a couple of minutes these small adhesion zones fuse. The graph
in ﬁgure 6.5 shows that the contacts appeared at diﬀerent points in time. As
expected, when two patches coalesce, the total area jumps. However, after
fusion, the patch continued to grow with the same speed. This graph shows
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that the growth velocity is the same for all patches.
Note that it was rather hard to follow these single adhesion patches in
microscopy for a long time, since fusion was rapid.
B.1.1 Theoretical Predictions
Similar adhesion behavior was described by P.-H. Puech et al. [179] for the
adhesion of biotin-carrying, ﬂoppy vesicles onto streptavidin covered supported
bilayers. They also observed the development of small adhesion zones which
fused during the experiment (see chapter 4). The ﬁrst stage of the adhesion
process can therefore be described by the same theory used in their work.
P.-G. de Gennes and F. Brochard-Wyart developed the following description
of the adhesion process. They considered a vesicle covered with a surface
concentration of stickers Γ0. The vesicle is adhering to a surface and in the
adhesion patch the sticker concentration is Γint.The growth of the contact
zone is essentially a dewetting process of the liquid cushion on which the
vesicle sits [178] (see also ﬁgure 6.7).
For small adhesion patches R2 < Dt (D= diﬀusion constant of the ligand in
the vesicle, t = time), the diﬀusion of the stickers (integrin proteins on the
vesicle surface) to the adhesion zone is important. For immobilized stickers,
the adhesion energy, W, per unit area is given by W =Γ0U, where U is the
energy gain per sticker ∼ 10kT. This corresponds to an equilibrium contact
angle θE which is deﬁned as [178]
W = σ(1− cosθE) ∼ σθ2E/2 (6.1)
where σ is the membrane tension.
At time t the number of stickers that entered the adhesion zone is piR2(Γint-
Γ0) (Γint = sticker concentration in adhesion zone, Γ0 = sticker concentration
on the rest of the vesicle).
This has to be equal to the reduction of the number of stickers on the surface
area Dt, which is Γ0Dt. From this, it follows that
R2(Γint − Γ0) ∼ DtΓ0 (6.2)
Using W = ΓintU = σθ2/2 gives
θ2 − θ2E =
Dt
R2
U
σ
Γ0 ∼ Dt
R2
θ2E (6.3)
The equation for the dewetting speed at equilibrium is given by [165]
vd ∼ σ
η
θ3E (6.4)
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Figure 6.7. The growth of the contact zone is essentially a dewetting process
of the liquid cushion on which the vesicle sits. From [179].
For θ ∼ θE (i.e. Γint is not much larger than Γ0), the dewetting speed vd
is given by [179]
vd =
σ
η
θ3E
(
1 +
Dt
R2
) 3
2
(6.5)
If R2 < Dt (which is the case for Dt ∼ 60 µm2), from equation 6.5 one
can obtain
R˙R3 ∼ σ
η
θ3ED
3
2 t
3
2 (6.6)
which gives
R = αt
5
8 (6.7)
with the prefactor α,
α ∼ (σ
η
θ3ED
3
2 )
1
4 (6.8)
B.1.2 Comparison with Experimental Data
B.1.2.1 Fitting the Data As the theory predicts a growth of the radius
R of the adhesion zone ∼ t 58 , the radius was calculated by assuming that
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the shape of the individual patches were roughly circular. To compare several
adhesion patches which appeared consecutively in time, the data was shifted
to t = 0. The predicted scaling law t
5
8 ﬁts the data very well, as shown in
ﬁgure 6.8:
Figure 6.8. The growth of the radius R of two individual adhesion patches is
plotted as a function of time, and ﬁtted to a scaling law, t
5
8 , with an oﬀ-set
in time to shift the data to t = 0.
A
√
t-behavior has been predicted by other theoretical models described
in chapter 4 so the data was also ﬁtted to R ∼ √t. As is evident from the
log-log plot in ﬁgure 6.9, both (R ∼ t 58 and R ∼ t 12 ) ﬁt the data very well and
are hard to distinguish. A clear distinction between the two exponents would
require more data than is currently available.
B.1.2.2 Discussion Fitting the data to R= α
√
t yields α = (0.22 ± 0.05)
× 10−6 S.I. while ﬁtting the data to the theoretically predicted power law R
∼ t 58 yields the prefactor α = (0.12 ± 0.01) × 10−6 S.I..
To check if these values are reasonable, they were compared to calculated
values of the prefactor. The integrin diﬀusion coeﬃcient was measured by
Gönnenwein et al. by Fluorescence Recovery After Photobleaching (FRAP)
to be D ∼ 0.6 µm2s [169]. The viscosity of the liquid is η = 10−3Pa×s. The
membrane tension σ is expected to be of the order of 10−6 Nm . According
to Cuvelier et al., θE is of the order of 0.2 rad. Substituting these values
into equation 6.8 gives a value of the prefactor of 2.4 × 10−6 S.I. which
is largely consistent with the experimental value. Thus, the PGG-Brochard-
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Figure 6.9. The growth of the radius of an adhesion patch is plotted in a
log-log plot and ﬁtted by a power law with an oﬀ-set in time to shift the data
to t = 0. blue line: the exponent = 0.625, as predicted by de Gennes and
Brochard-Wyart [179], red line: the exponent = 0.5, as predicted by Boulbitch
et al. [140].
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Wyart theory for the growth of adhesion patches of ﬂoppy vesicles is consistent
with the experimental results.
B.1.3 Conclusion
The adhesion of the integrin-functionalized vesicles starts with several single
patches which grow and eventually fuse. This section examined the initial
growth of individual patches and compared the experimental data to the theory
of de Gennes and Brochard-Wyart. They predicted a growth behavior of R∼
t
5
8 . The experimental data was compared to this law and to the R∼ t 12 law
proposed by other groups. Both models are consistent with the available data.
The value for the prefactor α was (0.22 ± 0.05) × 10−6 S.I. for the R ∼√
t -regime, and (0.12 ± 0.01) × 10−6 S.I. for the R ∼ t 58 -regime. The
estimated value was α = 2.4 × 10−6 S.I. which is reasonably close considering
the uncertainty in θE. Thus the PGG-Brochard-Wyart theory for the growth of
adhesion patches of ﬂoppy vesicles describes reasonably well the experimental
data.
B.2 Disk Formation
As discussed in section B.1, the ﬁrst stage of the observed adhesion dynamics
was quite similar to the results of P.-H. Puech [179]. In both cases, individual
adhesion patches appeared, grew and fused. However, in this system the
adhesive patch with a ring-like shape at the rim of the contact zone grew
further to eventually form a homogeneous adhesion disk. Interestingly, similar
adhesion patches with a ring-like shape were observed in the ”inversed” system
studied by the group of Prof Sackmann (see also ﬁgure 4.16 in chapter 4)
[187].
The evolution of the total perimeter (sum of the perimeter of each individual
patch) as a function of time (ﬁgure 6.6) provides insight into the conversion of
the adhesion patch from a ring to a disk. Initally, the total perimeter increased
quickly as each of the individual patches grew. After the individual patches
fused to form a ring, the total perimeter could then be divided into the inner
and outer perimeter of the ring. While the outer perimeter stayed roughly
constant, the inner perimeter decreased approximately linearly with time until
the ring became a homogeneous adhesion disk.
In ﬁgure 6.10, a schematic view of the ring closure is shown. The outer
perimeter R0 stays roughly constant while the inner perimeter Ri reduces to
form a disk (indicated by the red arrows). The area A of the adhesive ring can
be expressed as,
A = piR20 − piR2i . (6.9)
Figure 6.11 shows the inner radius Ri as a function of time during disk
formation. At short and intermediate times, R diminished linearly with time as
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Figure 6.10. Schematic view of the disk formation: The adhesion patch has
the shape of a ring in which the external radius R0 stays roughly constant while
the inner perimeter Ri diminishes.
Figure 6.11. The inner radius R diminishes linearly with time as the ring-
shaped adhesion patch extended toward the center.
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the adhesion patch grew towards the center.
As shown by de Gennes and Brochard-Wyart [178], this last stage can
also be described by a dewetting process (see ﬁgure 6.12). The liquid which
Figure 6.12. The ring-shaped adhesion patch grows toward the center via
a dewetting process. The excess liquid is collected in a rim of height h0 and
diameter l. VA and VB are respectively the growth velocity of the patch and
the retracting velocity of the cushion. hc is the height of the cushion. From
[178].
is pushed away during the spreading is collected in a rim of horizontal size l.
According to Laplace's law, the curvature of the rim proﬁle is constant and
the angle θ at both ends (point A and B) is the same. The velocities VA and
VB are nearly the same and are given by the scaling laws
η
θ
VA ∼= σ(cosθ − cosθE) ∼= σ2 (θ
2
E − θ2) (6.10)
and
η
θ
VB ∼= σ(1− cosθ) ∼= σ2 θ
2 (6.11)
Whenever the inner radius Ri  h0/θ (h0 being the height of the rim), it
follows lR (l is the diameter of the rim) and it can be assumed that VA =
VB. From equation 6.10 and 6.11 it follows that θ = θE/
√
2. The velocity
VA, which corresponds to the variation of the radius Ri with time, can then
be described as follows
VA =
dRi
dt
=
σ
η
θ3E (6.12)
Just outside of the patch there is a depletion of integrins and the concen-
tration of integrin is Γ+ < Γ0. Far from the patch the concentration is Γ0.
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The inward diﬀusion near the patch is,
J = kD
Γ0 − Γ+
lD
, (6.13)
where Γ+ is negligible, k is a numerical constant of order unity [178] and the
length lD is the size of the outer diﬀusion region given by,
lD =
D
V
, (6.14)
where V ∼= dRi/dt is the dewetting velocity.
The number of stickers in the patch is ΓintA = Γintpi(R20-R
2
i ) (A is the area
of the patch) and the patch grows with the ﬂux J, so that,
d
dt
[
pi
(
R20 −R2i
)
(Γint − Γ0)
]
= −2piRiJ. (6.15)
Thus,
(Γint − Γ0)dRi = −Jdt. (6.16)
Since Γ+  Γ0, it then follows that the constant k in equation 6.13 is
k =
Γint − Γ0
Γ0
. (6.17)
The concentration in the patch Γint is then expected to be a constant Γint =
Γ0(1+k), and to be of order of Γ0.
Equation 6.12 shows that θE is constant, and thus the dewetting velocity
must also be a constant. Since θE is constant, from equation 6.13 follows
Ri = −ε 32 σ
η
t (6.18)
with ε = 2UΓ0σ , as shown in [208].
B.2.1 The Dewetting Velocity
The inner perimeter of the adhesion zone shrinks with a velocity V, Ri=Vt with
V = -ε
3
2
σ
η according to equation 6.18. For the experimental data in ﬁgure 6.11,
the radius diminished linearly (with ∆R ∼ 10 µm) over an interval of roughly
∆t ∼ 600 s. Thus, the slope of the curve in ﬁgure 6.11 gives a value of
2×10−8 ms for V.
To see if the theoretical description of initial adhesion dynamics and disk
formation were consistent, the prefactors of the two processes were used to
compare the integrin diﬀusion coeﬃcient (see also section B.1 for prefactor α
of the ﬁrst regime).
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Keeping in mind that Γ0U =
σθ2E
2 (equation 6.1), equation 6.18 can be
rewritten
Ri = −
(
2UΓ0
σ
) 3
2 σ
η
t = θ3E
σ
η
t = V t (6.19)
V = -ση θ
3
E and α = (
σ
η θ
3
E D
3
2 )
1
4 , so,
α =
(
V D
3
2
) 1
4
, (6.20)
and therefore,
D =
(
α4
V
) 2
3
(6.21)
with α = 2 × 10−7 S.I. and V = 2 × 10−8 ms . This gives a value of D ∼ 2 ×
10−13 m
2
s . The integrin diﬀusion coeﬃcient was measured by Gönnenwein et
al. to be ∼ 6 × 10−13 m2s [169]. The experimentally measured value of the
dewetting velocity is therefore in reasonable agreement with the value obtained
from the model .
B.2.2 Growth from the Edge of the Ring
The ﬁnal stage of adhesion proceeds by the movement of the edge of the
ring toward the center, and not by nucleation of new adhesive patches. The
non-adhered membrane in the center of the adhesive ring is tense and it is
therefore unlikely that new adhesion patches would nucleate at the center of
the remaining water blister. Consequently the adhesion zone grows from the
edge of the adhesion zone.
B.2.3 Growth Acceleration at Longer Times
At later stages of adhesion, the center becomes more and more depleted of
liquid. From ﬁgure 6.11 it is evident that the velocity of the ring closure
speeds up and the radius diminishes much faster than ∼ t. This might be due
to membrane ﬂuctuations in the almost depleted dimple, which would allow
the membrane to come in contact with the surface. Bonds could then be
established more quickly and the adhesion zone would grow faster.
B.2.4 Mechanisms of Water Depletion
The mechanism of liquid depletion from the rim and the non-adhered zone is
not understood in detail. Two possible ways are shown in ﬁgure 6.13. The
liquid could permeate through the lipid membrane or it could ﬂow via the
narrow gap between the vesicle membrane and the substrate.
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Figure 6.13. Possible mechanisms for water depletion from the central water
dimple. A) RICM image of the dimple. B) The liquid can permeate the lipid
membrane (yellow) or it can ﬂow through the adhesion patch(red).
B.2.5 Conclusion
The last part of the adhesion process, the disk formation, can be described
by a dewetting process, as proposed by de Gennes and Brochard-Wyart [178].
As predicted, the inner radius R diminished at constant velocity (see ﬁgure
6.11). The dewetting velocity was approximately 2 × 10−7 ms which was
shown to be consistent with the theory. Furthermore, the de Gennes-Brochard-
Wyart model suggests that Γint is constant and similar to Γ0 implying that no
enrichment of stickers occurs in the adhesion zone.
C Conclusion and Perspective
The adhesion of integrin-functionalized vesicles can be separated into three
essential steps:
1. Formation of single adhesion patches
2. Coalescence of single patches and ring formation
3. Disk formation
The details of the formation of single patches and the disk formation were
compared with theoretical predictions. The intermediate stage, where some
patches have fused but others have not, is complex and was not discussed.
In the ﬁrst step, single adhesion patches of ≈ 200 nm in size appear, grow,
and eventually fuse. Theoretical modelling by de Gennes and Brochard-Wyart
predicts that the radius of an individual patch grows with R ∼ t 58 ,while other
models predict a growth rate of R ∼ √t [140]. The experimental data were
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ﬁtted equally well by either power law. A larger amount of data will be needed
to distinguish clearly between the two models.
Our experiments were consistent with the prediction that the concentration
of stickers in the adhesion zone, Γint, is comparable to the concentration on
the rest of the vesicle, Γ0. Thus, for this system diﬀusion does not lead to
an enrichment of stickers in the adhesion zone. This has interesting biological
consequences. For example, in cells the cytoskeleton might function as a
stabilizer to obtain the enrichment of integrin molecules needed to form focal
adhesions and similar structures. This could be a control system to prevent
unwanted accumulation of integrins.
The third observed stage of the adhesion process is the formation of a ho-
mogeneous adhesion patch. It was shown that the ring closes with a constant
velocity: R = Vt. This adhesion process can be well described by the dewet-
ting model of de Gennes and Brochard-Wyart [178]. The measured dewetting
velocity was of order 2 × 10−7 ms which was shown to be consistent with the
known integrin diﬀusion coeﬃcient. Furthermore, the model suggests that
the sticker concentration in the adhesion zone, Γint, should be a constant and
similar to the concentration on the rest of the vesicle, Γ0, meaning that by
diﬀusion does not enrich the stickers in the adhesion zone.
Several experiments can be proposed to conﬁrm these results. It appears
that the concentration in the adhesion patch, Γint, is comparable concentra-
tion on the rest of the vesicle, Γ0. It should be possible to conﬁrm this using
ﬂuorescently labeled integrin and total internal reﬂection ﬂuorescence (TIRF)
microscopy. TIRF is very sensitive to thin layers on surfaces and should there-
fore be ideal for observing the adhesion zone close to the substrate.
In addition, the inﬂuence of the initial integrin concentration Γ0 on the vesi-
cle, and the RGD concentration on the substrate should both be investigated.
The system could be further developed by introducing an actin cytoskleton
inside the integrin-containing vesicle. If the actin polymers were functionally
attached to the integrin proteins in the membrane it would be possible to verify
if the actin cortex can lead to enrichment of integrin in small patches, as in
the case of focal adhesions. These experiments would show that integrin alone
is not able to build focal adhesion spots (no enrichment in the adhesion zone
by diﬀusion), and that triggering actin binding to integrin is necessary. Such
a model system could conﬁrm the important role of the actin cytoskeleton in
stabilizing integrin-RGD adhesion in biological cells.
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Conclusion
Inspired by the work performed in the group of Prof. Sackmann at TU Munich
[168], [140], [169] a unique biomimetic system was developed to study early
integrin-mediated cell adhesion. The results could be explained with the help
of the theoretical models by Françoise Brochard-Wyart and Pierre-Gilles de
Gennes.
Improving a method previously developed in our laboratory [3], the trans-
membrane protein integrin αIIbβ3 was reconstituted into giant unilamellar vesi-
cles (GUVs). The ﬁrst step of the method is the detergent-mediated recon-
stitution of solubilized membrane proteins into small proteoliposomes. For the
second step, these preformed proteoliposomes are partially dried under con-
trolled humidity and GUVs are then formed by electroswelling of the partially
dried ﬁlm. The reconstitution process has been validated by analyzing pro-
tein incorporation and biological activity. Confocal microscopy showed that
the ﬂuorescently-labeled proteins were homogeneously incorporated into the
membrane.
Moreover, after reconstitution, the proteins retain their biological activity
as demonstrated by enzyme-linked immunosorbent assay (ELISA) of small vesi-
cles and spectroﬂuometry on small vesicles interacting with RGD-functionalized
quantum dots (RGD is a ligand of integrin αIIbβ3). Biological activity in GUVs
was checked by adhesion tests of the GUVs onto surfaces covered with RGD.
The adhesion of ﬂoppy integrin-carrying vesicles onto ﬁbrinogen covered
surfaces was studied in detail. In the ﬁrst step, single adhesion patches of
about 200 nm in size form, grow, and eventually fuse. Theoretical modelling
by de Gennes and Brochard-Wyart predicted that the radius of a single patch
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should grow as R ∼ t 58 , while other models predict growth following of R ∼ √t
[140]. The data were ﬁtted equally well by both power laws. A larger amount
of data will be needed to distinguish clearly between the two models. The
prefactor α obtained experimentally was in the same range as the theoretically
predicted prefactor.
The intermediate situation, where some patches have fused while others have
not, is complex and was not discussed. The third stage of the adhesion process
is the formation of a homogeneous adhesion patch. It was shown that the inner
ring radius shrinks with a constant velocity. This adhesion process can be well
described by a dewetting model of de Gennes and Brochard-Wyart [178]. The
measured dewetting velocity was of order 2 × 10−7 ms which was shown to be
consistent with theory.
The model suggests that the concentration of stickers in the adhesion
zone, Γint, is of the same order as the concentration in the rest of the vesicle,
Γ0. This has interesting biological consequences as it implies that enrichment
of stickers in the adhesion zones of cells does not result only from the diﬀu-
sion of stickers. Instead, to obtain enrichment in integrin-rich focal adhesions
and similar structures it may be necessary for the cytoskeleton to function
as a stabilizer. This may be a control system to prevent unwanted integrin
accumulation.
Additional experiments would be helpful to conﬁrm the that the concentra-
tion of integrin in the adhesion patch Γint is comparable to the concentration
on the rest of the vesicle Γ0. One approach would be to image ﬂuorescently
labeled integrin via total internal reﬂection ﬂuorescence (TIRF) microscopy.
TIRF is very sensitive to a thin layer above a surface so it would be ideal for
observing the adhesion zone. This would allow direct measurement of integrin
concentration in the adhered zones and the non-adhering regions.
The inﬂuence of the initial integrin concentration Γ0 on the adhesion dy-
namics should be investigated. Also, improving the reconstitution method or
by exploring new methods for electroformation [128], it might be possible to
obtain a higher integrin concentration on the vesicle. Presently, the maximum
achievable concentration is 125 integrins per µm2 which is comparable to the
biological concentration on cells. On platelets, however, the concentration of
integrin αIIbβ3 is 10-fold higher. Using other reconstitution methods (e.g.
other detergents) it may be possible to produce vesicles with higher protein
density.
The RGD concentration on the surface could also be better controlled and
varied by using controlled biofunctionalized substrates developed in the group
of M. Möller (RWTH Aachen, Germany). This group has developed a method
to control the RGD-density on a substrate using multi-branched star-shaped
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PEG polymers. First tests on these substrates are under way.
Alternatively, the substrate could be modiﬁed using the nanopatterned bio-
functionalized surfaces developed in the group of Joachim Spatz [54]. These
substrates provide good control of the surface density of RGD ligands. Using
these nanopatterned substrates, the Spatz group showed that cells can only
adhere to the underlying substrate when the distance between integrin binding
sites is below an upper limit. Furthermore, they established that many cell
types share this upper limit. Experiments with the integrin-carrying vesicles
should be compared with results for cells, to understand the role of the con-
formational change of adhering integrins, integrin clustering, and the impact
of the internal cytoskeleton.
The system could be further improved by introducing an actin cytoskle-
ton inside the integrin-containing vesicle. Several groups have been working
on actin networks in model cells [209], [210], [211] although this is still a
challenging task. If the actin polymers could be functionally attached to the
integrin proteins in the membrane (see chapter 2), one could check if the actin
cortex can lead to enrichment of integrin in small patches (as occurs in focal
adhesions) by stabilizing the integrin in the adhesion zone. Initial experiments
are under way to combine integrin-containing vesicles with an actin cytoskele-
ton. These experiments could show that integrin alone is not able to build
focal adhesion spots (no enrichment in adhesion zone by diﬀusion), and that
triggering actin binding to integrin is necessary for integrins to cluster in cells.
Eventually even proteins like ROCK or mDia1 (as discussed in chapter 2) could
be introduced to further expand the system. Such a model system could con-
ﬁrm the important role of the actin cytoskeleton in stabilizing integrin-RGD
adhesion in biological cells.
Furthermore, it would be interesting to investigate if integrins act as so-
called catch bonds. As reported for a member of the selectin family, low
forces decrease L-selectin-PSGL-1 oﬀ-rates (catch bonds), whereas higher
forces increase oﬀ-rates (slip bonds) [212]. Catch bonds enabled increasing
force to convert short-lived tethers into longer-lived tethers, which decreased
rolling velocities and increased the regularity of rolling steps. A similar behavior
is predicted for integrins [213], [214]. Using our model system, this hypothesis
could be investigated in ﬂow chamber assays.
Introducing more and more components of the complex integrin-actin sys-
tem would progressively build up the complexity of an artiﬁcial cell, bringing it
closer to biological systems. Numerous unsolved questions, such as the com-
plex proces of internal signaling, could be addressed with such a bottom-up
approach. However, the preparation of such complex systems is likely to be
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experimentally challenging.
Eventually, using such bottom-up approaches should lead to a deeper un-
derstanding of cell spreading and cell communication. This should be of inter-
est in medical research in ﬁelds such as the integrin-dependent development
of tumors. Biomimetic systems may contribute to understanding the role of
integrins in these processes and play a role in the development and testing of
new therapeutic approaches.
Figure 7.1. Scanning electron micrograph of a breast cancer cell, showing an
abnormally uneven surface and cytoplasmic projections. What is the role of
integrin in the development of carcinogenic tissue? From [215].
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Materials and Methods
A Materials
A.1 Lipids
Lipids were purchased from Avanti Polar Lipids, Inc., Alabaster, AL, USA.
Lipids stocks were in chloroform at a concentration of 10 mg/ml and were
stored under an argon atmosphere at -20 ◦C to prevent lipid degradation.
In this study, the following lipids were used:
Avanti Product Number: 840051
Egg PC 99%
L-α -Phosphatidylcholine (Egg, Chicken)
Molecular Weight: 760 g/mol.
Figure A.1. Molecular structure of Egg PC
Avanti Product Number: 840101
Egg PA
L-α -Phosphatidic Acid (Egg, Chicken-Monosodium Salt)
Molecular Weight: 697 g/mol.
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Figure A.2. Molecular structure of Egg PA
Avanti Product Number: 880130
18:1 PEG2 PE
1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-
2000] (Ammonium Salt)
Molecular Weight: 2,801 g/mol.
Figure A.3. Molecular structure of DOPE-PEG2000
Avanti Product Number: 880160
16:0 PEG2 PE
1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine-N-[Methoxy(Polyethylene
glycol)-2000] (Ammonium Salt)
Molecular Weight: 2,749 g/mol.
Figure A.4. Molecular structure of DMPE-PEG2000
Avanti Product Number: 880330
18:1 PEG3 PE
1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-
3000] (Ammonium Salt)
Molecular Weight: 3,771 g/mol.
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Figure A.5. Molecular structure of DOPE-PEG3000
Avanti Product Number: 880230
18:1 PEG5 PE
1,2-Dioleoyl-sn-Glycero-3-Phosphoethanolamine-N-[Methoxy(Polyethylene glycol)-
5000] (Ammonium Salt)
Molecular Weight: 5,797 g/mol
Figure A.6. Molecular structure of DOPE-PEG5000
Avanti Product Number: 850375
18:1 PC (cis)
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine (DOPC)
HYGROSCOPIC AS LYOPHILIZED POWDER
Molecular Weight: 786 g/mol
Figure A.7. Molecular structure of DOPC
A.2 Other Products
Solvents were purchased from VWR International, France.
Sugars, poly-L-Lysine (P8920) 0.1% w/v, casein (C6905) and Tris® buﬀer
were purchased from Sigma-Aldrich CO. St.Louis, MO, USA.
Fibrinogen (catalog number: 341578) was purchased from Calbiochem, EMD
Chemicals, Inc., Gibbstown, NJ, U.S.A..
Biobeads® SM-2 Adsorbent (catalog number 152-3920)were purchased from
Bio-Rad Laboratories, Hercules, CA, U.S.A..
mPEG-Mal-5000(Methoxy-Poly(Ethylene Glycol)Maleimide (average M.W. 5000))
was purchased from Nectar Therapeutics, and was later purchased at Sigma
Aldrich (catalog number 63187).
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HEPES buﬀer was purchased from ICN Biomedicals Inc., Aurora, OH, USA.
Sigillum wax was purchased from Vitrex Medical Limited, Denmark.
Paraﬁlm® 992 (Menasha, WI, USA) was used to build observation chambers.
ITO conducting glass slides were purchased from PJO GmbH, Iserlohn, Ger-
many.
Glass cover slides from Erie Scientiﬁc Company, Portsmouth, NH, USA (No.
1 quality, 0.13-0.16 mm, 40 x 60 mm) and Fisher Scientiﬁc International®,
USA (No. 1 quality, 0.13-0.17 mm, 25 x 25 mm) were used.
Water was ﬁltered with an Elix® Water Puriﬁcation System equipped with a
0.22 µm Millipak®ﬁlter.
A Heidolph Topmix 94323 was used to vortex the aqueous lipid solution.
SUVs were produced using a tip sonicator from MSE Scientiﬁc Instruments,
Crawley, UK.
Solution osmolarities were measured with a Roebling Micro-Osmometer Type
13.
B Methods
Microscope experiments were performed with a Zeiss Axiovert 135 equipped
with a CCD camera (CoolSnapHQ, Princeton Instruments) and a Uniblitz
shutter. All images were analyzed with software provided with the camera
(MetaVue, Universal Imaging Corp.). RICM and ﬂuorescence measurements
were perfomed using a HBO 100 mercury lamp on the epi-ﬂuorescent port
with an Antiﬂex 63x objective. For RICM an interference ﬁlter (λ= 546 nm)
was used. For phase contrast observation of GUVs, a phase 2 condenser was
used together with a 40x Neoﬂuar long distance objective.
For confocal microscopy, a setup based on a commercial Nikon TE2000 in-
verted microscope (Nikon) was used. The confocal head was an eC1 confocal
system (Nikon) with two laser lines (488nm, 543nm).
Images were analyzed with ImageJ (Wayne Rasband, National Institutes of
Health, USA, http://rsb.info.nih.gov/ij/) and data treated with Origin®
(http://www.OriginLab.com).
A Hettich EBA 12 centrifuge with a universal 307 rotor was used.
128
APPENDIX B
Experimental Techniques
This chapter presents all standard microscopy techniques used in this study.
The technical details for each experimental setup are given in appendix A.
These are
 Reﬂection Interference Contrast Microscopy (RICM)
 Epiﬂuorescence Microscopy
 Phase Contrast Microscopy
 Confocal Microscopy
A Reﬂection Interference Contrast Microscopy (RICM)
Reﬂection interference contrast microscopy (RICM) is a widely used quantita-
tive interference technique to determine the distance between an object and
a substrate with nanometer vertical resolution and a lateral resolution of (∼
200-300 nm).
As shown in Figure B.1, monochromatic light reﬂects from both the glass
surface and the membrane surface (of the GUV or cell) and the resulting
interference pattern depends upon the distance between the two surfaces. It
is well adapted to investigate adhesion phenomena in giant vesicles and cells.
Reﬂection interference microscopy (RIM) has been used as a powerful tool
for cell scientists since its introduction by Curtis in 1964 [216]. It was greatly
improved by the invention of reﬂection contrast by Ploem in 1975 [217]. How-
ever, quantitative analysis was only possible after the theoretical work of Rädler
and Sackmann in 1993 [218]. Currently, the resolution in the surface proﬁle is
0.3 µm laterally and 1 nm out of plane. The optical thickness of a membrane
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can be determined with 0.2 nm accuracy. Dual-wavelength reﬂection inter-
ference contrast microscopy (DW-RICM)using two diﬀerent wavelength for
illumination has been developed to measure absolute optical distances [219].
Figure B.1. Schematic of RICM method. A monochromatic light beam
(wavelength λ) reﬂects from both the object and the glass surface to form an
interferogram. n0 and n1 are the refractive indices of the glass substrate and
the medium. I0 is the initial light intensity, I1 is the intensity of light reﬂected
from the glass substrate and I2 is the intensity of the light reﬂected from the
object. From [218].
Figure B.1 depicts the experimental set-up for RICM. For our experiments,
the sample consisted of a vesicle sitting on (or adhered to) a glass cover slip
which was mounted on an inverted microscope. Monochromatic illumination is
provided by a combination of mercury lamp and interference ﬁlter ( λ = 546 nm,
∆λ = 5 nm, green). This illumination is episcopic, meaning that the sample
is illuminated through the objective. The reﬂected light is then collected by
the objective and high resolution images are recorded with a digital camera
(CoolSnapHQ, Ropper). An example of an RICM image from a tightly adhered
versicle is shown in ﬁgure B.2.
For each point in the image, the intensity is determined by the distance
between the substrate and the vesicle membrane at that point. For points in
adjacent interference rings, the substrate-vesicle separation diﬀers by,
i =
λ
2n1
, (B.1)
where λ is the light wavelength and n1 is the refraction index of the liquid (for
water, n1 = 1.33). When using a wavelength λ = 546 nm, i = 205 nm and the
change in separation for a half-fringe (going from light to dark) is only 102.5
nm. Consequently, interference fringes can only be resolved in regions where
the substrate and vesicle surfaces are almost parallel. For an approximately
spherical object such as a vesicle, this corresponds to the region where the
vesicle is close to the substrate (< 1 µm) (see ﬁgure B.2).
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Figure B.2. An RICM image of a vesicle strongly adhering to a substrate.
Interference fringes are visible. Bar = 10 µm.
The height proﬁle, h(x), of the object can be obtained by quantitative im-
age analysis. The intensity of the reﬂections from the substrate-water interface
and water-vesicle interface depend on the refractive indices of the substrate
(n0), water (n1) and vesicle (n2). The observed (reﬂected) intensity, I(h),
results from the coherent superposition of reﬂection from the substrate and
vesicle surface and is given by
I(h) = I0 × r
2
01 + 2r01r12 cos 2kh+ r
2
12
1 + (r01r12)2 − 2r01r12 cos 2kh (B.2)
where I0 is the intensity of the incoming beam, k = 2pin1/λ is the mag-
nitude of the incident wave-vector and rij=(ni-nj)/(ni+nj) is the reﬂection
coeﬃcient of the interface i/j. When terms rnij with n >2 are neglected (rij
∼ 7% for the glass-water interface)
I(x) = Iasin2
(
2pi
n1h(x)
λ
)
+ Ib (B.3)
where Imax = I0(|r01|+ |r12|)2 = Ia + Ib is the intensity of the white fringes
and Imin = I0(|r01| - |r12| )
2 = Ib is the intensity of the black fringes.
The black circular fringe in the center of ﬁgure B.2 corresponds to the
adhesion zone of the vesicle.
B Epiﬂuorescence Microscopy
When a ﬂuorescent molecule is illuminated with a light with an excitation
wavelength λexc, the molecule can make a transition from the ground state to
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Figure B.3. Schematic representation of molecular ﬂuorescence. From [220].
an exited state (ﬁgure B.3) by absorbing a photon. The molecule then relaxes
by radiationless decay to lowest excited state. From this lowest excited state,
the molecule can make a radiative transition back to the ground state by emit-
ting a photon with wavelength λem > λexc. In epiﬂuorescence microscopy, the
emitted photons are used to measure the spatial distribution of ﬂuorophores
in the sample.
Inverted ﬂuorescence microscopes are equipped with an epi-illumination
set-up incorporating interchangeable ﬁlter cubes that are matched to the ﬂuo-
rophore. The ﬁlter cube is placed beneath the objective and includes a dichroic
mirror that couples in the light from the excitation source (ﬁgure B.4). Light
from the mercury lamp is focussed by a source collector, spatially ﬁltered by
a ﬁeld diaphram, ﬁltered through a narrow band-pass excitation ﬁlter and re-
ﬂected into the objective by the dichroic beam-splitter. The beam-splitter
reﬂects wavelengths shorter than λc and transmits wavelengths longer than
λc (in practice λexc < λc < λem). Thus, the beam-splitter lets the objective
simultaneously serve as a condenser lens for the excitation wavelength and
the objective lens for emitted ﬂuorescence. Fluorescent light from the speci-
men passes straight through the dichroic beam splitter, is ﬁltered by a second
band-ﬁlter corresponding to λem and then passes through the optical train
of the microscope to reach the ocular and camera. Each ﬂuorescence cube
contains the appropriate excitation ﬁlter, dichroic beam-splitter, and emission
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Figure B.4. Illumination pathway in epiﬂuorescence microscopy.
ﬁlter so they can be rapidly switched as a group to allow imaging of specimens
containing multiple ﬂuorophores.
The ﬁlters used in our experiments are stated in the experimental section.
All images were taken on a Zeiss Axiovert 135 microscope using a cooled, elec-
tron multiplying, back-illuminated CCD camera (CoolSnapHQ, Ropper) and a
Uniblitz shutter. All images were analyzed with MetaVue software (Universal
Imaging Corp).
C Phase Contrast Microscopy
Microscopic objects that are distinguished from their surround only by a dif-
ference of refractive index lose their Becke line and disappear when brought
exactly into focus [221]. (The Becke line is a bright halo of light that ap-
pears around the perimeter of a particle when the indices of refraction of the
particle and the surrounding medium are diﬀerent or when the microscope is
defocused.) Phase contrast microscopy generates images in which contrast
depends on the diﬀerence between the refractive index of observed object
and the surrounding medium. In conventional dark-ﬁeld microscopy, a annu-
lar aperture is introduced in the focal plane of the condensor and an annular
beam-stop is placed in the back focal plane of the objective. When there is
no sample in the microscope, light that passes through the condensor annulus
is absorbed by the beam-stop in the objective and the image appears "dark".
However, a phase object (an object with a diﬀerent refractive index) scatters
some of the light passing through it. This scattered light is not blocked by the
annular beam-stop in the objective and forms a bright image of the object.
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D Confocal Microscopy
Confocal microscopy is a ﬂuorescence optical imaging technique which can
produce sharp ﬂuorescent images of thick specimens. Light from outside the
focal plane is eliminated using a confocal pinhole permitting high precision two-
and three-dimensional imaging of ﬂuorescent samples [222].
The principle of confocal imaging was patented by Marvin Minsky in 1957
[223], but only became a standard technique in biology at the end of the
1980's. In a conventional (i.e., wide-ﬁeld) ﬂuorescence microscope, the entire
specimen is ﬂooded with light from a light source and so ﬂuorescence is excited
throughout the specimen. Although only light originating from the focal plane
of the objective is in focus, ﬂuorescence from points behind and in front of the
focal plane are also transmitted to the camera. Consequently, sharp features
in the focal plane are often obscured by blurry, out-of-focus ﬂuorescence from
other parts of the sample.
In contrast, a modern laser scanning confocal microscope (LSCM) elimi-
nates out-of-focus signal using :
1) point by point illumination of the sample and
2) rejection of out-of-focus ﬂuorescent light.
Figure B.5. Schematic diagram of a conventional confocal microscope. The
two mirrors scan the light from the laser ( pixel by pixel) across the sample to
excite ﬂuorescence at each point in the focal plane. The ﬂuorescence signal
is collected by the objective, de-scanned by the two mirrors, passes through
the dichroic mirror and is brought to a focus at the plane of the observation
pinhole. Fluorescence from the focal plane passes through the pinhole and is
detected by the PMT. In contrast, ﬂuorescence from behind or in front of the
focal plane is out-of-focus at the pinhole and is blocked. Scanning the laser is
generally the rate-limiting step for obtaining an image. From [222]
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Figure B.5 shows the optical path of a conventional scanning confocal
microscope. A laser beam (blue line) passes through the ﬁrst pinhole and is
directed by a dichroic mirror towards a pair of mirrors that scan the light in
x and y. The light then passes through the objective and excites the ﬂuo-
rescent sample. The ﬂuorescent (light green) light from the sample passes
back through the objective and is descanned by the same mirrors used to scan
the sample. The light then passes through the dichroic mirror to a second
pinhole placed in the conjugate focal (hence the term confocal) plane of the
sample. Fluorescent light from the focal plane of the sample passes through
the pinhole, while light from other positions is blocked. Thus, the pinhole
selects only the light from the focal plane and the intensity of this signal is
then measured by a point detector such as a photomultiplier tube. At each
instant only one point of the sample is observed, but by scanning the beam
a 2D or 3D image can be obtained. Frequently, confocal microscopy is used
because it can isolate the ﬂuorescence from a single plane within the object
even in the presence of strong background ﬂuorescence. It is precisely this
”sectioning”-ability that enables eﬀective 3D confocal imaging.
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APPENDIX C
Protocols for Protein Puriﬁcation
A Puriﬁcation of the Human Platelet Membrane Gly-
coprotein αIIbβ3 complex
A.1 Buﬀers
Nota bene! All buﬀers should be prepared in plastic beakers.
1. Platelet washing buﬀer
pH 7.4
0.55 mM acetylsalicylic acid
150 mM NaCl
20 mM Tris HCl
1 mM EDTA
EDTA and acetylsalicylic acid are added to prevent platelet activation.
2. Lysing buﬀer
pH 7.4
50 mM Tris HCl
1 mM CaCl2
1 mM MgCl2
1 % Triton (1 g in 100 ml H20)
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3. Equilibrating buﬀer for Con A column
pH 7.4
100 mM NaCl
50 mM Tris HCl
1 mM CaCl2
1 mM MgCl2
0.1 % Triton (1 g in 1000 ml H20, about 1.6 mM)
0.02 % NaN3 (3 mM)
4. Elution buﬀer for Con A column
pH 7.4
100 mM NaCl
50 mM Tris HCl
1 mM CaCl2
1 mM MgCl2
0.1 % Triton (1 g in 1000 ml H20, about 1.6 mM)
0.02 % NaN3 (3 mM)
100 mM methyl - D mannopyranoside
5. Equilibrating buﬀer for Heparin column
pH 7.4
100 mM NaCl
50 mM Tris HCl
1 mM CaCl2
1 mM MgCl2
0.1 % Triton (1g in 1000 ml H20, about 1.6 mM)
0.02 % NaN3 (3 mM)
6. Equilibrating buﬀer for Sepharycryl S300 column
pH 7.4
150 mM NaCl
20 mM Tris HCl
1 mM CaCl2
1 mM MgCl2
0.1% Triton (1g in 1000ml H20, about 1.6 mM)
0.02 % NaN3 (3 mM) %
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7. Regeneration buﬀer for Con A/ Heparin columns
pH 7.4
20 mM Tris HCL
1 mM NaCl
8. Regeneration buﬀer for Sepharycryl S300 column
0.2 mM NaOH
A.2 Puriﬁcation
Day 1:
Removing Red Cells :
Outdated platelet concentrates (ca. 2500 ml) are used within 14 days of
venipuncture. Plastic beakers are used. The ConA-column is equilibrated with
buﬀers (buﬀers degassed overnight). After centrifugation the red cell pellet is
removed.
Centrifugation 215∗g for 20 min
Temperature 22◦C
Platelet washing:
Centrifugation 1750∗g for 30 min
Temperature 22◦C
The supernatant is removed and the pellet is weighed.
The pellet is resuspended in the "platelet washing buﬀer" and washed three
times.
Centrifugation 1050∗g for 25 min
Temperature 22◦C
Cell Lysis:
The pellet is resuspended in 60 ml of the "platelet washing buﬀer" us-
ing a Turrax disperser (20 second/time, 2 times, on ice) and one tablet of
Complete is added to provide protease inhibitors.
Centrifugation 119000∗g for 30 min
Temperature 4◦C
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Remove the supernatant and keep 1 ml for testing.
Membrane Solubilization:
The pellet is resuspended (Turrax disperser, 20 seconds/time, 2 times, on
ice) in 100 ml of the lysing buﬀer, which contains 1 % Triton. One tablet
of Complete protease inhibitors is added. The solution is then rotated for 1
hour at 4 ◦C. A new tablet is added before incubating the sample.
Centrifugation 28200∗g for 15 min
Temperature 4◦C
The pellet is removed and 1 ml of the supernatant is kept for testing.
The supernatant is now mixed with the material for the Concanavalin A-
Sepharose aﬃnity column and the material is applied to the column. Equili-
brating buﬀer for Con A is used to wash the column overnight (0.2 ml/min).
Day 2:
The S300-buﬀer is degassed. The bound glycoproteins on the Con A
column are eluted with the "eluting buﬀer for Con A".
Bed Volume 20 ml (1.6 x 10 cm)
Flow rate 0.5 ml/min 5ml
5ml/tube room temperature
A 10 % SDS page is prepared, 1 ml of the ﬂow through and the collected
elution, respectively, are kept for testing.
Heparin - Sepharose aﬃnity chromatography
The column is equilibrated with the equilibrating buﬀer for the Heparin
column. The elutate from the Con A column (70 ml) is applied to the column.
The integrin is in the ﬂow through fractions.
Bed Volume 20 ml (1.6 x 10 cm)
Flow rate 0.5 ml/min 5ml
5ml/tube room temperature
Day 3:
A 10 % SDS PAGE is prepared.
Sephacryl S300 gel ﬁltration
The column is equilibrated with the equilibrating buﬀer for the Sephacryl col-
umn. The elutate from the heparin-sepharous column (65 ml) is concentrated
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to around 10 ml (Amicon Centriprep) and applied to the column. The integrins
are eluted with the equilibrating solution.
Bed Volume 500 ml (2.6 x 100 cm)
Flow rate 1 ml/min
5ml/ tube room temperature
A 10 % SDS PAGE is prepared. The samples are divided into aliquots and
stored at -70 ◦C.
The columns can be regenerated. The Con A and Heparin columns are
washed with 1 M NaCl (2 bed volumes) followed by the appropriate column
buﬀer (5 bed volumes).
The S300 column is washed with 0.2M NaOH (2 bed volumes), followed
by the appropriate column buﬀer (3 bed volumes).
The concentration of the obtained integrin is measured using a Bradford
kit.
A.3 Enzyme-Linked Immunosorbent Assay (ELISA)
A.3.1 Buﬀers
1. S300 buﬀer
2L
pH 7.4
150 mM NaCl
20 mM Tris HCl
1 mM CaCl2
1 mM MgCl2
0.02 % NaN3
2. Diethanolamime solution
pH 9.5
0.5 mM MgCl2
100 ml H2O
10 mM Diethanolamime
3. p-Nitrophenylphosphat solution
15 mg in 15 ml Diethanolamime solution
4. EDTA
100 mM, pH 8.5
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5. S/T
400 ml, 0.16 g Tween
6. S/T/0.1 % Triton
30 ml, 30 mg Triton
7. S/T/B
30 ml, 0.9 g BSA
8. S/B
30 ml, 0.9 g BSA
9. ﬁbrinogen
plasminogen-depleted, human plasma
100 ml, 80 nM, 2.73 mg in S300
10. antibody 1
Rabbit anti-human integrin β3 polyclonal antibody
1:1000 in S/T/3% BSA
11. antibody 2
Anti-rabbit IgG (whole molecule), alkaline phosphate conjugate
1:1000 in S/T/3% BSA
A.3.2 Preparation
ELISA is performed on a 96-well plate (Nunc Immuno Plate, F96 MicroWell
Maxisorp, 439 454)
1. The wells are coated with ﬁbrinogen in buﬀer solution, 100 µl/well
overnight.
2. The coated wells are washed twice with 225 µl buﬀer solution per well.
3. Unspeciﬁc adsorption is blocked with a 3 % BSA solution in buﬀer solu-
tion, which is incubated for 2 h. The wells are not washed afterwards.
4. The integrin is added ( in S300/0.04 % Tween/0.01 % Triton solution,
100 µl/well) and incubated for 1 h.
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5. The coated wells are washed twice with 225 µl buﬀer solution + Tween
(S/T) per well.
6. Antibody 1 is applied, 1:1000 in S300/Tween/3 % BSA (S/T/B),
100 µl/well
7. The coated wells are washed four times with 225 µl buﬀer solution +
Tween (S/T) per well.
8. Antibody 2 is applied, 1:1000 in S300/Tween/3 % BSA (S/T/B),
100 µl/well
9. The coated wells are washed four times with 225 µl buﬀer solution +
Tween (S/T) per well.
10. The coated wells are washed twice with 225 µl diethanolamine solution
per well.
11. 100 µl of the nitrophenylphosphate solution is applied and incubated for
30 minutes. The solution is left in the well.
12. 100 µl of the EDTA solution is added to each well. The wells turn yellow.
Activity can then be quantiﬁed with an ELISA reader.
A.4 Fluorescent labeling of the Human Platelet Membrane Gly-
coprotein αIIbβ3 complex [1]
Nota bene! Since amine-reactive label is used, TRIS HCl or other buﬀer
containing amines should not be used.
10 mg of the integrin is dissolved in 1 ml 0.1 M NaHCO3, pH 8.3.
The amine-reactive compound (5-(and-6) carboxytetramethylrhodamine, suc-
cinimidyl ester, (5(6)-TAMRA, SE), mixed isomers) is dissolved in anhydrous
DMF (10mg/ml).
50-100 µl of the ﬂuorescent solution is added slowly (while stirring) to the
protein solution and then incubated for 1h at room temperature.
Optional: The reaction is stopped by adding 0.1 ml of freshly prepared 1.5 M
hydroxylamine, pH 8.5 and the solution is then left to incubate for 1h.
The protein and the non-bound compound are separated using a gel ﬁltration
column (Integrin: superose 6, Pharmacia, Sweden).
The eﬃciency of the labelling is checked via UV-Vis-spectroscopy.
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B Membrane Puriﬁcation from Human Platelets
B.0.1 Buﬀers
1. buﬀer 1
1L
pH 7.0
120 mM NaCl
13 mM trisodium citrate
30 mM dextrose
2. buﬀer A
2L
pH 7.4
150 mM NaCl
10 mM TRIS HCl
3. buﬀer A + protease blocker
0.1 mg/ml leupeptin
150 mM NaCl
10 mM TRIS HCl
0.1mM PMSF
10 µ/ml aprotonin
4. buﬀer A + Ca2+
2L
pH 7.4
150 mM NaCl
10 mM TRIS HCl
1 mM Ca2+
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5. Sucrose gradient
9.015 g sucrose
30 ml buﬀer A
B.1 Puriﬁcation
Platelet membranes were puriﬁed after Smyth et al. [201].
Day 1:
Removing Red Cells :
Outdated platelet concentrates (ca. 2500 ml) are used within 14 days of
venipuncture. Plastic beakers are used.
Red cells were removed by centrifugation (pellet = red blood cells)
Centrifugation 215∗g for 20 min
Temperature 22◦C
Platelets (2.5 L) were isolated from the solution and washed twice in buﬀer
1.
Centrifugation 700∗g for 20 min
Temperature 22◦C
The washed platelets were resuspended in buﬀer A and placed in the pres-
sure chamber (∼ 50 ml) of a Parr cell disruption bomb (Parr Instrument Co.,
Moline, IL, USA). The chamber was ﬁlled with nitrogen to a pressure of 8280
kPa and maintained at 22 ◦C for 30 min before the pressure was rapidly low-
ered. The contents were discharged into the same buﬀer + protease blocker.
Day 2:
The resultant suspension was centrifuged in an Ti45 Beckman rotor and re-
suspended in buﬀer A.
Centrifugation 100 000∗g for 30 min
Temperature 4◦C
Sucrose gradient
A 27 % sucrose gradient was prepared and layered over the resuspended
solution.
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Centrifugation 100 000∗g for 3h
Temperature 4◦C
The membranes were recovered from the interface of the sucrose solution,
resuspended in buﬀer A with 1mM CaCl2, and centrifuged again.
Centrifugation 100 000∗g for 1h
Temperature 4◦C
A qualitative Bradford test of functionality of the integrin was positive.
The protein concentration was not tested.
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Preparation Protocols for GUVs
A Preparation of Giant Unilamellar Vesicles without
integrin - Standard Protocol
12 µl of a 1 mg/ml lipid solution (typically EPC or DOPC) in chloroform
was spread onto glass ITO-coated slides (slides coated with a thin conductive
layer of indium titanium oxide (ITO)). Chloroform was removed by placing the
slides in a vacuum chamber for at least two hours. A growth chamber was
built using Vitrex Sigillum Wax® (see ﬁgure D.1B), ﬁlled with sucrose solution
(osmolarity ∼170 mOsM) and sealed with the wax. The growth chamber was
then connected to a signal generator and vesicles were allowed to swell for
three hours. At the beginning of the electroformation process, the voltage
was raised using a home-build ramp in intervals of 3 minutes from 20 mV, 60
mV, 0.1 V, 0.3 V, 0.5 V, 0.7 V, 0.9 V to 1.1 V (10 Hz sinusoid, RMS). For the
remainder of the three hours, the voltage remained at 1.1 V. Finally, a square
wave at 4 Hz and 1.1 V (RMS) was applied for 30 minutes to separate the
membranes of individual vesicles. The vesicles were kept at room temperature
and used within the following day.
B Preparation of Giant Unilamellar Vesicles with inte-
grin
B.1 Biobeads® Preparation
Biobeads® were washed once with methanol and then washed several times
with water. The solution was thoroughly degassed with the help of a vacuum
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pump. Cleaned biobeads® were kept at 4 °C for several weeks. To add
biobeads® to the reconstitution solution, a small portion of the biobeads®
suspension was poured onto a clean kimwipe. The biobeads® were then
rapidly transfered to the reconstitution solution to prevent inactivation via
dessication.
B.2 Initial Munich Protocol
200 µl of 10 mg/ml EPC : chlorofrom solution was transferred to a small round
glass vial, dried under a nitrogen ﬂow and then placed under vacuum for 2h.
40 µg of ﬂuorescently-labeled integrin (TAMRA) and 400 µg of non-labeled
integrin in S300/1% triton buﬀer was added to the lipids and rotated slowly
for 30 minutes. The mixture was kept in a water bath at 15 ◦C for 30 minutes,
and then incubated at 37 ◦C for 90 minutes. The solution was divided between
four 1.5 ml Eppendorf vials, each 1/3 ﬁlled with biobeads®, and incubated
for 1h. The solution was deposited in droplets of 2 µl onto clean ITO-glass
and kept in a saturated atmosphere overnight (see ﬁgure D.1A). A chamber
was built with Vitrex Sigillum Wax® (see ﬁgure D.1B), ﬁlled with sucrose
solution (osmolarity ∼170 mOsM) and sealed with the wax.
Figure D.1. A chamber is built with Vitrex Sigillum Wax®, ﬁlled with sucrose
solution (osmolarity ∼170 mOsM) and sealed with the wax.
The chamber was then connected to signal generator and vesicles were
allowed to swell for three hours. The voltage (AC sinusoid, 10Hz) was raised
using a home-build ramp in intervals of 3 minutes from 20 mV, 60 mV, 0.1
V,0.3 V, 0.5 V, 0.7 V, 0.9 V to 1.1 V. For the remainder of the 3 hours,
the voltage was kept at 1.1V. Finally, a square wave (4 Hz, 1.1V RMS) was
applied for 30 minutes. This method lead to very few, very small (diameter of
max. 5 µm) vesicles.
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B.3 Initial Paris Protocol
3800 µl CHCl3 was added to 200 µl of a 10 mg/ml EPC (in CHCl3) and the
solution was transferred to a round, glass-bottomed vial. The chloroform was
removed with a rotary evaporator and the lipid was then thoroughly dried in
vacuum for about 1h. 1 ml of H2O was added ( = 2mg/ml) and the solution
was vortexed and sonicated with a tip sonicator (90 s). The solution was then
divided into 4 aliquots of 250 µl.
Next, 13.4 µl of the integrin ( 1.5 mg/ml) and 2µl of a 5 % Triton solution
were slowly stirred overnight.
70 µl of the lipid solution and 3.6 µl of a 5% Triton solution were stirred
for 30 minutes at room temperature. The protein was then added and the
solution was stirred for another 30 minutes. To remove the detergent, 4.2
mg of biobeads® was added and the solution was stirred for 1h. Two further
rounds of biobeads were added.
The biobeads® were then removed and 72.2 µl of H2O was added.
The solution was deposited in droplets of 2 µl onto clean ITO-glass and
partially dehydrated overnight (see ﬁgureD.1A). A vesicle growth chamber was
built with Vitrex Sigillum Wax® (see ﬁgureD.1B), ﬁlled with sucrose solution
(osmolarity ∼170 mOsM) and sealed with the wax. The chamber was then
connected to a signal generator and vesicles were allowed to swell for three
hours. The voltage (10Hz sine wave, RMS) was raised using a home-build
ramp in intervals of 3 minutes from 20 mV, 60 mV, 0.1 V, 0.3 V, 0.5 V, 0.7
V, 0.9 V to 1.1 V. For the remainder of the growth period, the voltage was
kept at 1.1 V. Finally, a square wave (4Hz, 1.1 V RMS) was applied for 30
minutes although this step was not crucial. The method occasionally produced
vesicles.
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B.4 Final Paris Protocol (higher lipid-integrin-ratio)
280 µl of a 1 mg lipid : 1ml water solution containing 85 mol% EPC,
10 mol% EPA, and 5 mol% DMPE-PEG 2000 was prepared. First,
the lipid stock solutions (in chloroform) were mixed in the appropri-
ate proportions. The chloroform was then evaporated in a small vial
and the lipid was dried in a vaccum oven for two hours. Water was
added to yield a 1 mg/ml solution. The solution was then vortexed
and sonicated with a tip sonicater for 60 seconds. The aqueous lipid
solution was then mixed with 2.65 µl Triton solution 100x and stirred
for 30 minutes at room temperature. 10 µg of integrin (10% TAMRA
labeled) was added and stirred for another hour. 15 mg of biobeads®
was added and stirred overnight. The resulting solution (1.5 µl /
droplet) was deposited onto ITO slides and dried for 3-4 hours in a
water-saturated atmosphere. A chamber was built with Vitrex Sigillum
Wax® (see ﬁgure D.1), ﬁlled with sucrose solution (osmolarity ∼170
mOsM) and sealed with the wax. The chamber was then connected
to a signal generator (10 Hz sinusoid) and the vesicles were allowed
to swell overnight. The voltage was raised using a home-build ramp in
intervals of 3 minutes from 20 mV, 60 mV, 0.1 V, 0.3 V, 0.5 V, 0.7
V, 0.9 V to 1.1 V (RMS). For the remainder of the growth period the
voltage was kept at 1.1V (RMS).
On a number of occasions, this protocol gave large (> 15 µm in di-
ameter), unilamellar, round GUVs.
C Preparation of Giant Unilamellar Vesicles from pu-
riﬁed platelet membranes
Following the dehydration/hydration and electroformation protocol for integrin-
containing vesicles, GUVs were grown from the puriﬁed membrane preparation
(see appendix for preparation details). The solution obtained from membrane
puriﬁcation(1.5 µl / droplet) was deposited onto ITO slides and dried for 3-
4 hours (see ﬁgureD.1A). A chamber was built with Vitrex Sigillum Wax®
(see ﬁgure D.1B), ﬁlled with sucrose solution (osmolarity ∼170 mOsM) and
sealed with the wax. The chamber was then connected to signal generator
and vesicles were allowed to swell over night. The voltage (10Hz sine wave)
was raised using a home-build ramp in intervals of 3 minutes from 20 mV, 60
mV, 0.1 V, 0.3 V, 0.5 V, 0.7 V, 0.9 V to 1.1 V (RMS) and then left at this
level (1.1V RMS) for the rest of the growth period.
Deposits of the concentrated membrane solution did not produce vesicles.
The concentrated membrane solution was diluted with buﬀer A*. This diluted
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solution was then deposited on ITO slides and vesicles could then be obtained.
buﬀer A*
2L, pH 7.4
150 mM NaCl
10 mM TRIS
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APPENDIX E
Protocols for Adhesive Surfaces and Adhesion Tests
A Passivated Surfaces
A.1 Preparation of PEG surfaces
The PEG-passivated surfaces were prepared following procedures described by
Cuvelier et. al. [145]:
Glass cover slips (24 mm x 50 mm) were treated with a solution of 70 %
sulfuric acid and 30 % hydrogen peroxide (piranha solution) for 10 minutes,
washed with MilliQ water and stored in methanol. Before use they were dried
under nitrogen gas.
A.1.1 Silanisation
The following solution was prepared (in the following order!):
1. 55 ml methanol
2. 2.3 ml H2O
3. 473 µl glacial acetic acid
4. 1.17 ml mercaptopropyl-trimethoxy-silane
The glass cover slips were mounted on a rack, and incubated in the silaniza-
tion solution for two hours at room temperature (or overnight at 4 °C). The
cover slips were then rinsed twice with methanol, dried under nitrogen gas and
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Figure E.1. Observation chamber for RICM and ﬂuorescence microscopy
experiments
heated for 5 minutes at 120 °C in air. At this stage, the silanised surfaces
were quite stable and could be stored under vacuum for several days.
A.1.2 PEG Binding
A solution of 2 mg/ml mPEG-Mal-5000 (methoxy-poly(ethylene glycole) maleimide
average M.W. 5000) in PBS was freshly prepared. 100 µl of the solution was
put on the surface of the glass slide and spread using a piece of Paraﬁlm®.
The cover slips were incubated for 1h hour at room temperature. If the results
were unsatisfactory, the cover slips were incubated for 2h at room temperature,
or overnight at 4 °C.
After incubation the cover slips were washed with MilliQ water and dried
under nitrogen gas. Cover slips were then stored under vacuum and could be
used up to several weeks later.
A.1.3 Observation Chamber
Observation chambers were built as shown in ﬁgure E.1. Two glass cover
slips were separated by Paraﬁlm® strips (typically 6 layers) to give a chamber
with a volume of approximately 200 µl. A soldering iron was used to melt the
Paraﬁlm® strips so that they ﬁrmly adhered to to the glass.
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The chamber was ﬁlled with buﬀered glucose* solution and a few micro-
liters of vesicle solution was then injected.
*buﬀered glucose
pH 7.4
180 mM glucose
10 mM TRIS
1 mM Mg2+
1 mM Mn2+
The chamber was used for RICM, epiﬂuorescence, and phase contrast
microscopy.
A.2 Casein Surfaces
Glass cover slips (24 mm x 50 mm) were treated with a solution of 70 %
sulfuric acid and 30 % hydrogen peroxide (piranha solution) for 10 minutes,
washed with MilliQ water and stored in ethanol. Before use, cover slips were
dried under a stream of nitrogen gas. 100 µl of a 1 % w/v Poly-L-Lysin
: water solution was spread across the glass surface by placing a piece of
Paraﬁlm®on top of the droplet. The sample was incubated for 10 minutes at
room temperature before excess solution was removed with a KimWipe®. 100
µl of a 1mg/ml casein in 10 mM HEPES (pH 7.4) buﬀer was ﬁltered (0.2 µm
Millipore ﬁlter), spread across the glass surface with a piece of Paraﬁlm®,
and incubated for 1h. The sample was then rinsed with a buﬀered glucose
solution (as above). A chamber was assembled as described in Section A.1.3
(see ﬁgure E.1). The chamber was ﬁlled with the buﬀer glucose solution and
10 µl of the vesicle solution was slowly injected through a glass capillary. The
vesicles could then be studied by RICM, epiﬂuorescence and phase contrast
microscopy.
A.3 Fibrinogen Surfaces
RGD-covered ﬁbrinogen surfaces were prepared using the following protocol.
Glass cover slips (24 mm x 50 mm) were treated with a solution of 70 %
sulfuric acid and 30 % hydrogen peroxide (piranha solution) for 10 minutes,
washed with MilliQ water and stored in ethanol. Coverslips were dried under
nitrogen gas and 100 µl of a 1 % w/v Poly-L-Lysin: water solution was
spread across the surface using a piece of Paraﬁlm®. (see ﬁgure E.2)
The sample was incubated for 10 minutes at room temperature before ex-
cess solution was removed with a KimWipe®. 100 µl of a 1 mg/ml ﬁbrinogen
in 10 mM HEPES buﬀer was then spread onto the glass surface with a piece of
Paraﬁlm®, and incubated for 1h. Finally, the sample was rinsed with buﬀered
glucose solution (as above).
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Figure E.2. A droplet is spread across a glass substrate using a piece of
Paraﬁlm® .
A chamber was assembled as described in Section A.1.3 (see ﬁgure E.1).
The chamber was ﬁlled with the buﬀer glucose solution and 10 µl of the
vesicle solution was slowly injected using a glass capillary. The vesicles were
then studied by RICM, epiﬂuorescence and phase contrast microscopy.
B Adhesion Assay for Integrin-Containing GUVs
Fibrinogen surfaces were prepared as described above.
20 µl of the integrin carrying vesicle solution was injected into the observa-
tion chamber. The vesicles were studied via RICM, epiﬂuorescence and phase
contrast microscopy. First adhesion events occurred within 5 minutes and
adhesion took up to 60 minutes to complete.
C Adhesion Assay in the Presence of Soluble RGD
Fibrinogen surfaces were prepared as described above.
Meanwhile, 100 µl of the integrin containing GUVs were incubated with 100
µl of a 1 mg/ml RGD solution in 10 mM HEPES, pH 7.4. Vesicles were
incubated for 60 minutes. 20 µl of the vesicle-RGD solution was injected into
the observation chamber. The vesicles were observed for 30 to 60 minutes
using RICM, epiﬂuorescence and phase contrast microscopy.
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A Fluorescence Microscopy of QDs
Functionalized quantum dots were kindly provided by the group of V. Marchi-
Artzner, University of Rennes.
As shown in Figure F.1, the three types of QDs were functionalized with RGD,
PEG with a negatively charged end-group, and PEG with a zwitterionic end-
group.
Figure F.1. The functional group on the QDs : A) negatively charged PEG,
B) RGD, and C) the zwitterionic group. Private communication A. Dif / V.
Marchi-Artzner.
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A.1 Fluorescence Microscopy of Platelets
2 µl of a 2.0-4.2 x 109 platelets/ml solution was diluted into 100 µl buﬀer
adjusted to match the platelet's osmolarity and pH.
platelet buﬀer
314 mOsM, pH 7.4
150 mM NaCl
20 mM TRIS
1 mM Mn2+
1 mM Mg2+
This solution was then incubated with 2 µl of QDs solution (0.8 µM). A
50 % RGD : 50 % negatively charged QD solution was used to study speciﬁc
binding while a 100 % negatively charged QD solution was prepared for com-
parison.
The platelets were observed via ﬂuorescence microscopy using a green
excitation ﬁlter (λmax.exc. = 525 nm, λmax.em. = 565 nm).
B Spectroﬂuorimetry
B.1 Protocol for Platelets
Buﬀer was prepared to match the platelet's osmolarity and pH.
platelet buﬀer
314 mOsM, pH 7.4
150 mM NaCl
20 mM TRIS
1 mM Mn2+
1 mM Mg2+
50 µl of a 2.0-4.2 x 109 platlets/ml solution was diluted in 1 ml buﬀer.
This solution was then incubated for 2-5 minutes with 2 µl QDs (0.8 µM).
The quantum dot solution consisted of either a 50% RGD : 50 % negatively
charged endgroup solution or a 100 % negatively charged PEG solution.
A QD blank sample was prepared by mixing 10 µl of the QDs (50 % RGD: 50
% negatively charged endgroup, 0.8 µM) with 500 µl buﬀer.
To remove unbound quantum dots, the samples were centrifuged for 15
minutes at 14 000 rpm (140 000 g), the supernatant removed and the pellet
resuspended in 100µl of buﬀer. This process was then repeated. Finally, the
ﬂuorescence emission spectrum was measured for λexc = 360 nm.
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B.2 Protocol for Proteoliposomes
Several samples were prepared (all 200 nM):
1. A blank sample containing only QDs (50 % functionalized with RGD :
50 % zwitterionic endgroup) in H2O
2. Proteoliposomes + RGD QDs (50 % RGD-functionalized : 50 % zwit-
terionic endgroup)
3. Proteoliposomes + PEG QDs (100 % zwitterionic)
4. Small vesicles without protein + RGD QDs (50 % RGD-functionalized :
50 % zwitterionic endgroup)
5. Small vesicles without protein + PEG QDs (100 % zwitterionic)
While the liposomes/proteoliposomes were incubating (45-60 minutes),
solutions were prepared for a sucrose gradientto allow removal of the unbound
QDs via ultra-centrifugation.
First, the sample was mixed with a 60 % sucrose solution to give a total
volume of 1 ml. 6 ml of 40 % sucrose solution was carefully layered over
this solution followed by 3,5 ml of a 5 % sucrose solution. The sample was
then centrifuged for 15h at 4 °C (Beckmann L80, rotor SW41, 38 000 rpm).
After centrifugation, the liposomes/proteoliposomes formed a white band at
the interface of the 5 % and the 40 % solutions. The ﬂuorescence emission
spectrum for this fraction was measured for λex = 360 nm.
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